Trending Health: Recent Episodes
Vynamic
We approach the healthcare industry as five interwoven sectors, providing access to our unique perspective during a time of continuous change. The Trending Health podcast shares our perspective on healthcare topics that are real, relevant and worth exploring.
In this episode of Trending Health, we explore how the Inflation Reduction Act (IRA) is reshaping strategy across the life sciences industry.
Mindy McGrath is joined by Inizio Ignite colleagues, Scott Briggs and Ethan Johnson, to discuss how manufacturers are responding to Medicare price negotiation, Part D redesign, and increasing pressures on pricing and access.
The conversation highlights what has surprised leaders so far, how payer dynamics are evolving, and how companies are rethinking portfolio and lifecycle decisions in a more constrained market.
As future negotiation rounds approach, the episode offers a clear view into where organizations are focusing—and what they should be preparing for next.
Panel –Mindy McGrath, Scott Briggs, Ethan Johnson
Recording & Editing – Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
The brain health economy is emerging as a critical focus across healthcare and policy both for treating serious neurological and mental health diseases and for increasing brain capital for society. In this episode, Inizio Ignite’s Varun Renjen sits down with George Vradenburg, Chairman of the Davos Alzheimer\’s Collaborative and Harris Eyre, Executive Director of the Global Brain Economy Initiative to explore why it’s evolving so rapidly and what it means for life sciences companies.
From how the brain health economy is evolving at the global level with growing importance from the World Economic Forum, to CNS trends, and to the impact of initiatives like the Davos Alzheimer’s Collaborative and the Davos Brain House, our guests unpack key developments shaping this space. We also examine the role of public-private partnerships and how life sciences companies can better engage.
Finally, we look ahead: what does an ideal brain health ecosystem look like—and how can we build it?
Panel – Varun Renjen, George Vradenburg, Harris Eyre
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
In this news episode of Trending Health, Mindy McGrath and Everly Petruzzelli break down the evolving regulatory landscape at the FDA and what it means for life sciences leaders. This episode covers:
- Staff changes to the FDA and approval pathway pilot programs
- Rising scrutiny on trial design — especially in rare disease
- The FDA’s firmer stance on compounded GLP-1s as shortages ease
From regulatory unpredictability to access, pricing, and portfolio risk, we explore how life sciences leaders should adapt in a more dynamic regulatory environment.
For additional discussion and to see the sources referenced in this episode, check out TrendingHealth.com.
Panel – Mindy McGrath & Everly Petruzzelli
Recording & Editing – Mike Liberto & Rachel Skonecki
Source Links:
- J&J\’s Tecvayli-Darzalex multiple myeloma combo takes home FDA\’s 3rd national priority nod
- FDA slammed over rare disease drug decisions
- Disc\’s rare disease drug hit by FDA rejection
- FDA rejects Biohaven approval request for troriluzole, triggering cost cutting
- FDA reverses course, agrees to review Moderna’s flu vaccine
- FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters
As 2026 begins, pharma leaders are placing sharper bets earlier while navigating increasing pressure across pricing, access, and evidence. In this episode, Matt Riordan, Group President, Putnam, shares a candid, executive-level view of what leaders are prioritizing this year, where confidence is high, and where blind spots may limit impact. Drawing on real-world leadership conversations, the discussion explores how access and evidence expectations are shifting upstream and what it takes to pressure-test assumptions, align strategy earlier, and lead with greater clarity in 2026.
Panel – Mindy McGrath, Matt Riordan
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
As we kick off 2026, Mindy sits down with Inizio Ignite Global President, Remco op den Kelder, to discuss the industry forces shaping the year ahead for life sciences companies.
Panel – Mindy McGrath, Remco op den Kelder
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
The rules of product launch are changing fast. Policy reform, payer pressure, AI adoption, and shifting system dynamics are redefining how life sciences companies prepare for market.
In this episode, Summer Atkinson sits down with Vynamic Health Industry Advisor Mindy McGrath to unpack the biggest forces impacting launches today—from accelerating decision-making to growing health system control—and how leading organizations are building agility, transparency, and value-driven strategies to stay ahead.
To learn more about how we can help your team navigate these changing landscapes, please reach out to brian.stamm@vynamic.com or ashley.stanley@vynamic.com
Podcast Tags: life sciences, product launch, market access, payer strategy, AI
Panel – Summer Atkinson, Mindy McGrath
Research & Production – Summer Atkinson, Adrea Cope
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
In recent years, there has been renewed interest in psychedelic treatment for a variety of medical conditions ranging from depression to trauma, and even dementia, which has left countless people searching for real recovery. This exciting research is challenging the limits of what’s possible. Psychedelic compounds, once misunderstood or dismissed, are now being studied for their ability to promote neuroplasticity, neurogenesis, and reduction in inflammation.
In this episode of Trending Health, we’re joined by three individuals who are passionate about the growing clinical utility of psychedelic treatments. However, with these treatments, it is critical to think about how to put the patient in the middle and engaged with their treatment to help ensure optimal outcomes:
- Varun Renjen, a partner at Inizio Putnam and a physician who has been supporting biopharma clients as a strategy consultant for the past 15 years; especially in neurological diseases;
- Steve Levine, Chief Patient Officer at Compass Pathways and board-certified psychiatrist who has spent his career working to improve people’s lives through creating access to innovation in mental health;
- Daniel Carcillo, a former NHL hockey player who developed Traumatic Brain Injury (TBI) and depression from the sport who has been successfully treated with psychedelic therapy as a patient and is an advocate for access to psychedelic treatment for brain injury
Tags: healthcare, psychedelics, psilocybin, mushrooms, concussions, traumatic brain injuries, depression, mental health, medical affairs
Panel – Varun Renjen, Steve Levine, Daniel Carcillo
Recording & Editing – Mike Liberto
For additional discussion, please contact us at TrendingHealth.com.
The traditional path to patients is being rewritten. As affordability pressures rise and patient expectations shift, life sciences companies are rethinking the middle — moving beyond payers, providers, and pharmacies to create direct, digital pathways that meet patients where they are.
In this episode, host Adrea Cope is joined by Colleen Ferlotti and Rupa Mehta to unpack the rapid rise of Direct-to-Patient (DTP) models: what’s fueling the shift, how leaders are navigating regulatory and operational complexity, and why success depends on designing with both discipline and empathy.
To learn more about how we can help your team navigate these changing landscapes, please reach out to Mike.Zapiec@vynamic.com
Podcast Tags: healthcare, life sciences, life sciences marketing, direct to patient, patient centricity, digital health
Source Links:
Triangle Insights Group (August 2025). The Direct-to-Patient Channel in Pharma: A Practical Guide to Protect GTN, Expand Access, and Improve Patient Experience.
Panel – Adrea Cope, Colleen Ferlotti, Rupa Mehta
Research & Production – Adrea Cope, Colleen Ferlotti, Rupa Mehta, Peter Svalbe, Mike Zapiec
Recording & Editing – Mike Liberto
For additional discussion, please contact us at TrendingHealth.com.
As Gen Z steps into the healthcare workforce, they’re bringing new expectations for authenticity, technology, and purpose-driven brands. The old pharma playbook? Invisible to this generation.
In this episode of Trending Health, host Adrea Cope sits down with Carolyn Frantz and Mindy McGrath to explore how life sciences marketers can evolve to engage the next generation of HCPs and patients — from short-form content and streaming-first strategies to redefining the pharma rep of the future.
To learn more about how we can help your team navigate these changing landscapes, please reach out to Carolyn.Frantz@vynamic.com or Mike.Zapiec@vynamic.com
Podcast Tags: healthcare, life sciences, life sciences marketing, Gen Z, digital health, brand authenticity
Source Links:
- Gen Z more likely to report mental health concerns
- Generation X Faces Higher Cancer Rates Than Boomers: Study
Panel – Adrea Cope, Carolyn Frantz, Mindy McGrath
Research & Production – Adrea Cope, Carolyn Frantz, Hannah Yee, Mike Zapiec
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
With external shifts in regulatory uncertainty tied to the IRA, payer pressures, shifting Federal and state policies, and broader scrutiny around pricing, Life Science companies are transforming their operations to deliver better value, grow, and create meaningful impact in the future. In this last episode of the Strategic Transformation series, Mindy McGrath is joined by Karen Baldry and Andrew Sgarlato to discuss what’s driving strategic transformations, how life science companies are tackling this and key considerations for leaders embarking on this journey.
To learn more about how we can help your team navigate these strategic decisions, reach out to Karen.Baldry@vynamic.com and Andrew.Sgarlato@vynamic.com.
Podcast Tags: healthcare, life sciences, healthcare strategy, health innovation, strategic transformation
Panel – Mindy McGrath, Karen Baldry, Andrew Sgarlato
Research & Production – Mindy McGrath, Karen Baldry, Andrew Sgarlato
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
Between pharmacy closures, drug shortages, technological innovations, and workforce shortages, pharmacies are at a pivot point and must evolve to keep up with this changing environment. In this episode of the Strategic Transformation series, Mindy McGrath, Saurabh Raman, and Ryan Hummel explore how the Pharmacy Channel is reimagining the pharmacist’s role from prescription dispensers to trusted, longitudinal care partners.
To learn more about how we can help your team navigate these strategic decisions, reach out to Saurabh.Raman@vynamic.com and Ryan.Hummel@vynamic.com.
Podcast Tags: healthcare, pharmacy, pharmacy channel, healthcare strategy, health innovation, strategic transformation
Source Links:
- 2024-2025 Pharmacy Trends Include Improved Drug Shortages, More Pharmacy Closures
- Walgreens agrees to be acquired by private equity firm for almost $10 billion
- Combating the Post-Pandemic Pharmacy Workforce Shortage
- Honesty/Ethics in Professions
- CVS reaps benefits of improved pharmacy experience
- Why consumer experience is clinically important in health care
- Walgreens’ Move to Go Private: 4 Key Takeaways
- CVS is expanding its MinuteClinics into primary care. Here\’s why
- Where Are Amazon, CVS and Walgreens Headed in Health Care?
Panel – Mindy McGrath, Saurabh Raman, Ryan Hummel
Research & Production – Saurabh Raman, Ryan Hummel, Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
In a world of financial pressures, workforce challenges, and increased focus on the patient experience, health systems are continuing to assess their operations to improve efficiencies and grow through strategic transformation. In this episode of the Strategic Transformation series, Mindy McGrath, Saurabh Raman, and Ryan Hummel discuss how health systems can best optimize their operational systems through standardization and centralization to address some of these challenges and improve their patient and employee experience.
To learn more about how we can help your team navigate these strategic decisions, reach out to Saurabh.Raman@vynamic.com and Ryan.Hummel@vynamic.com.
Podcast Tags: healthcare, health systems, healthcare strategy, health innovation, strategic transformation
Source Links:
- 2025 Outlook: Hospital finances show signs of stability, but rising costs will be a major headwind
- Costs of Caring | AHA
- Emergency Department Utilization (EDU) – NCQA
- Patients as Consumers: New Research Report Shows A New Era of Expectations in Healthcare
- To Improve Health Care, Focus on Fixing Systems — Not People
Panel – Mindy McGrath, Saurabh Raman, Ryan Hummel
Research & Production – Saurabh Raman, Ryan Hummel, Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
In this Trending Health series, Vynamic team members will highlight how different sectors of the health industry are evolving to meet the demands of today’s ever-changing healthcare landscape through value creation and strategic transformations.
In this episode, Mindy McGrath, Saurabh Raman, and Ryan Hummel dive into how payers are shifting from short-term cost cutting to long-term strategic transformation as a result of rising costs, policy upheaval, and evolving consumer demands.
To learn more about how we can help your team navigate these strategic decisions, reach out to Saurabh.Raman@vynamic.com and Ryan.Hummel@vynamic.com.
Podcast Tags: healthcare, health plan, healthcare strategy, health innovation, strategic transformation
Source Links:
- Medical cost trend: Behind the numbers 2025
- UnitedHealth reports highest medical costs since COVID-19 pandemic’s start
- New Evernorth program to cap out-of-pocket costs for Wegovy, Zepbound at $200
- Spending growth on GLP-1s outpaces specialty drugs: Evernorth study
- Elevance Health Reports First Quarter 2024 Results
Panel – Mindy McGrath, Saurabh Raman, Ryan Hummel
Research & Production – Julia Morrison, Saurabh Raman, Ryan Hummel, Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
The complexity of today’s product launch environment demands a smarter, more optimized approach when it comes to planning—artificial intelligence (AI) is a potential tool to help teams keep up with the demanding pace. In the final episode of the Product Launch Series, Everly is joined by Ashley Stanley & Matt O\’Dell to explore how GenAI is already being leveraged across the launch lifecycle — from content creation to competitive intelligence — and how teams can build AI fluency now to stay ahead of tomorrow’s launch challenges.
To learn more about how we can help your team integrate or optimize AI tools into your next product launch, reach out to Ashley.Stanley@vynamic.com and Matt.ODell@vynamic.com.
Podcast Tags: healthcare, life sciences, product launch, product launch trends, life sciences trends, artificial intelligence, generative artificial intelligence, AI, GenAI
Sources: NYU AI Architect Says Mastering GenAI Means Changing Our Behavior
Panel –Everly Petruzzelli, Ashley Stanley, Matt O\’Dell
Research & Production – Zara Ahmad, Adrea Cope, Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
In this special episode of Trending Health, Mindy McGrath and Karen Baldry explore how recent changes across the U.S. federal health agencies and policies from the new administration are impacting the life sciences and biotech industry compounding with other pressures like the IRA, tariffs, and budget constraints. From launch delays at the FDA to supply chain strain and evolving patient access challenges, Mindy and Karen provide strategic considerations for commercial leaders as they navigate these shifts and uncertainties.
To learn more about how we can help your team with scenario planning and navigating these strategic decisions, reach out to . Check out our recent insights for more information: U.S. Federal Health Agency Layoffs Pose Strategic Risk and Disruption to Life Sciences & The Case for Strategic Transformation: An Executive Conversation with Vynamic’s Leaders
Podcast Tags: healthcare, life sciences, public health, life sciences trends, healthcare strategy, health innovation
Panel – Mindy McGrath, Karen Baldry
Research & Production – Mindy McGrath, Karen Baldry, Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
Healthcare providers (HCPs) are busier and more overwhelmed than ever before, meaning the customer experience can no longer be an afterthought—it must be a strategic priority. In this Trending Health episode, Everly is joined by Raina Dhir & Colleen Lawlor to tackle a challenge every launch team faces—how to break through the noise and truly connect with HCPs at launch. Raina, Colleen, and Everly explore strategies for creating personalized, high-impact HCP experiences to truly enable leaders to differentiate their launches.
To learn more about how we can help your team, reach out to colleen.lawlor@vynamic.com and raina.dhir@vynamic.com. Check out our recent Omnichannel Insight on our website for more information: From strategy to execution: Delivering an omnichannel transformation – Vynamic LLC
Podcast Tags: healthcare, life sciences, product launch, product launch trends, life sciences trends, launch excellence, customer engagement, customer experience
Panel –Everly Petruzzelli, Colleen Lawlor, Raina Dhir
Research & Production – Julia Morrison, Adrea Cope, Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
In today’s fast-paced environment of product launch, planning and preparation aren’t just important—they are essential to launch success. In our second episode of the Trending Health Product Launch Series, Everly is joined by two more Vynamic Launch Leaders, Christina and Swathi, as they explore critical launch readiness tools and key considerations to ensure launch teams, processes, and crucial systems are well prepared, tested, and ready for launch.
To learn more about how we can help your team to become launch ready or to conduct a mock launch, please contact christina.nikolos@vynamic.com and swathi.ramakrishnan@vynamic.com
Podcast Tags: healthcare, life sciences, product launch, product launch trends, life sciences trends, launch excellence, launch readiness, mock launch, launch navigation
Panel –Everly Petruzzelli, Christina Nikolos, Swathi Ramakrishnan
Research & Production – Zara Ahmad, Adrea Cope, Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
In this Trending Health Series, Vynamic Product Launch leaders will share their experience partnering with teams across the launch journey to provide tips and tricks for leaders to consider adopting in their next launch. For this episode, Everly, Alex, and Felice dive into how companies can establish a strong foundation for their launch by embedding launch excellence into the culture and establishing flexible frameworks to enable teams to be set up for long-term success.
To learn more about how we help organizations build or maintain a culture of launch excellence, reach out to . Please check out our other Launch Excellence Insights on the Vynamic website: Embedding Launch Excellence as a Cultural Mindset & Rethinking Launch Planning: Investing Early for Launch Success – Vynamic LLC
Podcast Tags: healthcare, life sciences, product launch, product launch trends, life sciences trends, launch excellence
Panel – Everly Petruzzelli, Alex Snopko, Felice Walter
Research & Production – Julia Morrison, Adrea Cope, Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
Can AI make supply chains smarter and more human?
In the latest episode of our European Healthcare Innovation Roadshow, Ollie May, Dan Ahern, and Andrés Vadillo from Roche explore how AI is reshaping supply chain planning—from everyday productivity boosts to balancing resilience, cost, and culture. Andrés is sharing his own personal views, which might not necessarily reflect Roche\’s position.
Podcast Tags: AI, Healthcare Innovation, Digital Health
Panel – Ollie May, Dan Ahern, Andres Vadillo
Research & Production – Dan Ahern, Andres Vadillo
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please leave a comment or contact us at TrendingHealth.com.
France is making waves in AI-driven healthcare—scaling fast, innovating boldly, and balancing Silicon Valley agility with EU oversight. But is this the winning formula? In the latest episode in our European Healthcare Innovation Roadshow series, Ollie May, Jack Young, and Nathan Carroll break it all down.
Podcast Tags: AI, Healthcare Innovation, Digital Health
Source Links:
- Artificial intelligence in drug development | Nature Medicine
- Using Artificial Intelligence to Fight Dengue | UNICEF USA
- France Artificial Intelligence (AI) in Healthcare Market Analysis
- France leads Europe in AI innovation with 751 start-ups
- Healthcare innovation 2030.pdf
- HealthTech: French companies tap into data and AI to become world leaders in medical innovation – Bpifrance.com
- Ethics are at the heart of France\’s digital health strategy | MobiHealthNews
- The French Health Data Hub and the German Medical Informatics Initiatives: Two National Projects to Promote Data Sharing in Healthcare
- HealthTech: French companies tap into data and AI to become world leaders in medical innovation – Bpifrance.com
- AP-HP has selected Aiforia as a partner for AI-assisted pathology image analysis
- AP-HP partners with Gleamer to innovate in the detection of thoracic radiological anomalies
- Federated learning in healthcare: the future of collaborative clinical and biomedical research
- Owkin unveils new insights into the opportunities and challenges for digital pathology and AI solutions in healthcare – Owkin
- Owkin launches PortrAIt, in collaboration with Gustave Roussy
- New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology | npj Precision Oncology
- Owkin launches PortrAIt – a €33 million project to make France a global leader in using AI to diagnose and treat diseases – Owkin
- Owkin and Cerba Path collaborate to use AI to improve breast and colorectal cancer diagnosis
- Perceptions of artificial intelligence in healthcare: findings from a qualitative survey study among actors in France
- Perceptions of artificial intelligence in healthcare: findings from a qualitative survey study among actors in France
- Partner Spotlight: Owkin and Sanofi embrace the “golden era” of precision medicine with AI
Panel – Ollie May, Jack Young, Nathan Carroll
Research & Production – Nathan Carroll
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please leave a comment or contact us at TrendingHealth.com.
How can we drive medical innovation while keeping healthcare costs in check? In the second episode of our European Healthcare Innovation Roadshow series, Ollie and Jack are joined by special guest Rosie Beacon from Reform UK to tackle this paradox. From government-backed initiatives to real-world success stories, this episode dives into the UK’s leadership in digital and AI —and what the world can learn from it.
Podcast Tags: digital health, AI, innovation
Source Links:
- OECD Data Explorer: Government budget allocations for R&D
- UK Life Sciences Vision
- NHS Long Term Plan: Research and innovation to drive future outcomes improvement
- UK invests £82.6 Million to support AI in cancer care and drug discovery
- Top Digital Health Trends to Watch in 2025
- NHS England commissions impact evaluation of virtual wards
- Digital transformation in the future of UK healthcare | RSM UK
Panel – Ollie May, Rosie Beacon, Jack Young
Research & Production – Nathan Carroll
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
In this episode, Ollie, Jack, and Nathan discuss the rise of Barcelona as a hotbed for Digital Health Innovation. They discuss digital health trends, how Barcelona has achieved such success, and what lessons the rest of the world can learn.
Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, digital health, digital, artificial intelligence, AI, telemedicine, virtual care, electronic patient records
Source Links:
- https://www.4yfn.com/news/barcelona-top-10-in-europe-and-the-middle-east-in-healthtech-investment
- https://ajuntament.barcelona.cat/digital/en/actualidad/noticias/barcelona-ranks-5th-among-european-cities-in-investment-in-digital-health-1096812
- https://gkc.himss.org/news/himss-defines-digital-health-global-healthcare-industry
- https://vynamic.com/insights/creating-a-digital-therapeutics-launch-playbook/
- https://catalonia.com/key-industries-technologies/technologies/digital-health-in-catalonia
- https://barcelonahealthhub.com/en/news/pharmaceutical-company-gebro-pharma-and-barcelona-health-hub-to-collaborate-to-promote-innovation-in-the-field-of-digital-health/
- https://www.techbarcelona.com/en/angelini-pharma-se-une-a-tech-barcelona-para-impulsar-el-ecosistema-de-salud-digital/
- https://barcelonahealthhub.com/en/news/4yfn-interview-with-iomed/
- https://healthtechforward.com
- https://echalliance.com/events-health-connector/flagship-events/the-digital-health-wellness-summit-2025/
- https://exteriors.gencat.cat/en/actualitat/not_240506_digital_health
- https://apiumhub.com/tech-blog-barcelona/digital-health/
- https://www.sjdhospitalbarcelona.org/en/news/sjd-barcelona-childrens-hospital-microsoft-are-collaborating-creation-ai-laboratory-development-digital-health-projects
- https://www.better.care/news/with-promoting-the-open-data-digital-health-platform-in-spain-better-joins-barcelona-health-hub/
- https://catalonia.com/w/cristian-pascual-barcelona-health-hub-barcelona-has-all-the-ingredients-to-become-one-of-the-world-s-digital-health-capitals-
- https://www.irsjd.org/en/news-and-events/news/811/retaining-talent-and-fostering-public-private-partnerships-some-of-the-challenges-that-is-facing-the-healthtech-sector
Panel – Ollie May, Jack Young, Nathan Carroll
Research & Production – Nathan Carroll
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, leave a comment or contact us at TrendingHealth.com.
For the final installment in Vynamic’s 2025 health industry outlook series, Jen is joined by Vynamic’s Head of Life Sciences, Karen Baldry, and Head of Life Sciences Europe, Gemma Pfister, to focus on the Life Sciences industry – the trends most impacting the pharmaceutical and biotech sectors.
To learn more about Vynamic’s overall 2025 Health Industry Outlook, visit: https://vynamic.com/insights/navigating-turbulence-and-transformation-2025-health-industry-outlook/
Podcast Tags: healthcare, healthcare news, life sciences, pharmaceutical, biotech, Inflation Reduction Act, product launch, direct-to-consumer, pharmacy, integrated delivery networks
Panel – Karen Baldry, Gemma Pfister, Jen Burke
Research & Production – Jen Burke, Mindy McGrath
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
For the second installment in Vynamic’s 2025 health industry outlook series, Jen is joined by Vynamic’s Head of Health Services, Ryan Hummel, and Director, Vish Kaushik, to focus on the Health Services industry – the trends most impacting providers, health plans, and pharmacy.
To learn more about Vynamic’s 2025 Health Industry Outlook, visit: https://vynamic.com/insights/navigating-turbulence-and-transformation-2025-health-industry-outlook/
Podcast Tags: healthcare, healthcare news, health services, providers, pharmacy, PBMs, hybrid care, virtual care, value-based care, Inflation Reduction Act, AI, digital tools, next-generation medicine, drug shortages, supply chain
Panel – Jen Burke, Ryan Hummel, Vish Kaushik
Research & Production – Jen Burke, Mindy McGrath
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
As 2025 begins, the health industry is charging forward into a transformative era. Faced with unprecedented challenges and opportunities, leaders are rethinking how health care is delivered, financed, and optimized. On this episode, Jen & Mindy dive into the pressing trends, bold outlooks, and actionable strategies leaders need to know to stay ahead in 2025.
Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, Inflation Reduction Act, AI, digital tools, product launch, next-generation medicine, drug shortages, supply chain, CXT
Panel – Jen Burke, Mindy McGrath
Research & Production – Jen Burke, Mindy McGrath
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
When it comes to deploying AI technologies, there are both technical and ethical considerations – in healthcare, given the critical and sensitive data and decisions at play, these can be magnified nearly exponentially. Jen is joined by Vynamic’s AI Mobilization Lead, Todd Quartiere, and Director, Vish Kaushik to discuss core principles and applications of responsible AI for health services organizations.
To learn more about applications of responsible AI in your health services organization, check out the AI At Vynamic page for more information.
Podcast Tags: healthcare, health services, responsible AI, artificial intelligence, innovation, responsible use, tech transformation, digital transformation
Panel – Todd Quartiere, Vish Kaushik, Jen Burke
Research & Production – Jen Burke
Recording & Editing – Mike Liberto
For additional discussion, please contact us at TrendingHealth.com.
On November 6th, Donald Trump was announced as the 47th President of the United States, returning to the White House for his second term. In this episode, Jen, Mindy, and Ryan discuss the potential changes to the healthcare industry that Republicans could look to enact over the next four years, including limiting reproductive rights and abortion access, making changes to the Affordable Care Act, and cutting funding to Medicaid.
Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, reproductive rights, abortion, Affordable Care Act, Inflation Reduction Act, health insurance, Medicare, Medicaid, pharmaceuticals
Source Links:
- Voters in Seven States Approve Constitutional Amendments to Protect Abortion Rights
- With a Trump Presidency, Grave Threats to Reproductive Freedoms Expected
- 10 Reasons a Second Trump Presidency Will Decimate Sexual and Reproductive Health
- What Trump’s 2024 Victory Means for the Affordable Care Act
- Under the Biden-Harris Administration, Over 20 Million Selected Affordable Health Coverage in ACA Marketplace Since Start of Open Enrollment Period, a Record High
- Millions at risk of losing health insurance after Trump\’s victory
- Fact check: Vance’s promise to cover people with preexisting conditions
- How a Donald Trump presidency would change health care, from Medicaid to chronic disease
Panel –Jen Burke, Mindy McGrath, Ryan Hummel
Research & Production – Adrea Cope, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Last month, Life Sciences marketing, commercial and medical leaders from across the country gathered at Reuter’s Pharma Customer Engagement to address current challenges and share industry best practices. In this episode, Jen is joined by Vynamic’s Customer Experience Transformation Lead, Mike Zapiec, and Head of Life Sciences, Karen Baldry to share what they learned about effectively engaging customers.
For more information about Vynamic’s work in Customer Experience Transformation, visit: https://vynamic.com/what-we-do/services/customer-experience-transformation-cxt/
Podcast Tags: healthcare, life sciences, customer experience, omnichannel
Panel – Mike Zapiec, Karen Baldry, Jen Burke
Research & Production – Mike Zapiec, Karen Baldry, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
With the first round of CMS price negotiations behind us, and the next list of targets to be released in February 2026, it’s clear that theorized implications from the Inflation Reduction Act are becoming realities for the life sciences industry. In this episode, Jen and Mindy are joined by Putnam Associates Partner, Scott Briggs, to explore how companies can navigate the new pricing pressures and negotiation frameworks while continuing to innovate and ensure patient access to critical therapies.
For more information about Putnam’s work in Value, Pricing and Access, visit their website: https://www.putassoc.com/our-expertise/value-pricing-access/
For more information about Vynamic’s work in Market Access, visit: https://vynamic.com/what-we-do/health-industry/life-sciences/market-access/
Podcast Tags: healthcare, life sciences, product launch, market access, drug pricing, life sciences trends
Panel – Scott Briggs, Mindy McGrath, Jen Burke
Research & Production – Scott Briggs, Mindy McGrath, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
With increasing pressure to bring products to market faster than ever, Life Sciences companies need to balance supply chain speed with global complexities, regulatory hurdles, and digital integration to maintain competitiveness. In this episode, Jen is joined by Vynamic’s Dan Ahern and Roche Product Strategy Leader within Global Supply Chain, Devon Blackburn, to discuss how pharmaceutical companies are embracing change to drive launch success.
Disclaimer: Devon is sharing his own opinions, which might not necessarily reflect the perspective of Roche.
Podcast Tags: healthcare, life sciences, product launch, supply chain, life sciences trends
Panel – Devon Blackburn, Dan Ahern, Jen Burke
Research & Production – Devon Blackburn, Dan Ahern, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Organizational AI adoption has dramatically increased over the years largely due to generative AI, leaving organizations to navigate challenges while rapidly scaling and adopting new technologies. In this episode, Jen is joined by Vynamic’s Chris Wuenschel & Frank Longo, as well as AI Mobilization Offering Lead, Todd Quartiere, to discuss their experiences with different factors that can make or break AI transformation programs.
To learn more about implementing AI within your organization, check out the AI At Vynamic page on Vynamic’s website for more information.
Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, ChatGPT, tech transformation, digital transformation, life sciences
Source Links:
- The state of AI in early 2024: Gen AI adoption spikes and starts to generate value
Panel – Jen Burke, Todd Quartiere, Chris Wuenschel, Frank Longo
Research & Production – Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In today’s competitive and dynamic pharmaceutical landscape, mastering the art of brand planning and management is crucial to success. In this episode, Jen and Mindy are joined by Vynamic’s Brand Strategy Offering Lead, Liza Flaherty, to discuss common challenges, best practices, and latest trends impacting the process of creating an effective brand plan.
For our listeners, if you want to learn more about Vynamic’s Brand Strategy offering and brand planning capabilities, please email Liza.Flaherty@vynamic.com or visit our website for more information.
Podcast Tags: healthcare, life sciences, product launch, brand planning, life sciences trends
Source Links:
- The Essential Guide to Creating and Implementing a Successful Pharmaceutical Brand Plan
- Navigating the Inflation Reduction Act’s Impact on Drug Pricing and Innovation
- The Inflation Reduction Act: the Undoing of Pharma Marketing or a Catalyst for Innovation?.
- Go-to-Market Strategy for Pharmaceuticals
- Reimagining the Brand Planning Process in Healthcare
Panel – Jen Burke, Mindy McGrath, Liza Flaherty
Research & Production – Liza Flaherty, Adrea Cope & Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Two years after the announcement that Veeva and Salesforce would part ways, Life Sciences organizations are racing to evaluate their options and select their CRM partner before the 2025 cutover. Jen is joined by Vynamic’s Life Sciences Commercial Operations Lead, Jeremy Shirey, and Tech & Digital Transformation Service Lead, Vince Annerhed-Harris as well as special guests, CodeScience’s CEO, Mike Utell, and Chief Revenue Officer, Sean Hogan, to discuss how Life Sciences leaders should approach this decision and transition to minimize disruption and maximize business value.
For more information about CodeScience, visit their website: https://www.codescience.com/
For more information about Vynamic’s work in Commercial Operations and Tech & Digital Transformation, visit: https://vynamic.com/
Podcast Tags: healthcare, life sciences, healthcare technology, healthcare news, Veeva, Salesforce, tech and digital transformation, CRM, commercial operations, CodeScience
Panel – Jen Burke, Jeremy Shirey, Vince Annerhed-Harris, Mike Utell, Sean Hogan
Research & Production – Jen Burke, Jeremy Shirey, Vince Annerhed-Harris
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the Supreme Court’s overturning of Chevron Deference and what this will mean for the health industry, as well as strategic shifts made by Walgreens under their new CEO, and the ongoing impact of Microsoft’s global IT outage on health systems, hospitals, and clinics.
Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, Supreme Court, Chevron Deference, Walgreens, pharma, pharmacy, CrowdStrike, Microsoft, IT outage
Source Links:
- Health Care Impacts Following Chevron Decision
- Supreme Court overrules Chevron deference, dealing blow to federal healthcare agencies
- After Billions in Losses, Walgreens Doesn’t Want to Own VillageMD
- Walgreens slashes profit guidance with plans to close more pharmacy stores, cut stake in VillageMD
- Impacts from global IT outage
Panel – Jen Burke, Mindy McGrath, Ryan Hummel
Research & Production – Anna Briccetti, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
One of the advantages of serving clients across multiple geographies is that Vynamic can see firsthand how the differences in health systems play out in terms of spend, outcomes, and innovation. Jen & Ryan are joined by Vynamic London’s Oliver White to discuss key differences between the health systems in each country and what they can learn from one another as they move healthcare delivery out of the hospital and into the community setting. In one sense, the US and UK represent two extremes on the delivery system spectrum: the US has the largest private sector system globally while the UK has the largest publicly funded system. They also differ in key metrics around healthcare spend and outcomes (01:19), science and technology (04:21), and wait times for elective procedures and emergency care (06:21). Despite these differences, both systems are focused on improving cost and customer satisfaction – especially when it comes to telehealth and home care (09:05). One model the NHS has put forward in this effort is Community Crisis Response Teams (12:38) – a model that could be attractive as US health systems look to transition care to the home and alleviate emergency department (ED) volumes (15:13). While implementing such a model could present scaling challenges in the US market (16:45), it could also offer opportunities for health plans and providers to improve quality, outcomes, and patient satisfaction (18:29).
Podcast Tags: healthcare, providers, health plans, public health, NHS, CMS, telehealth, crisis care
Source Links:
· https://www.usnews.com/news/healthiest-communities/articles/2019-12-11/survey-finds-fragmented-us-health-care-impedes-coordination-among-providers
· https://www.commonwealthfund.org/international-health-policy-center/countries/england
· https://www.commonwealthfund.org/international-health-policy-center/countries/united-states
· https://www.commonwealthfund.org/blog/2018/what-can-us-and-england-learn-each-others-health-care-reforms
· https://www.healthcareadministration.com/brief-comparison-uk-healthcare-system-vs-u-s-healthcare-system/#:~:text=While%20both%20systems%20have%20world,tax%20based%20system%20versus%20the
· https://www.england.nhs.uk/community-health-services/urgent-community-response-services/
· https://www.england.nhs.uk/wp-content/uploads/2020/11/B0252-Urgent-community-response-2-hour-and-2-days-standards-guidance-30-November-2020.pdf
· https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465904/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Oliver White, Director
Oliver.white@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Director and Healthcare Industry Strategist
jen.burke@vynamic.com
The FemTech sector has seen major growth in the last 5 years – and as the healthcare industry increases its focus on equity, is only projected to keep growing. In this Women’s History Month episode, Jen is joined by Vynamic’s Diana Kuritza, Jen Proietti-Fox and HelloGina’s Daphne Petrich to discuss the latest trends in FemTech and what it could mean for women’s health going forward.
Podcast Tags: healthcare, health tech, women’s health, women’s history month, health equity, digital health
Source Links:
· Make 2023 the year of prioritizing women’s health
· 2023 PREDICTIONS—THE GOOD, THE BAD, AND THE UGLY
· European FemTech trends and startups to watch in 2023 | With insights from Essity Ventures
· What To Expect for Femtech in 2023?
· Despite 2022’s headwinds, women’s health startups did better than ever before
· The dawn of the FemTech revolution
· How FemTech is tackling the female health gap
· Femtech’s Limited Role in Tackling Healthcare Inequity
For more information on HelloGina please visit, https://www.helloginahealth.com/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Daphne Petrich, US Business Development Lead at HelloBetter
d.petrich@hellobetter.de
Jen Proietti-Fox, Director
Jen.proietti-fox@vynamic.com
Diana Kuritza, Manager
Diana.kuritza@vynamic.com
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
The re-emergence of clinical research into psychedelics as mental health treatment has become a promising development – particularly in light of the current global mental health crisis. However, persistent stigma around psychedelics, regulatory hurdles, and research challenges are a few factors to overcome before psychedelics could be more widely available. In today’s episode, Jen is joined by Vynamic’s Nick Fletcher and Grace Burtonwood to shine light on the opportunities and challenges psychedelics present to the mental health market.
Podcast Tags: healthcare, life sciences, healthcare news, mental health, psychedelics
Source Links:
- WHO Topics: Mental Health
- WHO Fact Sheets: Mental Disorders
- WHO: Global Health Estimates
- Multidisciplinary Association for Psychedelic Studies (MAPS)
- National Institute on Drug Abuse (NIDA)
- Compass Pathways
- BBC – FDA Advisory Committee Vote on MDMA
- FDA Guidance on Clinical Trials with Psychedelic Drugs
- How To Change Your Mind (Michael Pollen)
- European Medicines Agency (EMA)
Panel – Grace Burtonwood, Jen Burke, Nick Fletcher
Research & Production – Everly Petruzzelli, Nick Fletcher
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this episode, Jen, Karan, and Ollie discuss recent newsworthy items, including the political shifts taking place across Europe and their potential impact to the pharma sector, as well as the challenges posed by medicine stockpiling and breakthroughs in hemophilia treatment.
Podcast Tags: healthcare, healthcare news, public health, Labour, pharma, medicine stockpiling, haemophilia, NHS, Novo Nordisk
Source Links:
- With Europe facing right turn, how will public health be affected?
- Pharma responds to 2024 UK General Election
- Romanian hard-right takes healthcare on the road ahead of EU polls
- EU elections: a moment for pan-European health
- New Labour government backs pharma reform in UK
- Massive stockpiling of medicines increases patient risks, warns EU coalition
- Czechia slams Germany over drug stockpiling
- EU plan for medicine stockpile could worsen UK’s record shortages
- Six EU countries push to end mandatory stockpiling of medicines
- Haemophilia gene therapy now available to NHS patients
- Novo Nordisk shares positive results for Mim8 in late-stage haemophilia A trial
- England, Denmark back CSL’s haemophilia B gene therapy
- I have £2.6m blood and it has \’cured\’ my haemophilia
Panel – Jen Burke, Karan Pandya, Ollie May
Research & Production – Karan Pandya
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
The healthcare industry is in an unprecedented era of change as rapidly advancing technologies, changing consumer expectations, and rising costs force organizations to adapt. With a landscape that is becoming increasingly more competitive, organizations are facing a choice: transform traditional models of healthcare delivery or face the risk of being left behind. Today, Mindy and Jen are joined by Vynamic’s Executive and Head of Health Technology Sector, Mary Virzi, to discuss this call to action and how leaders can ensure that these transformations are successful.
Podcast Tags: healthcare, healthcare technology, transformations, digital transformations, healthcare transformations
Source Links:
- Digital Transformation in Healthcare in 2024: 7 Key Trends
- New Chartis survey finds that digital transformation gap is growing among health systems
- From belief to transformation: Digital market leaders focus on value
- Top Issues Confronting Hospitals
- Defining your ‘true north’: A road map to successful transformation
- Why digital transformation in healthcare is so difficult and long-overdue
- 2024 and beyond: Will it be economic stagnation or the advent of productivity-driven abundance?
Panel – Mary Virzi, Mindy McGrath, Jen Burke
Research & Production – Adrea Cope, Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
The World Health Organization (WHO) has designated climate change the top risk to global healthcare. The relationship between climate change and human health is becoming increasingly pronounced as health systems and organisations are responding to public/private sustainability initiatives to mitigate climate risks while advancing the pursuit of health equity. In this episode, Mindy and Ryan are joined by Vynamic’s Ollie May to help us understand the NHS’s pledge to reach Net Zero emissions and how the healthcare industry can play a leading role in promoting greener business practices. The discussion begins with understanding the definition of Net Zero and how it is relevant to the healthcare industry (1:26). The conversation transitions to explaining the NHS’s carbon emission history and drivers impacting utilisation (3:27) before providing an overview of the system’s Net Zero commitment (6:50) and how waste factors into these plans (10:30). The team discusses the progress to-date since the NHS published their strategies (11:35) and the impact COVID-19 has had on their plans (15:49). The U.S. Net Zero practices are also discussed (19:05) before the team wraps up by weighing the benefits and challenges of these initiatives overall (21:45).
Podcast Tags: healthcare, healthcare news, Net Zero, Climate Change, NHS, COVID-19, health outcomes
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
List of Sources:
- https://www.england.nhs.uk/greenernhs/wp-content/uploads/sites/51/2022/07/B1728-delivering-a-net-zero-nhs-july-2022.pdf
- https://www.england.nhs.uk/greenernhs/a-net-zero-nhs/
- https://www.england.nhs.uk/2020/10/nhs-becomes-the-worlds-national-health-system-to-commit-to-become-carbon-net-zero-backed-by-clear-deliverables-and-milestones/
Mindy McGrath, Healthcare Industry Advisor
Mindy.Mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Oliver May, Director
Oliver.May@vynamic.com
In this episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the recent ruling by the United States Supreme Court on access to the abortion pill mifepristone, the declaration of bankruptcy by the Massachusetts-based Steward Health Care system, and the combination flu and COVID-19 vaccine under development by Moderna.
Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, Supreme Court, abortion, mifepristone, telemedicine, IVF, in vitro fertilization, private equity, hospitals, Steward Health Care, bankruptcy, COVID-19, flu, Moderna, mRNA, vaccines
Source Links:
- Supreme Court rejects challenge to abortion pill accessibility
- The Threat to Abortion Rights You Haven’t Heard of
- Senate Republicans block bill on women’s right to IVF as Democrats make push on reproductive care
- Senate GOP Blocks IVF Access Bill as Democrats Press for Political Edge
- Steward secures funding to run its hospitals through end of June
- Unpacking Massachusetts’ Steward health system crisis
- The 3rd Largest Mass Hospital system is in bankruptcy, here is what you need to know
- Lawmakers seek healthcare and retirement protections for Steward Health Care Workers
- Moderna flu/COVID combo beats immune responses for approved shots in phase 3 after speedy season
Panel – Jen Burke, Mindy McGrath, Ryan Hummel
Research & Production – Anna Briccetti, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this episode, Jack and Jen welcome special guest Nico Renner, Patient Partnership Lead at Roche, to discuss the transformative impact of social media on patient engagement. Together they explore how pharmaceutical companies can embrace this shift to enhance patient interaction and outcomes.
Podcast Tags: healthcare, life sciences, patient engagement, patient centricity, patient outcomes, social media, metrics, innovation
Disclaimer: Nico is sharing his own opinions, which might not necessarily reflect Roche’s perspective
Check out Nico’s profile LinkedIn profile here: https://www.linkedin.com/in/nicorenner/
Source Links:
- Harnessing the Power of Social Media in Pharmaceutical Marketing
- Pharma and Healthcare Social Media Marketing Market
- The Relationship Between the Pharmaceutical Industry and Social Media
- Intelligent Post-launch Patient Support
- Patient Education on Social Media is not the future…
Panel – Jack Young, Nico Renner and Jen Burke
Research & Production – Jack Young, Nico Renner and Jen Burke
Recording & Editing –Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this episode, Jack, Jen, and Ollie discuss recent newsworthy items, including a roundup of key insights from the NEXT Pharma Summit, AstraZeneca’s announcements at ASCO, and the NHS’s groundbreaking trials for personalised cancer vaccines.
Podcast Tags: healthcare, healthcare news, NEXT Pharma Summit, life sciences, Novartis, generative AI, Lilly, omnichannel, AstraZeneca, Tagrisso, lung cancer, ASCO, NHS, vaccine
Source Links:
- Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
- ASCO: AstraZeneca\’s Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation
- ASCO24: AstraZeneca won cancer’s big meeting — again. Will that help it fulfill its $80 billion ambition?
- ASCO Daily Recap: AstraZeneca’s hat trick, a GSK turnaround, and palliative care as telehealth
- At ASCO, AstraZeneca Adds Data Supporting Expanded Use of Its Drugs in Lung Cancer
- What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
- Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
- Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
- ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
- Moderna And Merck Advance Cancer Treatment With Promising Vaccine
- NHS patients in England to be offered trials for world-first cancer vaccine
- Thousands of cancer patients to trial personalised vaccines
Panel – Jack Young, Jen Burke, Ollie May
Research & Production – Jack Young, Karan Pandya
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
As healthcare organizations strive to accelerate innovations through Artificial Intelligence (AI), it can be complicated to navigate through the number of possibilities that exist and know how to get started. In this episode, Jen is joined by Vynamic’s Tech & Digital Transformation Service Lead, Vince Annerhed-Harris and Lantern’s Chief Experience Officer, Brian Sturgeon, to discuss how healthcare leaders can plot the course for their AI journey and prioritize their investments to better accelerate their business objectives utilizing AI tools.
Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, tech transformation, digital transformation
Source Links:
- The AI Strategy Roadmap: Navigating the stages of value creation | The Microsoft Cloud Blog
- Introducing: Lantern – A Digital Innovation Consultancy Designed for the Era of AI (youtube.com)
- A Practical Guide to Enabling AI within your Organization. (youtube.com)
- Reimagining Technology Consulting for the Era of AI – Lantern (lanternstudios.com)
Panel – Jen Burke, Vince Annerhed-Harris, Brian Sturgeon
Research & Production – Everly Petruzzelli, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For more information on Lantern, please visit: Lantern – Microsoft Solutions Partner (lanternstudios.com), Lantern’s LinkedIn Page, Build and Modernize AI Apps – Microsoft Azure Marketplace
If you want to learn more about implementing AI within your organization, you can check out Vynamic | Tech & Digital Transformation | Health Industry Consulting
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this Trending News US episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including legislation aimed at addressing drug shortages and telehealth regulations, the ongoing legal challenges to the Inflation Reduction Act, and the role of ride share apps in healthcare.
Podcast Tags: healthcare, healthcare news, health policy, drug shortages, Medicare, hospitals, providers, FDA, telehealth, inflation reduction act, IRA, ride share, Lyft, Uber
Source Links:
- Senators float Medicare program that would offer incentive payments to combat drug shortages
- Second House panel advances two-year telehealth extension
- Bristol Myers, Johnson & Johnson plot appeal after US judge dismisses IRA lawsuits
- CMS proposes new mandatory organ transplant model for end-stage renal disease
Panel – Jen Burke, Mindy McGrath, Ryan Hummel
Research & Production – Anna Briccetti, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
During Fierce Life Science’s MASS East, Medical Affairs leaders gathered to address current challenges and share industry best practices. In this episode, Jen is joined by Vynamic’s Tamaron Bertelli and Head of Life Sciences Europe, Gemma Pfister to share what they learned about transformation and operating with impact.
To receive a copy of Vynamic’s ”Operating with Impact: Topical Transformation Dilemmas and Decisions” presentation, please email gemmapfister@vynamic.com
For more information about Vynamic’s work in Medical Affairs, please visit https://vynamic.com/what-we-do/health-industry/life-sciences/medical-affairs/
Podcast Tags: healthcare, healthcare news, life sciences, medical affairs, MASS East, Fierce, MSL
Panel – Gemma Pfister, Jen Burke, Tamaron Bertelli
Research & Production – Danielle Lewis, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this Trending News Europe episode, Jack, Jen, and Ollie discuss a few recent newsworthy items, including an increase in cyberattacks on the healthcare sector, Europe’s plan to future-proof its Biotech Sector and New Research from the University of Oxford into psilocybin as a potential treatment for depression.
Podcast Tags: healthcare, healthcare news, life sciences, NHS, cybersecurity, biotech, research & development, pharmaceuticals, depression, psilocybin, mental health, psychedelics, mental health awareness week
Source Links:
- ’Large volume’ of data stolen from NHS Dumfries and Galloway published on dark web
- Huge volume of NHS patient and staff data released by hacker
- NHS cyber attack: Why stolen medical information is so much more valuable than financial data
- Cyber attacks are one of the biggest threats facing healthcare systems
- Government Launches NHS Cyber Security Strategy
- US tech group Palantir wins lucrative NHS data contract
- Patient privacy fears as US spy tech firm Palantir wins £330m NHS contract
- European Commission lays down path to future-proof EU biotechnology
- Roche to buy Carmot for up to $3.1bn as race for obesity drugs intensifies
- Roche agrees $7.1bn deal for Telavant to boost drug pipeline
- Europe’s biotech innovation in the balance
- Commission takes action to boost biotechnology and biomanufacturing in the EU
- Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis
- EU launches landmark €6.5M study on use of psychedelics to treat mental disorders
- Magic mushrooms’ psilocybin can alleviate severe depression when used with therapy
- Psychedelic drug research held back by UK rules and attitudes, say scientists
- King’s College Psychoactive Trials Group
Panel – Jack Young, Jen Burke, Ollie May
Research & Production – Karan Pandya, Jack Young
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
As competitive and regulatory pressures increase, Life Sciences organizations are tightening their timelines and budgets when bringing products to market. In this environment, it’s become essential to start commercialization planning earlier to ensure a successful launch and hit revenue targets. In this deep dive episode, Jen is joined by Vynamic’s Product Launch Service Leads, Ashley Stanley and Brian Stamm, as well as Managing Director of PROPENSITY4, Chris Savage, to discuss why early planning is so critical and how leaders can incorporate some of these changes into their organizations.
To learn more about Vynamic’s work in Product Launch, visit Vynamic’s Product Launch page. To read more on navigating alliance product launches, see Vynamic’s latest insight here.
PROPENSITY4, part of Inizio Engage, is transforming pharmaceutical commercialization through seamless integration of data, expertise and cutting-edge analytics. See more about what PROPENSITY4 can do for your team at Data and Integrated Insights | Inizio Engage.
Podcast Tags: healthcare, life sciences, product launch, healthcare news, life sciences trends, product launch trends
Source Links:
- Product launch challenges and how to overcome them
- Drug launches reflect overall company performance
- TO SPEND OR NOT TO SPEND: Investing For Launch Success As An Emerging Company
- Revenue of the worldwide pharmaceutical market from 2001 to 2023
- Prices for new US drugs rose 35% in 2023, more than the previous year
- Next in pharma 2024: Reinventing for returns
- The Unbearable Cost of Drug Development
- Understanding the Factors that Impact the Pre-Launch Phase and New Product Launch Excellence in the Pharmaceutical Industry
- FDA Approves Many New Drugs in 2023 that Will Benefit Patients and Consumers
Panel – Jen Burke, Ashley Stanley, Chris Savage, Brian Stamm
Research & Production – Adrea Cope & Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the FDA approval of Rejoyn, the first prescription digital treatment for major depressive disorder. They also discuss the ongoing drug shortage crisis, as well as changes coming out of the Centers for Medicare & Medicaid Services and the impact those decisions will have over the next year.
Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, depression, mental health, digital treatment, drugs, pharmaceuticals, shortages, medications, FDA, CMS, Medicare Advantage, breakthrough technology, medical devices
Source Links:
- FDA clears first digital treatment for depression, but experts caution that research is still early
- Number of ongoing US drug shortages reaches new high, pharmacist group says
- FDA commissioner tells lawmakers his agency needs more authority to prevent drug shortages
- CMS final rule on broker comp, health equity could shake up Medicare Advantage
- Medicare official says breakthrough device reimbursement rule coming in early summer
Panel – Jen Burke, Mindy McGrath, Ryan Hummel
Research & Production – Anna Briccetti, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
While the health industry is not always an early adopter of new technologies, the growth of generative artificial intelligence (GenAI) has empowered organizations to start transforming their AI aspirations into actions. In this episode, Mindy and Jen are joined by Vynamic’s Innovation Lead, Michael Hudson, and Responsible AI Lead, Todd Quartiere, to discuss where we see health organizations experimenting with AI and what it will take for them to achieve their long-term AI ambitions.
To learn more about implementing AI within your organization, check out our recent insight: Why AI fails or flourishes: The underestimated role of culture.
Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, ChatGPT
Source Links:
- The Unexpected Winners of the ChatGPT Generative AI Revolution
- Generative AI in healthcare: Emerging use for care
- US healthcare leadership: How to respond and thrive
- How Can AI Improve Health Care?
- Envisioning Healthcare in a Post-COVID-19 World
- Three-quarters of health professionals project widespread AI adoption
- 5 Key Healthcare Industry Trends to Watch in 2024
- What Do We Mean When We Talk About “AI Democratisation”?
Panel – Jen Burke, Michael Hudson, Mindy McGrath, Todd Quartiere
Research & Production – Danielle Lewis, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this Trending News Europe episode, Jack, Jen, and Ollie discuss recent newsworthy items from across Europe, including the impact of and deterrents against “no shows” at medical appointments, the role bacteria play in cancer treatment, and inequalities in the rare disease market, along with the steps being taken to ease these issues.
Podcast Tags: healthcare, healthcare news, life sciences, public health, France, medical, bacteria, cancer, immunotherapy, chemotherapy, microbiome, rare disease, Germany, Italy, health disparity
Source Links:
- Dutch hospitals use AI to solve no-show patient problems that cost them millions
- Cancellations of NHS care are having serious impacts on two-thirds of patients
- Would charging patients for missed appointments help fund the NHS?
- GP \’no shows\’ cost Norfolk NHS more than 1m in a one month
- France planning €5 no-show fees in a bid to improve community healthcare
- France divided over ‘no-show tax’ for patients failing medical appointments
- Researchers compile detailed catalog of bacteria living in cancer metastases
- Boehringer builds out cancer capabilities with $500M deal for bacteria-focused Swiss biotech
- The key to young onset bowel cancer may be gut bacteria
- The mystery of microbes that live inside tumours
- Diversity of Bacteria in Cancer Metastases
- It’s the Little Things: A Role for Bacteria in Cancer Treatment
- The UK is missing out on EU collaboration to improve treatment for rare diseases
- Overcoming the burden of rare diseases in Europe
- Stronger together in the fight against rare diseases
- Is Europe on track to be the leader in rare diseases?
- Right here, right now European public health policies must start giving people living with rare diseases a fair chance
- New rare diseases action plan on horizon, Europe at turning point
- Europe needs new 360 rare diseases strategy
Panel – Jack Young, Jen Burke, Ollie May
Research & Production – Karan Pandya
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In recent years, we’ve seen an increasing number of Life Sciences companies publicly declare commitments to sustainability efforts as a result of increased pressure from governments, customers, and research. Trending Health UK’s Ollie May sits down with two members of Vynamic’s Sustainability Council, Rosanna Vellacott and Matt O’Dell, to discuss why pharmaceutical organizations should be paying attention to sustainability goals, some innovative practices underway, and what leaders should be considering as they embed more sustainable practices into their organizations.
Podcast Tags: healthcare, life sciences, sustainability, healthcare news, climate change, climate crisis, emissions, net zero, supply chain
Source Links:
- Striving for sustainable drug discovery using Green Chemistry
- Accelerating the transition to net zero in life sciences
- Process Digital Twin for Pharma
- Sanofi harnesses Dassault\’s digital twin tech to optimize production at future vaccine plants
- Strategies for Sustainability in the Global Pharmaceutical Supply Chain
- Bayer: Improving Sustainability Practices in the Supply Chain
- Bayer: Commitments in Action Creating a Sustainable Product Supply
- Making biopharma’s supply chains more environmentally sustainable
- The pharma companies working towards supply chain sustainability
- Carbon footprint of the global pharmaceutical industry and relative impact of its major players
- The Greenhouse Gas Protocol: Technical Report
- Understanding pharma’s challenges and opportunities in relation to the climate crisis
- Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies
- Pharma’s path to Net Zero: Targeting Scope 3 emissions
Panel – Oliver May, Rosanna Vellacott, Matt O’Dell
Research & Production – Adrea Cope, Everly Petruzzelli, Oliver May
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this Trending News US episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the introduction of rebate credits by CVS to account for more biosimilars entering the market, as well as a recent ruling by a federal appeals court that drugmakers cannot restrict 340B program offerings from community and specialty pharmacies. Finally, we discuss a groundbreaking procedure in which a kidney from a CRISPR gene edited pig was transplanted into a human.
Podcast Tags: healthcare, healthcare news, CVS health, PBMs, biosimilars, 340B, pharmacies, hospitals, providers, xenotransplantation, CRISPR, gene editing
Source Links:
- As Humira biosimilars take over the market, CVS has created a new ploy; the drug “rebate credit”
- Federal appeals court sides with 340B contract pharmacies
- American Hospital Association 340B Factsheet
- Gene edited pig kidney transplanted into a living patient for the first time
- Kidney Disease Statistics for the United States
Panel – Jen Burke, Mindy McGrath, Ryan Hummel
Research & Production – Anna Briccetti, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
One of the core tenets of the omnichannel philosophy is continuous learning and refinement – bringing together experience and data to evolve the marketing and model. Jen is joined by Vynamic’s Customer Experience Transformation Lead Mike Zapiec and Omnichannel Offering Lead Josh Padams to discuss what we’ve learned partnering with clients to build their omnichannel capabilities and what Life Sciences organizations can do to take their customer engagement to the next level.
For more information on Vynamic’s work in Customer Experience Transformation, check out our service page: https://vynamic.com/what-we-do/services/customer-experience-transformation-cxt/
Podcast Tags: omnichannel, customer engagement, customer experience, marketing, healthcare, life sciences
Panel – Mike Zapiec, Josh Padams, Jen Burke
Research & Production – Danielle Lewis, Hannah Yee, Aisling McAtamney, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this episode, Jack, Ollie, and Jen discuss a substantial investment package in the UK’s Life Sciences and manufacturing sectors, the role of an AI chatbot in bridging Europe\’s mental health care gap, and how Spain is reshaping pharmaceutical supply chains in Europe.
Podcast Tags: healthcare, Europe, healthcare news, manufacturing, research, AI, chatbots, mental health, patient care, Spain, supply chain
Source Links:
- UK lacks plans to make pandemic vaccines quickly, MPs hear
- Spring Budget puts UK on fast-track to becoming science and technology superpower
- UK Spring Budget allocates funds to life sciences manufacturing
- £360 million to boost British manufacturing and R&D
- ABPI response to the Budget
- UK Chancellor trumpets £650m AstraZeneca investment
- Meet the AI chatbot therapists filling the gaps in Europe’s mental health care shortfall
- Mental health services facing ‘vicious cycle’ workforce issue
- A chatbot helped more people access mental-health services
- Closing the accessibility gap to mental health treatment with a personalized self-referral chatbot
- A child in Poland has to wait 238 days to see a psychiatrist, activist says
- From ‘crisis’ to ‘pandemic’: mental health in Europe
- Europe\’s mental health crisis: Which country uses the most antidepressants?
- Belgium leads the charge on the EU’s medicines reshoring plans
- EU capitals propose Chips Act for medicines
- Onshoring and global health – has the pandemic sent globalisation into reverse?
- France\’s Emmanuel Macron seeks to relocate domestic production of key drugs to avoid shortages
- Barcelona identified as Europe’s second-best hub for biotech investment
- Moderna opens international centre for analytical excellence in Madrid
- Spain showing great pharma potential as Barcelona named Europe’s No.2 hub for biotech investment
- Spain Has All the Right Elements To Become a Fast-Growing Life Science Hub
- Spain’s plan to become Europe’s pharmaceutical epicentre
Panel – Jack Young, Jen Burke, Ollie May
Research & Production – Jack Young, Karan Pandya, Ollie May
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
The obesity drug market has grown dramatically in the last few years, especially with the help of social media and influencers. The immense popularity of anti-obesity medications has transformed a health industry development into a cultural phenomenon. While this market has so much opportunity, it also faces supply issues and coverage gaps. Mindy and Jen are joined by Vynamic’s Head of Life Sciences, Karen Baldry, and Head of Health Plans, Saurabh Raman, to talk about the growth and challenges obesity medications present for the health industry.
Podcast Tags: healthcare, obesity, weight loss, diabetes, health services, health plans, life sciences
Source Links:
- What Is Ozempic and Why Is It Getting So Much Attention?
- We Know Where New Weight Loss Drugs Came From, but Not Why They Work
- What the Scientists Who Pioneered Weight-Loss Drugs Want You to Know
- Supply Updates about Wegovy
- The increase in appetite for obesity drugs
- Demand for GLP-1 drugs is growing. Here\’s why payers are hesitant to cover them for weight loss
- More than 4,000 ads for Ozempic-style drugs found running on Instagram and Facebook
- Wegovy heart health data is promising — but insurers face long road, high cost to cover obesity drugs
- Medicare is barred from paying for weight-loss drugs like Wegovy. Lawmakers just took the first step to change that
- Cost isn’t the only reason Medicare doesn’t cover Wegovy
- New marketing push by Ozempic and others sparks body-positive backlash
- What You Need to Know About Compounded Versions of Popular Weight Loss Drugs
- Novo antes up $16.5B to poach CDMO giant Catalent amid Wegovy surge
- Wegovy, other GLP-1s could lower heart disease: Study
- Novo kidney trial finds Ozempic cuts cardiac deaths in diabetics
- How Ozempic and Weight Loss Drugs Are Reshaping Denmark’s Economy
- Novo Nordisk\’s Wegovy bonanza looms large in Denmark
- Big pharma’s blockbuster obesity drug battle is just getting started, and it’s headed for $100 billion
- Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect
- Ozempic vs Wegovy
- Obesity drug boom pushes Novo Nordisk shares to record high
- Popular use of obesity drugs like Ozempic could change consumer habits
Panel – Jen Burke, Mindy McGrath, Karen Baldry, Saurabh Raman
Research & Production – Adrea Cope, Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Since it was signed into law in 2022, the health industry has been abuzz about the longer-term impact of the Inflation Reduction Act. In this episode, Jen & Mindy sit down to discuss recent headlines and developments around this landmark legislation and what Life Sciences companies should expect over the course of the next year.
For more perspective on the Inflation Reduction Act\’s impact on Life Sciences companies, check out Mindy’s article in Pharmaphorum, "Seizing the moment: The life sciences industry at the threshold of change”.
Podcast Tags: healthcare, healthcare news, life sciences, health policy, inflation reduction act, drug prices, pharmaceutical
Panel – Jen Burke, Mindy McGrath
Research & Production – Jen Burke, Mindy McGrath
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the ruling by Alabama’s Supreme Court that frozen embryos can be legally regarded as “extrauterine children” under state law, and the impact this decision has had on in vitro fertilization (IVF) procedures. They also cover the release of additional guidance from CMS on the Medicare Prescription Payment Plan and a new report from Reuters that revealed the dramatic increase in new drug prices throughout 2023.
Podcast Tags: healthcare, healthcare news, IVF, embryos, supreme court, reproductive health, life sciences, health policy, inflation reduction act, CMS, medicare, medicaid, drug prices, pharmaceutical
Source Links:
- The science of IVF: What to know about Alabama\’s \’extrauterine children\’ ruling
- Rare Diseases at FDA
- Prices for new US drugs rose 35% in 2023, more than the previous year.
Panel – Jen Burke, Mindy McGrath, Ryan Hummel
Research & Production – Anna Briccetti, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, covering a prominent oncology society\’s push for tumor classification reform that could have profound impacts on cancer survival rates, the critical need for measles vaccination, and Sweden\’s pioneering use of drones in cardiac arrest intervention.
Podcast Tags: healthcare, healthcare news, life sciences, precision oncology, cancer, molecular testing, infectious diseases, vaccination, NHS sustainability, innovation, Sweden
Source Links:
- We’re naming cancers all wrong, oncology leader says
- Forget lung, breast or prostate cancer: why tumour naming needs to change
- Redefining Cancer Classification: A Shift from Organ-based to Molecular-based Approach
- A 30-fold rise of measles cases in 2023 in the WHO European Region warrants urgent action
- Measles in Europe: WHO calls for ‘urgent’ vaccinations as cases surge
- Europe Needs to Get on Top of Its Measles Outbreak
- Europe faces resurgence of measles due to low vaccination coverage
- Europe\’s first transport of blood bags by drone takes place in Belgium
- NHS to pioneer drone deliveries in bid to improve service
- Drone chemotherapy becomes an NHS net zero cancer strategy
- Sweden uses drones to fight cardiac arrest
- Healthcare From Above: Challenges And Opportunities Of Medical Drones
- Flight Trials for Scots Medicine-carrying Drones Conducted
- Government to invest £30 million in innovative technology for NHS
- Department of Health and Social Care: Medical Technology Strategy
- Drones to deliver NHS medication to care homes and GP surgeries in major roll-out
- NHS to begin delivering critical medical supplies by drone
Panel – Jack Young, Jen Burke, Ollie May
Research & Production – Jack Young, Karan Pandya, Ollie May
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Over the last few years, the MedTech market has been navigating an unpredictable environment due to macro-economic factors and pandemic-driven activity. As we start off 2024, there’s a prevailing feeling that this market is finally starting to stabilize. In this episode, Jen is joined by Vynamic’s Anila Patel and Head of Health Technology Sector, Mary Virzi, to chat about what MedTech moves we’ve seen so far and what we can expect as 2024 kicks into gear.
Podcast Tags: healthcare, medtech, product launch, medical device, health tech, healthcare technology
Source Links:
- The biggest stories from the 2024 J.P. Morgan Healthcare Conference
- 5 medtech trends to watch in 2024
- MEDTECH AND DIAGNOSTICS MARKET: 2023 TRENDS AND 2024 OUTLOOK
- Medtronic aims to leverage medical device data for AI-enabled care
- 4 heart device trends shaping the medtech sector in 2024
- J&J\’s Biosense Webster puts forward pulsed field ablation data showing no afib after one year
- Boston Scientific nets Farapulse approval, pushes back US TAVR launch
- J&J\’s Biosense Webster puts forward pulsed field ablation data showing no afib after one year
- Medtronic snags first pulsed field ablation approval in US
- Spotlight – J&J takes on Medtronic and Boston in pulsed field ablation
- Increasing diabetes awareness boosts the diabetes care devices market
Panel – Mary Virzi, Anila Patel, Jen Burke
Research & Production – Adrea Cope, Everly Petruzzelli
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this episode, Jen sits down with Vynamic’s Deal Activation & Partnership Enablement Service Leads, Senior Director Kevin Fletcher and Executive Sean Martin, to discuss recent newsworthy items coming out of the J.P. Morgan Healthcare Conference, including the major acquisitions and deals announced, particularly those focused on AI and digital innovation.
Check out Vynamic’s Deal Activation & Partnership Enablement Service page to learn more about how Vynamic helps clients manage critical, time-sensitive activities across the deal life cycle.
Podcast Tags: healthcare, healthcare news, life sciences, pharmaceutical, JP Morgan, deal activation, partnerships, mergers, acquisitions, AI, digital innovation
Source Links:
- Inizio Biotech key takeaways from JPM industry event
- Cigna sells Medicare business to Health Care Service for $3.3 bln
- Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
- J&J, Merck and Boston Scientific Go on $6.4 Billion Buying Spree
- Amazon rolls out digital health benefits program, taps Omada Health as launch partner
- What the Health Care Sector Was Selling at the J.P. Morgan Confab
- Jefferson Health says LVHN merger would double its insurance business within 2 years
Panel – Jen Burke, Kevin Fletcher, Sean Martin
Research & Production – Anna Briccetti, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Within Life Sciences companies, Medical Affairs teams are tasked with gathering and communicating scientific data, a job that has only grown in importance as therapies have grown more complex and stakeholders have multiplied. Stretched in many directions and under high scrutiny, Medical Affairs teams need to be able to effectively measure and communicate the value of their work. In this deep dive episode, Jen is joined by Gemma Pfister, Head of Life Sciences Europe at Vynamic and Lori Klein, Partner, Medical & Scientific Affairs Practice Lead at Putnam, to discuss what leaders should be thinking about when it comes to measuring impact in Medical Affairs.
For more information about the work Putnam does in the Medical Affairs space, visit Putnam’s Medical & Scientific Affairs page. To learn more about Vynamic’s work in Medical Affairs, visit Vynamic’s Medical Affairs page.
Podcast Tags: healthcare, life sciences, medical affairs, omnichannel, AI
Panel – Gemma Pfister, Jen Burke, Lori Klein
Research & Production – Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, including the potential impact of Wegovy in reducing excess deaths in the UK, a groundbreaking report on minimising the environmental footprint of surgical care, and Lithuania\’s innovation wave in biotech and MedTech.
Podcast Tags: healthcare, healthcare news, life sciences, obesity, medtech, sustainability, biotech, medtech, innovation, lithuania
Source Links:
- Excess mortality in England post COVID-19 pandemic: implications for secondary prevention
- UK life expectancy falls to lowest level in a decade
- Excess deaths involving cardiovascular disease: an analysis
- Wegovy made available in the uk for weight loss in people with prediabetes and type 2 diabetes
- Our response to serious supply issues of drugs for people with type 2 diabetes
- Ministers launch £40m pilot scheme to trial wider access to slimming jab
- Health Inequalities, Lives, Cut Short, January 2024
- Can Denmark\’s world-beating drugs maker stay ahead?
- Landmark report on reducing environmental impact of surgical care published
- Green Surgery – Reducing the environmental impact of surgical care
- Lithuania Set to Become Home to Largest Biotech City
- Northway Group to build $7.6bn ‘biotech city’ in Lithuania
- Baltic-bound: is Lithuania desirable for EU life science investment?
Panel – Jack Young, Jen Burke, Ollie May
Research & Production – Jack Young, Karan Pandya, Ollie May
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
The US Pharmacy Industry is the largest in the world, with many different players involved in ensuring pharmaceutical products reach consumers. These channels and distribution outlets have drastically changed over the years and will only continue to evolve. The pharmacy channel has reimagined how they are reaching patients, managing risks, and deriving value, expanding their business models beyond dispensing prescription drugs to become wellness destinations. Mindy and Jen are joined by Health Services Heads of Sector, Saurabh Raman and Ryan Hummel, to discuss this complex industry and its evolution.
For more information about the work discussed in this episode, check out https://vynamic.com/what-we-do/health-industry/health-services/
Podcast Tags: healthcare, mergers & acquisitions, pharmacy, PBMs, pharmacists, specialty pharmacy, health services
Source Links:
- Market Insights: Pharmacies–Worldwide
- 7 surprising facts about the pharmaceutical industry
- The Impact of Pharmaceutical Wholesalers on U.S. Drug Spending
- Pharmacy Benefit Managers: Practices, Controversies, and What Lies Ahead
- Competition, Consolidation, and Evolution in the Pharmacy Market
- CVS Pharmacy Downsizes: 10 Industry Trends Driving the Retail Shakeout
- 2023 Forecast: Pharmacists push to take on a greater role in patient care
- A new day in retail pharmacy: The evolving role of pharmacist
- Five Trends Transforming Pharmacies into Wellness Centers of the Future
- Community Pharmacists’ Contributions to Disease Management During the COVID-19 Pandemic
- An Inside Look at Walgreens\’ primary care and pharmacy model
- CVS Health completes acquisition of Oak Street Health
- CVS launches new venture in biosimilar drug experiment
- AMA: Don\’t expand scope of practice for already overworked pharmacists
Panel – Jen Burke, Mindy McGrath, Ryan Hummel, Saurabh Raman
Research & Production – Adrea Cope, Everly Petruzzelli, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the announcement that Bristol Myers Squibb is purchasing RayzeBio, the use of artificial intelligence in discovering antibiotics that stop MRSA infections, and recent reports revealing an increase in medical errors at hospitals owned by private equity firms.
Podcast Tags: healthcare, healthcare news, life sciences, mergers & acquisitions, radiopharma, medtech, artificial intelligence, antibiotics, health services, providers, private equity, hospitals
Source Links:
- BMS enters radiopharma race with $4.1B acquisition of RayzeBio just 3 months after biotech went public
- ‘Explainable’ AI discovers new class of antibiotics that stop MRSA in mice
- Discovery of a structural class of antibiotics with explainable deep learning
- Serious Medical Errors Rose After Private Equity Firms Bought Hospitals
Panel – Jen Burke, Mindy McGrath, Ryan Hummel
Research & Production – Anna Briccetti, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this special episode, we conclude our annual series on the biggest health industry trends of the next year. Jen sits down with Vynamic Senior Executives Karen Baldry, Mindy McGrath, and Ryan Hummel, and Executives Mary Virzi and Saurabh Raman to discuss the five trends they expect to be most impactful in 2024. These trends include 1) policy implications & judicial decisions, 2) realizing the value of convergence, 3) healthcare as a service, 4) revolutionizing healthcare through AI tech, and 5) next-gen meds.
To learn more about Vynamic’s 2024 health industry outlook, visit https://vynamic.com/insights/2024-health-industry-outlook/
Podcast Tags: healthcare, healthcare news, healthcare trends
Panel – Jen Burke, Karen Baldry, Mary Virzi, Mindy McGrath, Ryan Hummel, Saurabh Raman
Research & Production – Jen Burke, Mindy McGrath
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this special minisode, we continue our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Executive & Head of Health Technology Mary Virzi to discuss the five MedTech trends Mary expects to be most impactful in 2024. These trends include 1) increased research & development spend, 2) embracing remote patient monitoring, 3) spinoffs to expand access, 4) global regulation and policy shifts, and 5) concentrated mergers and acquisitions.
To learn more about Vynamic’s perspective on MedTech, visit https://vynamic.com/insights/2024-medtech-outlook/
Podcast Tags: healthcare, healthcare news, health technology, medtech, healthcare trends
Panel – Mary Virzi, Jen Burke
Research & Production – Mary Virzi, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this special minisode, we continue our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Senior Executive & Head of Life Sciences Karen Baldry to discuss the five Life Sciences trends Karen expects to be most impactful in 2024. These trends include 1) balancing innovation & affordability, 2) launching for value, 3) breaking down silos, 4) mastering omnichannel, and 5) integrating AI.
To learn more about Vynamic’s work in the Life Sciences sector, visit https://vynamic.com/what-we-do/health-industry/life-sciences/
Podcast Tags: healthcare, healthcare news, life sciences, healthcare trends, healthcare innovation, product launch, omnichannel, AI
Panel – Karen Baldry, Jen Burke
Research & Production – Karen Baldry, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this episode, Jen is joined by members of Vynamic’s London office to unpack key insights from two recent conferences. First, Senior Executive Gemma Pfister and Director Nick Fletcher discuss the recent Evidence Life Science Medical Affairs Insights & Omnichannel Conference in London. Then, Senior Directors Jack Young and Owen Thomas cover the Next Pharma Customer Experience Summit in Vienna. Join us to stay ahead in the evolving world of omnichannel and customer experience, med affairs, and launch as our team shares expert perspectives, innovative strategies, and the latest trends shaping the Life Sciences industry.
Podcast Tags: healthcare, healthcare news, life sciences, customer experience, medical affairs, omnichannel, patient centricity, digital transformation, nextpharmasummit, product launch
Source Links:
- From Excellent to Exceptional: The Power of Authenticity in Product Launch
- Evidence Life Science
- Next Pharma Summit
Panel – Gemma Pfister, Jack Young, Jen Burke, Nick Fletcher, Owen Thomas
Research & Production – Jack Young
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this special minisode, we continue our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Executive & Head of Payers Saurabh Raman to discuss the five Payer trends Saurabh expects to be most impactful in 2024. These trends include 1) product diversification and a strategic shift to government markets, 2) regulatory changes to Medicare, 3) improving care for enrollees with social risk factors, and 4) emphasizing value and putting the patient first.
To learn more about Vynamic’s work with Payers in the Health Services sector, visit https://vynamic.com/what-we-do/health-industry/health-services/#payers
Podcast Tags: healthcare, healthcare news, payers, health systems, health services, hospitals, healthcare trends
Panel – Saurabh Raman, Jen Burke
Research & Production – Saurabh Raman, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this special minisode, we begin our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Senior Executive & Head of Providers Ryan Hummel to discuss the five Provider trends Ryan expects to be most impactful in 2024. These trends include 1) increased financial stability, 2) digitizing the patient experience, 3) accelerating health equity progress with partnerships, 4) creating the workforce of the future, and 5) a changing competitive landscape.
To learn more about Vynamic’s work with Providers in the Health Services sector, visit .
Podcast Tags: healthcare, healthcare news, providers, health systems, hospitals, healthcare trends
Panel – Ryan Hummel, Jen Burke
Research & Production – Ryan Hummel, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Deals, mergers, partnerships, and acquisitions are key mechanisms as health organizations look to enter new markets, differentiate their value proposition, and achieve growth strategies. Despite a less than favorable economic environment, the health industry has seen some major headlines in this space this year. Jen and Mindy are joined by Vynamic’s Deal Activation & Partnership Enablement Service Leads, Sean Martin and Kevin Fletcher, to discuss what’s driving these deals and what health industry leaders should be thinking about to maximize their value.
For more information about the work discussed in this episode, visit https://vynamic.com/what-we-do/services/deal-activation-partnership-enablement/
Podcast Tags: healthcare, healthcare news, mergers, acquisitions, deal activation, partnerships, health services, payers, providers, life sciences
Source Links:
- Optimistic outlook for deals through 2023
- M&A and venture trends in life sciences in 2023
- A Look at Q2 M&A and Beyond: Are Conditions Ripe for a Strong 2024 M&A Rebound?
- The Kaiser Permanente-Geisinger deal: Questions and answers
- CVS closed $8B deal for health services company Signify Health
- Pfizer buys Seagen for $43B, boosts access to cancer drugs
- Amgen completes $27.8 billion Horizon Therapeutics deal
Panel – Sean Martin, Kevin Fletcher, Mindy McGrath, Jen Burke
Research & Production – Adrea Cope, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Payer organizations are betting big on government markets, with some abandoning commercial opportunities entirely. In this episode, Jen is joined by two leaders in Vynamic\’s Health Services sector, Executive Saurabh Raman and Senior Director Keith Sutter to explore what this trend means for the health industry, the complexities involved in these markets, and the steps payers can take to guarantee success.
For more information about the work discussed in this episode, check out https://vynamic.com/what-we-do/health-industry/health-services/
Podcast Tags: healthcare, healthcare news, health plans, CMS, Medicare, Medicaid
Source Links:
- Medicare Advantage in 2023: Enrollment Update and Key Trends
- The Employer Strikes Back: The Hollowing of the Commercial Health Insurance Market and Its Impact on Payers and Providers
- Medicare Advantage\’s growth spurt brings tensions
- The subtle privatization of Medicare
- Expanding Medicare Advantage could address \’fragmented\’ care for dual-enrolled individuals
- 10 Things to Know About the Unwinding of the Medicaid Continuous Enrollment Provision
- A Profile of Medicare-Medicaid Enrollees (Dual Eligibles)
- CMS Shared Savings Program In the News
- Medicare Shared Savings Program Saves Medicare More Than $1.8 Billion in 2022 and Continues to Deliver High-quality Care
Panel – Keith Sutter, Saurabh Raman, Jen Burke
Research & Production –Marc Young, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this episode, Mindy and Jen catch up on the impact that the Inflation Reduction Act has had on the health industry over the last year and look ahead to how life sciences organizations, payors, and providers can prepare for the changes that this legislation will cause.
If you missed our initial coverage of the Inflation Reduction Act, check out our Trending News episode from August 18, 2022.
Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, payors, providers, Medicare, drug prices
Source Links:
- Biden-Harris Administration Moves Forward with Medicare Drug Price Negotiations to Lower Prescription Drug Costs for People with Medicare
- U.S. Announces First Drugs Picked for Medicare Price Negotiations
- On the First Anniversary of the Inflation Reduction Act, Millions of Medicare Enrollees See Savings on Health Care Costs
- Understanding the Health Provisions in the Inflation Reduction Act
- Inflation Reduction Act and Medicare
Panel – Jen Burke, Mindy McGrath
Research & Production – Jen Burke, Mindy McGrath
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
The growth of the biotech industry has become a recurring topic on Trending Health episodes, from headlines about Novo Nordisk products Ozempic and Wegovy, to the emergence of Moderna as a household name thanks to their mRNA COVID-19 vaccine. As more biotech companies emerge into the market, they bring with them a mix of challenges and opportunities. On this episode of Trending Health, Jen and Mindy are joined by special guest, Dean McAlister, EVP of Inizio Biotech, to discuss the latest headlines and stories from the biotech sector.
For more information about the work discussed in this episode & Inizio Biotech, check out “The Phase II Inflection Point: Investing to Maximize Asset Value”.
Podcast Tags: healthcare, healthcare news, life sciences, biotech
Panel – Dean McAlister, Jen Burke, Mindy McGrath
Research & Production – Anna Briccetti, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
The global medical device market is expected to grow at a compound rate of nearly 5% in the next few years – fueled by a forecasted uptick in product launches. On this episode, Jen is joined by Vynamic\’s Head of Health Technology Sector Mary Virzi and Senior Manager Christina Nikolos, to discuss how MedTech companies should approach launch to capitalize on this opportunity.
For information about how Vynamic can support Med and Health tech companies preparing for launch, visit vynamic.com/what-we-do/health-industry/health-technology/
Podcast Tags: healthcare, medtech, product launch, medical device, health tech, healthcare technology
Source Links:
- Special Report—The top 10 medtech companies of 2024
- MedTech Industry Trends 2023 – What\’s the Future?
- The 10 most innovative medical device companies of 2023
- Medical devices and pharmaceuticals: Two different worlds in one health setting
- Future of medtech: Build resilience, deliver value
- MedTech is going consumer; capturing the opportunity requires a new approach
- The Future of MedTech Defined by Healthcare Consumerism
- Value-centricity is key for MedTech to become a strategic partner to customers
Panel – Mary Virzi, Christina Nikolos, Jen Burke
Research & Production – Adrea Cope, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Cell and gene therapies present an enormous opportunity for patients – the ability to insert or adapt genetic material is a true breakthrough for precision medicine and brings hope to those with previously incurable diseases. However, bringing these therapies to patients comes with enormous complexity – from research and approval through manufacturing and administration. In this episode, Jen and Mindy are joined by special guests Karen Baldry and Rebecca Sisselman to discuss the opportunities cell and gene therapies present, the challenges industry partners may be facing, and key considerations for navigating towards success.
For a recent example of Vynamic’s work in cell and gene therapy, check out our case study “Market Access Capability Analysis & Process Mapping for a Cell and Gene Therapy (CGT) Biotech”
Podcast Tags: healthcare, life sciences, cell and gene therapy, gene therapy, rare disease, drug launch
Source Links:
- Eight imperatives for launching cell and gene therapies
- Why Integrated Partners are Critical to Cell and Gene Therapy Success
- Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective
Panel – Karen Baldry, Rebecca Sisselman, Mindy McGrath, Jen Burke
Research & Production – Marc Young, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
In this episode, Jack, Ollie, and Jen discuss some recent EU-based newsworthy items, including the importance of ethnicity data and its impact on healthcare systems (0.35), exciting and emerging retail health opportunities (8.08), and a landmark report calling for urgent investment in digital health literacy (16.20).
Podcast Tags: healthcare, healthcare news, life sciences, ethnicity, DEI, WHO, Retail Health, Digital, Digital Health, health policy, public health
Source Links:
- Hidden in plain sight: addition of race and ethnicity improves clinical algorithm performance
- The problem with ethnicity categories in UK health data
- How can we make better use of ethnicity data to improve healthcare services?
- Healthcare AI Caution: Addressing ethnic health inequalities
- How can we make better use of ethnicity data to improve healthcare services?
- AI in healthcare could exacerbate ethnic and income inequalities, scientists warn
- The health of people from ethnic minority groups in England
- Understanding consistency of ethnicity data recorded in health-related administrative datasets in England: 2011 to 2021
- One-stop shop: Where healthcare meets retail
- Retail Healthcare Continues to Consolidate in Europe
- Boots boss calls for data sharing between pharmacies and the NHS
- The Future of Retail Health and the New Healthcare Experience
- UK public becoming more comfortable with healthcare in retail settings
- High Street giant Boots is taking digital healthcare to the people
- Many people on Medicare lack internet access and digital literacy, and it’s harming their health. How some groups are addressing the problem
- Statement – We are on the cusp of a digital health revolution yet millions risk being left behind
- Digital health divide: only 1 in 2 countries in Europe and central Asia have policies to improve digital health literacy, leaving millions behind
- Millions left behind by a lack of regulation on improving digital health literacy
- WHO Europe Calls for Urgent Investment in Digital Health Literacy
- Safety of telehealth and digital health services is being neglected, says WHO Europe
Panel – Jack Young, Jen Burke, Ollie May
Research & Production – Jack Young, Karan Pandya, Ollie May
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us atTrendingHealth.comor share a voicemail at
1-888-VYNAMIC.
Artificial intelligence (AI) has become a hot topic this year with the rapid adoption of ChatGPT, a powerful generative language model that was released late last year. In this special Trending News US episode, Jen, Ryan, and Mindy are joined by Vynamic’s Todd Quartiere to discuss the latest news when it comes to AI in the health industry.
Podcast Tags: healthcare, artificial intelligence, ChatGPT, health services, life sciences, health technology
Source Links:
- QuantHealth brings its AI-informed clinical drug trials to the US with $15M round
- Google Cloud, HCA team up to deploy AI in the emergency department
- AWS rolls out generative AI service for healthcare documentation software
- Epic taps Microsoft to accelerate generative AI-powered 'copilot' tools to help clinicians save time
- BLUE CROSS BLUE SHIELD OF MASSACHUSETTS USES ARTIFICIAL INTELLIGENCE TO SPEED REVIEW TIME, AUTOMATE AUTHORIZATIONS & ELIMINATE ADMINISTRATIVE COSTS
- Shaping A Responsible AI-Powered Future In Life Science
- How machine-learning models can amplify inequities in medical diagnosis and treatment
- ChatGPT’s Performance Found Lacking on Cancer Treatment Recommendations
- Generative AI brings great potential—and risks—to payer space
Panel – Todd Quartiere, Ryan Hummel, Mindy McGrath, Jen Burke
Research & Production – Anna Briccetti, Natalie Blahunka, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki, Mindy McGrath
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
As healthcare providers incorporate an expanding landscape of technologies and strive to meet patient expectations in the post-pandemic world, the standards of healthcare delivery are rapidly changing. The typical point of care experience for patients is shifting beyond the hospital, as facilities begin to prioritize digitization, AI-informed decision making, and operational efficiency. In this episode, Jen and Mindy are joined by Vynamic’s Head of Provider Sector, Ryan Hummel, as well as health system leaders across the nation, to discuss what the hospital of the future could look like.
Podcast Tags: healthcare, health services, providers, hospitals
Source Links:
- The digital hospital of the future
- In the Future, Patients Won’t Go to the Hospital—It Will Come to Them
- When the walls come tumbling down: the hospital of the future
- The future of hospitals: a consultancy viewpoint
- 5 Trends That Will Determine The Hospital From The Future
Panel – Ryan Hummel, Mindy McGrath, Jen Burke
Research & Production – Marc Young, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Across the healthcare industry, organizations are beginning to think and operate differently to expand capabilities and adapt to a changing environment. Historically separate entities, such as health plans, providers, and technology companies, are coming together to collaborate on innovative solutions to a complex healthcare system. In this episode, Jen and Mindy are joined by Vynamic’s Provider Head of Sector, Ryan Hummel, and Health Plans Head of Sector, Saurabh Raman, to discuss how, and why, these health service organizations are re-imagining traditional sectors.
For more of Vynamic’s perspective on Convergence in Healthcare, check out:
- Breaking Boundaries: The Convergence Evolution
- The Convergence Conversation
- Health Plans: Big Bets for Convergence & Strategic Capital Diversification
- The Rise of Primary Care: Leading the Convergence Movement
- 2023 Healthcare Industry Trends
Podcast Tags: healthcare, health services, health plans, providers, convergence
Panel – Saurabh Raman, Mindy McGrath, Ryan Hummel, Jen Burke
Research & Production – Adrea Cope, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
On this week’s Trending News EU episode, Jack and Ollie discuss a few recent EU-based newsworthy items including the potential for robotics to transform surgical and patient care (0.35), exciting progress being made in Europe to advance decentralised clinical trials (7.26), and much needed hope for those suffering with postpartum depression following approval in the US of an innovative new medicine (15.48).
Podcast Tags: healthcare, healthcare news, robotics, AI, artificial intelligence, NHS, health equity, EU, clinical trials, neuroscience, depression, postpartum depression, major depressive disorder, biogen
Source Links:
- Outdated legacy tech risks driving frustrated staff out of the NHS
- Millions of hours of doctors’ time lost each year to ‘inadequate’ IT systems
- St Bartholomew’s perform first robotic-assisted lung biopsy
- Is Outdated Technology Holding Back UK Surgeons?
- The robotics revolution has arrived, and it is changing how we do surgery
- €60 million committed to establish AI and robotics in healthcare
- Robotic surgery supporting faster recoveries and better outcomes
- Different, But Not Poles Apart: Running Decentralized Clinical Trials In EU & US
- Principles-Based vs Prescriptive: How US & EU Compare In Their Approach To Decentralized Trials
- How clinical trials benefit from decentralized solutions: A Nordic case study
- The trial of the future: using digital technologies to enable decentralized trials
- Decentralized trials getting some attention on the international regulatory front
- No place like home? Stepping up the decentralization of clinical trials
- A new pill in the U.S. offers hope to mothers with postpartum depression
- Postpartum psychosis: new mothers speak out over need for support
- Clinical Efficacy of a 2-Week Treatment Course of Zuranolone for the Treatment of Major Depressive Disorder and Postpartum Depression: Outcomes From the Clinical Development Program
- Impact of new pill to treat postpartum depression will depend on price
- Biogen, Sage's postpartum depression approval overshadowed by larger rejection
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Jen Burke, Director
Jen.Burke@vynamic.com
Jack Young, Senior Director
Jack.Young@vynamic.com
Oliver May, Senior Manager
Oliver.May@vynamic.com
In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the latest in drug shortages across the US market, the damaging impact of cybersecurity and ransomware attacks on health systems and hospitals, and the FDA’s approval of Zurzuvae, a depression pill specific to treat severe depression after childbirth.
Podcast Tags: healthcare, healthcare news, life sciences, public health, drug shortages, cybersecurity, ransomware, FDA, women’s health, reproductive health, post-partum depression, mental health
Source Links:
- Pfizer adds rocky mount meds emergency ordering list thwart hospital shortages
- Drugmakers are abandoning cheap generics and now US cancer patients can’t get meds
- South Dakota Drug Shortage Stockpile
- Hackers force hospital system to take its nation computer system offline
- Hospitals risk of data breach doubles just before, after a merger deal, research shows
- HHS release free online cybersecurity training, best practice reports for healthcare
- Hospitals top all industries when it comes to money lost in data breach
- FDA Approves First Pill for Postpartum Depression
- FDA Approves first postpartum depression pill in the US
- Biogen, Sage’s postpartum depression approval overshadowed by larger rejection
- More US counties have become maternity deserts since 2020
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Mindy.McGrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Jen Burke, Director
Jen.Burke@vynamic.com
The impact of climate change on global health systems and health outcomes necessitates comprehensive action across healthcare decision making, policy formation, governance, structures, and systems. In this episode, Jen, Ryan, and Ollie are joined by Vynamic’s Rosanna Vellacott, to discuss how healthcare systems are grappling with the impacts of climate change and the multi-pronged approach required to address the accompanying public health crisis.
Podcast Tags: healthcare, climate change, public health, mental health, providers
Source Links:
· Five key links between climate change and health
· WHO issues urgent call for global climate action to create resilient and sustainable health systems
· Why climate resilience is key to building the health care organization of the future
· Valley fever, historically found only in the Southwest, is spreading. It can have devastating consequences.
· UW study strengthens evidence of link between air pollution and child brain development
· A Scoping Review of Interventions for the Treatment of Eco-Anxiety
· Yale Experts Explain Climate Anxiety
· Climate anxiety in children and young people and their beliefs about government responses to climate change: a global survey
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Rosanna Vellacott, Manager
Rosanna.Vellacott@vynamic.com
Oliver May, Senior Manager
Oliver.May@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Jen Burke, Director
Jen.Burke@vynamic.com
The US primary care industry is in a period of rapid disruption, as dozens of new players raise capital like never before. While the operating methods of these new companies vary, the mission is the same – to utilize primary care to provide high quality, convenient care at a lower cost. In this episode, Jen, Mindy, and Ryan are joined by Vynamic’s Jed Barnes, to discuss what these changes mean for the future of primary care and healthcare industry at large.
Podcast Tags: healthcare, primary care, providers, value based care, fee for service
For more information about Vynamic’s work in the Provider sector, please visit https://vynamic.com/sectors/providers/
Source Links:
· Primary Care in High-Income Countries: How the United States Compares
· 5 Things to Know about Amazon’s Recent One Medical Acquisition
· How Amazon built its healthcare strategy from Haven to One Medical
· Amazon’s Foray into Primary Care Won’t Be Easy
· CVS closes $10.6B acquisition of Oak Street Health to expand primary care footprint
· JPM21: Oak Street Health, One Medical CEOs explain how healthcare models can actually scale
· Convergence in Healthcare: Providers, Employers, and Health Plan
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Jed Barnes, Manager
Jed.Barnes@vynamic.com
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Mindy.McGrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Jen Burke, Director
Jen.Burke@vynamic.com
On this week’s Trending News EU episode, Jack and Ollie discuss a few recent EU-based newsworthy items including new therapies slowing Alzheimer’s progression (0:35), practical application of AI to reduce waiting times in NHS hospitals (8:34), and the impact of the recent European heatwave on healthcare systems (14:03).
Podcast Tags: healthcare, healthcare news, life sciences, AI, machine learning, artificial intelligence, NHS, health equity, EU, neuroscience, scientific research, innovation, alzheimers, dementia, climate change, heatwave
Source Links:
· Alzheimer’s drug donanemab helps most when taken at earliest disease stage
· NHS ‘nowhere near ready’ to deliver new Alzheimer’s drug
· Drug donanemab seen as turning point in dementia fight
· Donanemab: NHS ‘not ready’ for Alzheimer’s wonder drugs as patients face postcode lottery for brain scans
· Life sciences competitiveness indicators 2023
· There's Finally a Fully Approved Alzheimer's Drug—But Getting It Won't Be Easy
· How AI is helping to shrink waiting times for NHS cancer patients
· AI cuts waiting times for cancer patients in NHS first
· Google and Microsoft Vie for Dominance in AI Healthcare
· Heatwaves, hospitals and health system resilience in England: a qualitative assessment of frontline perspectives from the hot summer of 2019
· Why do NHS hospitals struggle to handle heatwaves?
· The impact of the 2003 heat wave on mortality and hospital admissions in England
· Heat and health in the WHO European Region: updated evidence for effective prevention
· UK heatwave piles further pressure on stretched NHS services
· Heat, Heatwaves and Cardiorespiratory Hospital Admissions in Helsinki, Finland
· Italian hospitals report sharp rise in emergency cases as Rome hits 41.8C
· Parisians are most at risk of dying in European heatwaves
· Medicines manufacturing has the potential to drive UK growth over the next 10 years
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Jen Burke, Director
Jen.Burke@vynamic.com
Jack Young, Senior Director
Jack.Young@vynamic.com
Oliver May, Senior Manager
Oliver.May@vynamic.com
In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the recent FDA approvals of Leqembi and Opill, a price transparency and PBM reform package working its way through Congress, and the recent series C funding raise for Octave.
Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, CMS, DA, Medicare, drug prices, PBM, Alzheimer’s, women’s health, reproductive health, mental health, telemedicine, virtual care
Source Links:
- New Federal Decisions Make Alzheimer’s Drug Leqembi Widely Accessible
- With nonprescription nod for Perrigo's Opill, the age of the over-the-counter birth control pill arrives in the US
- House committee moves another price transparency, PBM reform package forward
- Education and the Workforce Committee Passes Landmark Health Care Package
- Octave nabs $52M, eyes expansion of in-network therapy services to all 50 states in 2024
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Mindy.McGrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Jen Burke, Director
Jen.Burke@vynamic.com
Life Sciences and MedTech companies are transforming the way they interact with customers; working to create experiences that are personalized, digital, timely, and intuitive. In this episode, Jen is joined by Vynamic’s Customer Experience Transformation Lead, Mike Zapiec, Omnichannel Offering Lead Josh Padams, and MedTech Omnichannel Expert Jess Werle to discuss what omnichannel really is, why it’s changing the game, and how Life Sciences and MedTech organizations can take their first steps on this journey.
Podcast Tags: healthcare, life sciences, medtech, medical devices, customer experience, omnichannel, digital marketing
For more information about Vynamic’s Customer Experience Transformation offerings, please visit https://vynamic.com/offerings/customer-experience-transformation-cxt/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mike Zapiec, Senior Director
Mike.Zapiec@vynamic.com
Josh Padams, Director
Josh.Padams@vynamic.com
Jess Werle, Director
Jess.Werle@vynamic.com
Jen Burke, Director
Jen.Burke@vynamic.com
While Life Sciences organizations understand the growing potential of the global medicines market, executing successful launches in diverse markets remains a formidable challenge – requiring a balance of efficient globalized frameworks and tactics adapted to local market dynamics. In this episode, Jen is joined by Vynamic’s Global Launch Experts, Stephanie Farrell and Felice Walter, to discuss how to win when it comes to global product launch.
Podcast Tags: healthcare, life sciences, product launch, global medicine
For more information about Vynamic’s Product Launch offerings, please visit https://vynamic.com/services/actionable-strategy/product-launch/
Source Links:
· Global Trends in R&D 2023
· The Global Use of Medicines 2022
· Deloitte’s 13th Annual Pharmaceutical Innovation Report: Pharma R&D Return on Investment Falls in Post-Pandemic Market
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Stephanie Farrell, Senior Director
Stephanie.Farrell@vynamic.com
Felice Walter, Senior Director
Felice.Walter@vynamic.com
Jen Burke, Director
Jen.Burke@vynamic.com
On this week’s Trending News EU episode, Jack and Ollie discuss a few recent EU-based newsworthy items including the significant inequalities faced by LGBTQ+ communities in the UK (0.35), a landmark mental health strategy announced by the EU Commission (7.17), and some exciting investments and developments in Neuroscience Centres of Excellence in the UK (13.17).
Podcast Tags: healthcare, healthcare news, life sciences, DEI, diversity, LGBTQ+, mental health, health equity, EU, neuroscience, scientific research, innovation, alzheimers, dementia
Source Links:
LGBT Youth Scotland survey highlights hostile NHS healthcare | HeraldScotland
NHS Report Reveals Significant Health And Social Inequalities Faced By Scotland’s LGBT+ Communities – News & Media (nhslothian.scot)
LGBTQ+ staff and patients deserve better from the NHS | The King's Fund (kingsfund.org.uk)
‘A giant step’: charities welcome plan to widen access to IVF on NHS | IVF | The Guardian
The hidden costs facing potential LGBTQ+ parents | Stonewall
European Commission spending €1.23bn to reform EU’s mental health - EU Reporter
EU Commission allocates $1.3 billion to tackle mental health 'silent epidemic' | Reuters
Antidepressants: Two million taking them for five years or more - BBC News
Chart: Europe Is Facing a Dementia Problem | Statista
UK on verge of new dawn for dementia treatments, says taskforce chair | Dementia | The Guardian
UCL Neuroscience Centre of Excellence tops out | Mirage News
Wrexham: Global drug production site gets new £75m facility - BBC News
Medicines manufacturing has the potential to drive UK growth over the next 10 years (abpi.org.uk)
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Jen Burke, Director
Jen.Burke@vynamic.com
Jack Young, Senior Director
jack.young@vynamic.com
Oliver May, Senior Manager
oliver.may@vynamic.com
In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including legal challenges to the Medicare Drug Price Negotiation Program established by the Inflation Reduction Act.
Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, CMS, HHS, Medicare, drug prices
Source Links:
- Merck sues to block Medicare negotiation of drug prices
- Bristol Myers follows Merck's lead with its own lawsuit blasting IRA's Medicare negotiations
- PhRMA joins legal battle over Inflation Reduction Act's 'price-setting' measures
- Explaining the Prescription Drug Provisions in the Inflation Reduction Act
- Pfizer, BMS' Eliquis tops list of drugs destined for Medicare price negotiations in 2026: Moody's
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Mindy.McGrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Jen Burke, Director
Jen.Burke@vynamic.com
The role of Medical Affairs function within Life Sciences organizations continues to expand – increasing its focus on patient centricity and requiring the development of new capabilities, partnerships, and cross-functional collaboration. In this episode, Jen is joined by Vynamic’s Tamaron Bertelli and Nick Fletcher to discuss these trends and how Medical Affairs organizations can optimize their ways of working.
Podcast Tags: healthcare, life sciences, medical affairs, patient centricity, omnichannel
For more information about Vynamic’s Medical Affairs offerings, please visit https://vynamic.com/offerings/medical-affairs-2/
To learn more about the role of Medical Affairs when it comes to successful product launch, please visit https://vynamic.com/insights/six-key-elements-for-medical-affairs-in-product-launch-planning/
Source Links:
· Medical Affairs Professional Society (MAPS) Releases Vision for Future of Medical Affairs 2030
· Top 4 Medical Affairs Trends for 2023 & Beyond
· Biopharma Medical Affairs: Where We’ve Been and Where We’re Headed
· A vision for Medical Affairs in 2025
· Developing Medical Affairs Leaders Who Create the Future
· Mastering medical affairs
· The Influence Data, Digitalization & Diversity Will Have on Medical Affairs in 2023
· Medical affairs, AI and insight generation
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Tamaron Bertelli, Senior Director
Tamaron.Bertelli@vynamic.com
Nick Fletcher, Director
Nick.Fletcher@vynamic.com
Jen Burke, Director
Jen.Burke@vynamic.com
Regular changes to and state-to-state variations in US data privacy laws often leave the public wondering who has access to their data and how it might be used. This is especially concerning when it comes to consumer health data, where misuse of personal information could negatively impact patients’ care, treatment, and livelihood – concerns that have only been exacerbated with the overturning of Roe v. Wade. In this episode, Jen is joined by Vynamic's Jen Proietti-Fox and Courtney Ciccarelli, to discuss data privacy rules and their implications for patients, health tech companies, and the industry at large.
Podcast Tags: healthcare, healthcare technology, health tech, digital health, data privacy, women’s health, health equity
Source Links:
· The State of Consumer Data Privacy Laws in the US (And Why It Matters)
· Patient perspectives around data privacy
· State Laws Related to Digital Privacy
· U.S. Data Privacy Protection Laws: A Comprehensive Guide
· How period tracking apps and data privacy fit into a post-Roe v. Wade climate
· Period tracker Flo launches anonymous mode amid post-Roe privacy concerns
· These Period Tracker Apps Say They Put Privacy First. Here’s What We Found.
· SXSW 2023: Data privacy, healthcare websites new battlegrounds over reproductive rights
· ‘Shut it off immediately’: The health industry responds to data privacy crackdown
· Examining the intersection of data privacy and civil rights
· ACLU OF FLORIDA STATEMENT ON BILL THAT ALLOWS HEALTHCARE PROVIDERS AND PAYORS TO REFUSE HEALTHCARE TO FLORIDIANS
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Jen Proietti-Fox, Director
Jen.Proietti-Fox@vynamic.com
Courtney Ciccarelli, Director
Courtney.Ciccarelli@vynamic.com
Jen Burke, Director
Jen.Burke@vynamic.com
On this week’s Trending News EU episode, Jack and Ollie discuss a few recent EU-based newsworthy items including an update on the UK’s Life Sciences Plan, pharmaceutical industry growth in Denmark and Sweden, and UK funding for extended reality mental health projects.
Podcast Tags: healthcare, healthcare news, biopharma, life sciences, UK, Denmark, Sweden, public health, mental health, virtual reality, augmented reality, extended reality
Source Links:
· Bold new life sciences vision sets path for UK to build on pandemic response and deliver life-changing innovations to patients
· Delivery pivotal as UK life sciences plan takes shape
· Happy pills: How Sweden and Denmark became rare bright spots for Europe’s pharma industry
· Leading countries by research and development (R&D) expenditure as share of gross domestic product (GDP) worldwide in 2022
· AstraZeneca chair Johansson to retire in 2023 after 11 years in role
· Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW)
· Novo Nordisk Foundation Quantum Computing Programme
· UK funds extended reality projects for mental health
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Jack Young, Senior Director
Jack.Young@vynamic.com
Oliver May, Senior Manager
Oliver.May@vynamic.com
Jen Burke, Director
Jen.Burke@vynamic.com
In this episode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including recent approvals from the House Energy and Commerce Subcommittee on Health and Phase 3 clinical trial results for oral semaglutide to treat obesity.
Podcast Tags: healthcare, healthcare news, health plans, life sciences, health policy, public health, Medicare, drug prices, PBMs, 340B, obesity
Source Links:
- A key House panel approved a slew of health policies. Here's a look at 4 of them
- Novo Nordisk A/S: Oral semaglutide 50 mg achieved 15.1% weight loss (17.4% if all people adhered to treatment) in adults with obesity or overweight in the OASIS 1 trial
- Anti-obesity medications are set to skyrocket this year. But how will we afford them?
- What Could New Anti-Obesity Drugs Mean for Medicare?
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Mindy.McGrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
The emerging need for connected, digital patient healthcare solutions has been accelerated by the healthcare workforce crisis – and improved options for scalable patient monitoring and data analytics have provided opportunities for the MedTech industry to jump in. In this episode, Jen is joined by Vynamic Director Andrew Sgarlato and Executive and Head of Healthcare Technology, Mary Virzi, to discuss what MedTech organizations should be thinking about as they invest in the burgeoning digital health space.
Podcast Tags: healthcare, healthcare technology, health tech, med tech, medical devices, digital health, remote patient monitoring, big data, machine learning, artificial intelligence
Source Links:
· What Medtech Startups Need to know About Remote Monitoring
· A Knee Replacement that talks to your Doctor? It’s just the beginning.
· When does a digital health project become a medical device
· How the right infrastructure increases the resilience of your HealthTech devices
· Friday Q&A: For GE HealthCare, the future is digital, CEO Arduini says
· How the medtech industry can capture value from digital health
· Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound
· Medtech buyouts by private equity in Q4 shed light on deal-making trends in 2023: report
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mary Virzi, Executive and Head of Healthcare Technology
Mary.virzi@vynamic.com
Andrew Sgarlato, Director
Andrew.sgarlato@vynamic.com
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
On this week’s Trending News EU episode, Jack, Gemma, and Adrien share their insights from the recent Reuters Pharma 2023 conference held in Barcelona including the latest developments on Digital Health (1.51), Medical Affairs (3.50), Patient Engagement (7.11), and the perspectives from pharma leaders who attended Vynamic’s roundtable on patient initiative impact measurement (10.06)
Podcast Tags: healthcare, pharma, digital health, medical affairs, patient engagement, omnichannel patient experience, metrics, impact
Source Links:
Pharma 2023 (reutersevents.com)
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
Jack Young, Senior Director
jack.young@vynamic.com
Gemma Pfister, Senior Executive
gemma.pfister@vynamic.com
Adrien Moucquot, Senior Director
adrien.moucquot@vynamic.com
In this episode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including the judicial activity surrounding Mifepristone, a medical abortion drug, and the recent announcement of Kaiser’s acquisition of Geisinger to launch Risant Health.
Podcast Tags: healthcare, healthcare news, health plans, life sciences, health policy, public health, mergers and acquisitions, FDA
Source Links:
- Texas judge halts FDA approval of abortion pill
- Supreme Court preserves access to key abortion drug as appeal proceeds
- Supreme Court Delays Decision on Abortion Pill, Preserving Access for Now
- Generic abortion pill manufacturer sues FDA in effort to preserve access
- Supreme Court Ensures, for Now, Broad Access to Abortion Pill
- 6 Ways the Mifepristone Rulings May Impact Future FDA Approvals
- Kaiser Permanente to Acquire Geisinger
- Kaiser Permanente and Geisinger come together to launch Risant Health
- Kaiser Permanente: Commitments and Impact
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Mindy.McGrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
A lack of clinical and epidemiological data for women, racial, and ethnic groups can contribute to diagnostic uncertainty, lower rates of clinical development for conditions most impacting these communities, and enduring disparities in health. In this episode, Jen is joined by Inizio’s Global Head of Diversity, Equity, & Inclusion, Stef Christmas, and special guest Soo Son, a Health Equity Change Agent from Unlocking Eve to discuss healthcare data gaps, biases, and what we can do to advance health equity.
Podcast Tags: healthcare, DEI, life sciences, clinical studies, epidemiology, health equity, big data, machine learning
Source Links:
· Understanding gender roles in health equity: Perspectives from women leaders in healthcare
· Hysterical Health: Unpicking the cultural beliefs that shape women's healthcare
· Closing the data gaps in women’s health
· Enhancing Diversity and Inclusion in Clinical Trials
· Integrating Research into Community Practice — Toward Increased Diversity in Clinical Trials
· Increasing Diversity in Clinical Trials: Overcoming Critical Barriers
· Racial Disparities in Clinical Trials
· Addressing Demographic Disparities in Clinical Trials
For additional information on DEI in Clinical Trials, check out Vynamic’s podcast “DEI & Clinical Trials – Driving Meaningful Change”, insight “Integrating Diversity, Equity, & Inclusion Throughout Clinical Trials” and case study “Prioritizing Diversity, Equity, & Inclusion Across Research & Development.”
For more information on Inizio, please visit https://inizio.health/what-matters-to-us/diversity-equity-inclusion/
For more information on Unlocking Eve please visit https://www.unlockingeve.org/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Stefanie Christmas, Global Head of Diversity, Equity, & Inclusion, Inizio
Stefanie.Christmas@inizio.health
Soo Son, Health Equity Change Agent and Coach, Unlocking Eve
soomson@gmail.com
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
In this episode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including Medicare Part D impacts from the Inflation Reduction Act, Novo Nordisk’s cuts to insulin prices, and the PBM Transparency Act of 2023.
Podcast Tags: healthcare, healthcare news, health plans, life sciences, health policy, public health, Medicare, drug prices, PBMs
Source Links:
- True catastrophic coverage and shifting liability: Preparing for IRA changes
- Inflation Reduction Act: What health plans and Part D sponsors need to know to be prepared
- Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US
- Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom.
- Senate panel advances bill to reform PBMs and bring more FTC scrutiny on industry
- Commerce Committee Approves Cantwell, Grassley Bipartisan Bill to Combat Rising Prescription Drug Prices
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Mindy.McGrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
In this week’s Trending News EU episode, Jack, Ollie, and Will discuss a few recent newsworthy items on UK Life Sciences policy including what the latest spring budget means for Life Sciences (1.00), future pricing of branded medicines in the UK and differences with other countries (6.10), and how Life Sciences policy is working to attract investment and talent to the UK (18.55).
Podcast Tags: healthcare, healthcare news, NHS, life sciences policy, healthcare policy, government budget, life sciences, brexit, life sciences regulation, healthcare regulation, medicine pricing, VPAS, healthcare costs, healthcare investment
Source Links:
Spring Budget 2023 (HTML) - GOV.UK (www.gov.uk)
MHRA to receive £10m from HM Treasury to fast-track patient access to cutting-edge medical products - GOV.UK (www.gov.uk)
Chancellor gives boost to medical innovation and life sciences industry in Spring Budget | BIA (bioindustry.org)
ABPI response to the Budget
Industry reacts to approvals and R&D tax credit changes in Budget - Med-Tech Innovation (med-technews.com)
Voluntary Scheme on branded medicines (abpi.org.uk)
Comparing International Prescription Drug Prices | RAND
Leading global pharma firms exit UK drug pricing agreement (abpi.org.uk)
Life Sciences Innovative Manufacturing Fund (LSIMF) (closed to Expressions of Interest) - GOV.UK (www.gov.uk)
Life sciences companies supercharged with £277 million in government and private investment - GOV.UK (www.gov.uk)
UK government, private investors dole out $340M+ to drug, diagnostic manufacturers – Endpoints News (endpts.com)
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Jen Burke, Director
Jen.Burke@vynamic.com
Jack Young, Director
jack.young@vynamic.com
Oliver May, Senior Manager
oliver.may@vynamic.com
Will Turnbull, Senior Manager
Will.turnbull@vynamic.com
In this episode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including the Senate vote to end the Public Health Emergency ahead of the May 11th deadline, Judge O’Connor’s invalidation of the Preventive Services Mandate of the ACA, and the CMS decision to raise Medicare Advantage pay rates by 3.3% in 2024.
Podcast Tags: healthcare, healthcare news, public health, health plans, COVID-19, Affordable Care Act, ACA, CMS, Medicare
Source Links:
- Biden won’t veto Republican-led bill ending COVID emergency
- Q&A: Implications of the Ruling on the ACA’s Preventive Services Requirement
- Health Plans No Longer Have to Cover All Preventive Care at No Cost. Here’s What to Know.
- A Texas Judge Just Invalidated The Preventive Services Mandate. What Happens Next?
- CMS to raise Medicare Advantage pay rates by 3.3% in 2024; phase in risk adjustment changes
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Mindy.McGrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
For the second year in a row, financial challenges were tagged as a top concern of Hospital CEOs in the annual American College of Healthcare Executives survey – specifically increased staff and supply costs, reduced operating costs, and government funding cuts. In this episode, Jen is joined by Vynamic’s Jay York and Provider Head of Sector, Ryan Hummel, to discuss why margins are shrinking (00:52) and what provider organizations can do to weather the current financial challenges (24:00).
Podcast Tags: healthcare, providers, reimbursement, workforce crisis, Medicare, Medicaid, public health
Source Links:
- Top Issues Confronting Hospitals in 2022
- Temp nurses cost hospitals big during pandemic. Lawmakers are now mulling limits
- Nonprofit health systems' Q3 earnings: Baylor Scott & White, Sutter Health's operations stand tall among the pack
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Jay York, Executive
Jay.York@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
The FemTech sector has seen major growth in the last 5 years – and as the healthcare industry increases its focus on equity, is only projected to keep growing. In this Women’s History Month episode, Jen is joined by Vynamic’s Diana Kuritza, Jen Proietti-Fox, Shari Robbins, and HelloGina’s Daphne Petrich to discuss the latest trends in FemTech and what it could mean for women’s health going forward.
Podcast Tags: healthcare, health tech, women’s health, women’s history month, health equity, digital health
Source Links:
· Make 2023 the year of prioritizing women’s health
· 2023 PREDICTIONS—THE GOOD, THE BAD, AND THE UGLY
· European FemTech trends and startups to watch in 2023 | With insights from Essity Ventures
· What To Expect for Femtech in 2023?
· Despite 2022’s headwinds, women’s health startups did better than ever before
· The dawn of the FemTech revolution
· How FemTech is tackling the female health gap
· Femtech’s Limited Role in Tackling Healthcare Inequity
For more information on HelloGina please visit, https://www.helloginahealth.com/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Daphne Petrich, US Business Development Lead at HelloBetter
d.petrich@hellobetter.de
Shari Robbins, Senior Director
Shari.robbins@vynamic.com
Jen Proietti-Fox, Director
Jen.proietti-fox@vynamic.com
Diana Kuritza, Manager
Diana.kuritza@vynamic.com
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
On this week’s Trending News EU episode, Jack and Ollie discuss a few recent EU-based newsworthy items including a third stem cell transplant patient cured of HIV (00:40), NHS approval and investment in digital mental health therapies (04:37), a recent poll on patient centricity in biopharma (08:22), and the announcement of a Moderna campus in Oxfordshire (15:50).
Podcast Tags: healthcare, healthcare news, NHS, virtual, HIV, stem cells, public health, NICE, digital, mental health, patient centricity, biopharma, life sciences, UK
Source Links:
- HIV Patient cured after bone marrow transplant in rare case, research shows
- Germany's 'Düsseldorf Patient' cured of HIV
- German man third to be completely cured of HIV after stem cell transplant
- More digital mental health therapies backed for NHS use
- Is pharma patient centric? Not according to most doctors
- Moderna opts for Oxfordshire in quest for innovation
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Jack Young, Director
Jack.Young@vynamic.com
Oliver May, Manager
Oliver.May@vynamic.com
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
In this episode, Jen is joined by Vynamic’s Michael Hudson, Mike Cottone, and Vish Kaushik to discuss a major news item that has had everyone buzzing over the last few months – ChatGPT.
Podcast Tags: healthcare, healthcare news, AI, artificial intelligence, healthcare technology, health plans, providers, life sciences
Source Links:
- Top 10 Applications of OpenAI’s ChatGPT in the Healthcare Industry
- 5 Ways ChatGPT Will Change Healthcare Forever, For Better
- Transforming healthcare: the chatbot will see you now
- Understanding Chat-GPT, And Why It’s Even Bigger Than You Think
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Michael Hudson, Senior Director
Michael.Hudson@vynamic.com
Mike Cottone, Director
Michael.Cottone@vynamic.com
Vish Kaushik, Director
Vishal.Kaushik@vynamic.com
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
In the United States, most employers choose to pay for at least some of their workers’ health services directly from their own funds. Lately, concerns over affordability have led them to take an increasingly active role in their healthcare strategies. In this episode, Jen is joined by Vynamic Director Kirsten Meisterling and Executive & Head of Health Plans, Saurabh Raman, to discuss why health plans should be thinking about self-funded employers now (02:23), what this market segment needs (07:18), and how health plans can communicate their value potential effectively (15:23).
Podcast Tags: healthcare, health plans, self-funded employers, health insurance
Source Links:
- Health Insurance Coverage of the Total Population | KFF
- Section 10: Plan Funding – 9805 | KFF
- The development and growth of employer-provided health insurance (bls.gov)
- 2023 forecast: Self-insured employers face new challenges (fiercehealthcare.com)
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Saurabh Raman, Executive and Head of Health Plans Sector
Saurabh.Raman@vynamic.com
Kirsten Meisterling, Director
Kirsten.Meisterling@vynamic.com
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
On this week’s Trending News EU episode, Jack and Ollie discuss a few recent EU-based newsworthy items including NHS virtual wards to alleviate healthcare pressure (0:40), conclusion of the infected blood enquiry (6:15), and three NICE regulatory green lights for a paediatric-onset hypophosphatasia treatment, a cannabidiol based treatment for TSC, and another CAR-T cell therapy recommended for lymphoma (9:25).
Podcast Tags: healthcare, healthcare news, NHS, virtual wards, telehealth, public health, NICE, healthcare regulation, cannabidiol, CDB treatment, cell therapy, gene therapy, leukemia, cancer, EU, regulation
Source Links:
- https://www.nursingtimes.net/news/research-and-innovation/analysis-virtual-wards-offer-potential-benefits-but-come-with-risks-02-11-2022/
- Government plans 500% expansion of virtual wards (digitalhealth.net)
- Rishi Sunak set to unveil emergency care plan to slash NHS waiting times | Health | The Guardian
- https://www.bmj.com/content/380/bmj.p294
- https://www.bbc.co.uk/news/health-64497868
- https://www.pharmatimes.com/news/nice_recommends_alexions_asfotase_alfa_across_england_1485973
- https://www.pharmatimes.com/news/vital_nice_nod_for_jazzs_epidyolex_1486167
- https://www.pharmatimes.com/news/gileads_car_t-cell_therapy_recommended_for_use_across_the_nhs_1485911
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Jen Burke, Director
Jen.Burke@vynamic.com
Jack Young, Director
jack.young@vynamic.com
Oliver May, Manager
oliver.may@vynamic.com
In this episode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including Amazon’s RxPass (00:30), a study on the impact of high-deductible health plans on health outcomes (05:08), and a push from Blue Cross Blue Shield to expand site-neutral payments (08:34).
Podcast Tags: healthcare, healthcare news, drug costs, generics, public health, health plans, health outcomes
Source Links:
- https://www.fiercehealthcare.com/health-tech/amazon-pharmacy-rolls-out-rolls-out-service-unlimited-generic-prescriptions-5-month
- https://www.fiercehealthcare.com/health-tech/how-amazons-latest-pharmacy-move-lays-groundwork-longer-term-play
- https://www.advisory.com/daily-briefing/2023/01/25/amazon-rx-pass
- https://www.healthaffairs.org/do/10.1377/forefront.20200615.238552/
- https://www.fiercehealthcare.com/payers/employers-should-carefully-weigh-benefits-high-deductible-health-plans-study
- https://www.fiercehealthcare.com/providers/blues-press-congress-expand-site-neutral-payment-reforms-more-outpatient-clinics
- https://www.beckersasc.com/asc-coding-billing-and-collections/bcbs-leans-into-site-neutral-payments.html
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Mindy.McGrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
Innovation, technology, and heightened competition continue to force the healthcare industry to adapt, and more specifically, converge – blurring boundaries between sectors as organizations look to control costs, stratify risk, and improve outcomes. In this episode, the team discusses this transformational opportunity – from where we see convergence today (01:00), to how healthcare industry leaders should be responding strategically (15:18).
Podcast Tags: healthcare, providers, health plans, health technology, primary care, value based care
Source Links:
- https://vynamic.com/insights/2023-healthcare-industry-trends/
- https://www.fiercehealthcare.com/hospitals/nearly-60-health-systems-aim-to-become-payviders-2022-survey-finds
- https://drrohitvarma.com/how-verily-uses-convergence-to-innovate-healthcare/
- https://www.aha.org/aha-center-health-innovation-market-scan/2021-09-28-most-consumers-would-switch-other-providers
- https://www.rand.org/content/dam/rand/pubs/research_briefs/RB9400/RB9491-2/RAND_RB9491-2.pdf
- https://www.businesswire.com/news/home/20220830005611/en/United-States-Home-Healthcare-Market-TrendsAnalysis-Report-2022-A-250-Billion-Industry-by-2030---ResearchAndMarkets.com
- https://www.hhmglobal.com/knowledge-bank/articles/trends-shaping-the-future-of-healthcare-delivery
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Mindy.McGrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
On this week’s Trending News EU episode, Jack and Ollie discuss a few recent EU-based newsworthy items including UK funding for genomic sequencing (0:32), world-first gene base editing treatment to treat leukemia (4:07), EU medical device regulation extensions (7:57), and the current NHS crisis including Prime Minister Rishi Sunak’s speech, strikes, and labour shortages (10:52).
Podcast Tags: healthcare, healthcare news, NHS, strike, public health, genomic sequencing, genetics, genetic testing, gene therapy, leukemia, cancer, EU, regulation, medical device, Rishi Sunak,
Source Links:
- https://www.bbc.co.uk/news/health-63561317
- https://www.pharmatimes.com/news/multi-million-pound_funding_for_genomics_research_1484753
- https://www.theguardian.com/science/2021/dec/02/what-are-pros-and-cons-of-whole-genome-sequencing-for-every-uk-baby
- https://www.science.org/content/article/teen-s-leukemia-goes-remission-after-experimental-gene-editing-therapy
- https://www.bbc.co.uk/news/uk-politics-64162849
- https://www.theguardian.com/society/2023/jan/01/nhs-unions-2-pay-rise-next-year-could-mean-more-strikes
- https://www.telegraph.co.uk/news/2023/01/06/nhs-strike-dates-january-2023-nurses-junior-doctor-ambulance/
- https://www.bbc.co.uk/news/health-63561305
- https://news.sky.com/story/new-strike-laws-to-guarantee-minimum-levels-of-safety-in-critical-sectors-confirmed-by-government-12780531
- European Commission formalizes plan to extend MDR transition out to 2027, 2028 | MedTech Dive
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Jen Burke, Director
Jen.Burke@vynamic.com
Jack Young, Director
jack.young@vynamic.com
Oliver May, Manager
oliver.may@vynamic.com
In this episode, Mindy and Ryan welcome back Jen from family leave before diving into the impacts of the federal omnibus package on the healthcare industry (00:50). Beyond funding increases to major public health agencies (01:17), this legislation covers telehealth extensions (02:52), Medicaid disenrollment (04:20), expanded mental health and addiction services (05:31), the healthcare workforce crisis (08:24), and FDA oversight for accelerated approvals (09:47).
Podcast Tags: healthcare, healthcare news, public health, mental health, telehealth, healthcare workforce, FDA, life sciences
Source Links:
- https://www.washingtonpost.com/politics/2022/12/21/under-the-radar-health-provisions-massive-government-funding-bill/
- https://www.beckershospitalreview.com/finance/congress-last-minute-1-7-trillion-omnibus-package-8-healthcare-takeaways.html?origin=CIOE&utm_source=CIOE&utm_medium=email&utm_content=newsletter&oly_enc_id=6900I7480478J2A
- https://www.counseling.org/news/updates/news-detail/2022/12/23/we-did-it!-medicare-reimbursement-now-law
- https://www.cnn.com/2022/12/20/politics/spending-bill-congress-omnibus/index.html
- https://www.hklaw.com/en/insights/publications/2022/12/whats-in-and-out-for-healthcare-in-the-year-end-funding-package
- https://www.forbes.com/sites/debgordon/2022/12/27/president-biden-signed-a-17-trillion-spending-bill-heres-what-it-means-for-your-healthcare/?sh=4d996e5d6175
- https://www.aha.org/special-bulletin/2022-12-20-appropriations-committees-release-omnibus-spending-bill-health-provisions
- https://www.biopharmadive.com/news/fda-accelerated-approval-congress-omnibus-bill-spending/639196/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Mindy.McGrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
Jen.Burke@vynamic.com
In this episode, Mindy kicks off the new year by bringing Karen Baldry (Life Sciences), Ryan Hummel (Providers), Saurabh Raman (Health Plans), and Mary Virzi (Healthcare Technology) together to discuss the most impactful industry trends shaping 2023. Particularly appropriate given the top trend Vynamic has identified this year – the convergence of healthcare to create value (1:15). Collaboration will also be critical in addressing the next trend – the growing healthcare workforce crisis (6:00). The next two trends have to do with expansion – in the definition of health to include healthcare plus selfcare (10:40) and the marketplace for precision therapy and digital therapeutics (14:02). The final trend explored is the shift from acknowledgment to activation when it comes to health equity (17:30). Finally, the group ties it all together with a discussion on how listeners can incorporate these trends into their 2023 plans (22:50).
For additional information on these 2023 Healthcare Industry Trends, check out Vynamic’s recent insight and infographic.
Podcast Tags: healthcare, healthcare news, healthcare trends, healthcare technology, providers, health plans, health equity, healthcare workforce, public health, life sciences, precision therapy
Source Links:
- https://vynamic.com/insights/2023-healthcare-industry-trends/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Mindy.McGrath@vynamic.com
Karen Baldry, Executive and Head of Life Sciences Sector
Karen.Baldry@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Saurabh Raman, Director and Head of Health Plan Sector
Saurabh.Raman@vynamic.com
Mary Virzi, Executive and Head of Healthcare Technology Sector
Mary.Virzi@vynamic.com
In this special minisode, Mindy sits down with Vynamic’s Mary Virzi to continue our series on healthcare sector trends, focusing on the Healthcare Technology sector trends Mary expects to be most impactful in 2023. These include funding flatlining within the sector (1:05), the war on talent (2:23), data access and interoperability (4:00), cyber security (5:10), and acquisitions, mergers, and partnerships (6:37).
Podcast Tags: healthcare, healthcare news, healthcare trends, cyber security, healthcare technology, data access, interoperability
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
Mindy.McGrath@vynamic.com
Mary Virzi, Executive and Head of Healthcare Technology Sector
Mary.Virzi@vynamic.com
In this special minisode, Ryan sits down with Vynamic’s Karen Baldry to continue our series on healthcare sector trends, focusing on the five Life Sciences trends Karen expects to be most impactful in 2023. These include advanced digital capabilities at scale (0:55), evolution and innovation in Market Access (1:45), product launch planning taking place earlier (2:30), moving health equity from rhetoric into action (3:15), and true business model transformation (4:15).
Podcast Tags: healthcare, healthcare news, life sciences, healthcare trends, product launch, Market Access, health equity
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Karen Baldry, Executive and Head of Life Sciences Sector
Karen.Baldry@vynamic.com
In this special minisode, Mindy and Ryan continue our series on healthcare sector trends, focusing on the five Provider trends Ryan expects to be most impactful in 2023. These include financial pressures intensifying within the sector (1:13), the clinical workforce crisis (2:44), digital health innovation as strong but changeable (4:30), care redesign efforts risking loss of focus (5:45), and patient care decisions becoming political (7:29).
Podcast Tags: healthcare, healthcare news, providers, health systems, hospitals, healthcare trends
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
Mindy.McGrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
On this week’s Trending News EU episode, Jack and Ollie discuss a few recent EU-based newsworthy items including the planned NHS nurses’ strike (1.22), recent groundbreaking treatment approvals (5.22), how pharma companies are teaming to tackle climate change (7.21), and the UK’s R&D capabilities and level of diversity (11.17).
Podcast Tags: healthcare, healthcare news, NHS, strike, public health, breast cancer, laser therapy, COP27, emissions, climate change, sustainability, diagnostics, diversity, R&D, research
Source Links:
- https://www.bbc.co.uk/news/health-63561317
- Nursing union RCN expected to announce biggest-ever strike | UK News | Sky News
- NHS reaches deal for life-saving breast-cancer drug - BBC News
- NICE backs use of MSD's KEYTRUDA for triple-negative breast cancer - (pharmaphorum.com)
- https://www.pharmatimes.com/news/nhs_to_offer_epilepsy_patients_brain_laser_therapy_1479657
- https://www.healtheuropa.com/cutting-edge-bionic-arms-are-now-available-on-the-nhs/119212/
- https://www.who.int/europe/news/item/07-11-2022-statement---climate-change-is-already-killing-us--but-strong-action-now-can-prevent-more-deaths
- https://www.fiercepharma.com/pharma/fellowship-green-astrazeneca-samsung-gsk-and-4-other-eco-minded-pharma-majors-unite-slash
- https://reaction.life/why-is-germany-able-to-test-for-coronavirus-so-much-more-than-the-uk/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Executive and Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Jack Young, Director
jack.young@vynamic.com
Oliver May, Manager
oliver.may@vynamic.com
In this minisode, Mindy and Ryan take a break from the 2023 sector trends to discuss the initial midterm election results and potential impacts on healthcare. This episode begins with a breakdown of the current state of the Senate and House before the election (0:48). Ryan then provides an overview of the initial midterm election results as we understand them (1:11) before diving into the healthcare topics that were front and center in this election cycle (2:00), specifically noting surprise outcomes in Kentucky (4:05) and South Dakota (4:55). With this new congress in mind, Mindy and Ryan discuss the potential future of the Inflation Reduction Act (5:55) and other healthcare impacts in 2023 and beyond (8:15). The conversation transitions to focus on election results at the state level (11:40) before summarizing key takeaways from the midterm elections overall (14:00).
Podcast Tags: healthcare, healthcare news, public health, election, Medicaid, midterm elections
Source Links:
- https://www.statnews.com/2022/11/07/health-science-midterms-what-were-watching/
- https://www.statnews.com/2022/10/27/republican-ideas-to-reform-medicare-could-rile-health-care-industry/
- https://www.fiercehealthcare.com/payers/what-divided-congress-could-mean-healthcare-next-year
- https://www.scientificamerican.com/article/the-most-urgent-science-health-and-climate-issues-in-the-2022-midterm-elections/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
In this special minisode, Mindy sits down with Vynamic’s Saurabh Raman to discuss the five Health Plan trends he sees being most impactful in 2023, including focusing on the customer experience (1:05), rising cost pressures building for employers (2:00), experimenting in different business models and alternative revenue streams (3:55), reacting to a dynamic regulatory environment (5:10), and focusing on the evolution of virtual plan design (6:07).
Podcast Tags: healthcare, healthcare news, health plans, healthcare trends, access
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
Mindy.McGrath@vynamic.com
Saurabh Raman, Director and Head of Health Plan Sector
Saurabh.Raman@vynamic.com
In this special minisode, Ryan sits down with Mindy to discuss the public health trends she sees being most impactful in 2023, including climate change/sustainability (3:20), pursuit of equity (5:37), addressing mental health and wellbeing (8:25), reimagining public health (9:50), and transparency in data sharing (10:50).
Podcast Tags: healthcare, healthcare news, public health, mental health, wellness, health equity, healthcare trends, access, affordability, Medicare, Medicaid, data
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
Mindy.McGrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
While Prevention and Wellness has oftentimes been left out of Healthcare Industry conversations or viewed as a side-line player, it is high time that we begin formally bringing it into the fold. Today Ryan is joined by Vynamic’s Staci Carney, Sarah Lenhard, and Mary Virzi to discuss the evolution of what most of us know as the ‘Wellness Industry’, led by healthcare companies on the forefront of consumerism who are aiming to empower individuals to take healthcare into their own hands. The conversation begins by reviewing the factors that are propelling the Prevention and Wellness Industry’s rapid expansion (0:51) before diving deep into the impact the rise of consumerism has had on the Wellness market (3:20). With consumerism in mind, Sarah details some of the key customer experience design imperatives we have seen among the Prevention and Wellness players recently (4:56). In particular, companies in this space that share and promote similar values as their customers are standing out (5:58). Other specific examples of Wellness companies that are successfully executing on these consumer imperatives are mentioned (8:00). The team then shifts to discuss how the Prevention and Wellness industry has changed over the years (12:08), how these companies are embedding themselves deeper into healthcare (14:18), and the overall implications of the Prevention and Wellness industry on the healthcare landscape (19:00).
Podcast Tags: healthcare, healthcare news, health outcomes, wellness, prevention, digital health, patient experience
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
List of Sources:
- https://globalwellnessinstitute.org/industry-research/the-global-wellness-economy-looking-beyond-covid/
- https://globalwellnessinstitute.org/what-is-wellness/history-of-wellness/
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Mary Virzi, Executive and Head of Healthcare Technology Sector
Mary.Virzi@vynamic.com
Sarah Lenhard, Executive and Go-To-Market Strategy Service Lead
Sarah.Lenhard@vynamic.com
Staci Carney, Director and Go-To-Market Strategy Service Lead
Staci.Carney@vynamic.com
In this minisode, Ryan is joined by Vynamic’s Brian Schachter to discuss a few recent newsworthy items including: the Medicare reimbursement for biosimilars (00:32), 2023 Medicare Advantage Star Ratings and overall sentiment of the US Healthcare system (03:51), drug price increases outpacing inflation (10:18), and Mark Cuban’s Cost Plus Drug Company partnering with Capital Blue Cross (11:48).
Podcast Tags: healthcare, healthcare news, life sciences, Inflation Reduction Act, biosimilars, Medicare, , drug pricing, healthcare access, Mark Cuban, Capital Blue Cross
Source Links:
- https://www.cms.gov/files/document/10522-inflation-reduction-act-timeline.pdf)
- https://www.fiercepharma.com/pharma/nearing-watershed-year-biosimilars-industry-should-get-boost-new-measure-inflation-reduction
- https://healthpayerintelligence.com/news/ma-part-d-contracts-see-lower-2023-medicare-advantage-star-ratings
- https://www.fiercehealthcare.com/providers/poll-gallup-and-west-health-shows-75-americans-grade-affordability-us-healthcare-d-or-f
- https://www.fiercehealthcare.com/payers/medicare-advantage-star-ratings-show-steep-declines-2023-pandemic-flexibilities-go-away#:~:text=Payers-,Medicare%20Advantage%20star%20ratings%20show%20steep%20declines,as%20pandemic%20flexibilities%20go%20away&text=Approximately%2051%25%20of%20Medicare%20Advantage,rating%20or%20higher%20for%202022.
- https://www.fiercehealthcare.com/payers/hhs-more-1200-drugs-rose-their-prices-past-inflation-2021
- https://www.fiercehealthcare.com/payers/mark-cuban-cost-plus-drug-company-bags-first-health-plan-partner
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Brian Schachter, Director
brian.schachter@vynamic.com
In this Trending News EU episode, Mindy, Ollie, and Peter Stevens discuss a few recent EU-based newsworthy items including: the new NHS plan announced by the Health Secretary (1:10), the success of an experimental Alzheimer’s drug (5:05), and the impact of air pollution on healthcare systems (8:10).
Podcast Tags: healthcare, healthcare news, public health, NHS, climate change, health equity
Source Links:
- https://inews.co.uk/news/therese-coffey-unveils-nhs-plan-7000-extra-hospital-beds-500m-social-care-fund-and-new-staffing-plan-1871772 https://www.theguardian.com/society/2022/sep/11/nhs-is-over-the-precipice-warns-nurses-leader-as-strike-vote-looms
- https://www.healtheuropa.com/new-health-social-care-plan-set-by-nhs/118193/
- https://www.theguardian.com/society/2022/sep/11/nhs-is-over-the-precipice-warns-nurses-leader-as-strike-vote-looms
- https://news.sky.com/story/cost-of-living-crisis-nurses-leaving-for-better-paid-jobs-in-shops-because-they-cant-afford-to-work-for-nhs-12707742#:~:text=NHS%20staff%20are%20leaving%20for,staff%20leaving%20for%20other%20sectors
- https://www.theguardian.com/society/2022/oct/06/nurses-across-uk-to-vote-in-first-ever-rcn-strike-ballot-over-pay
- https://news.sky.com/story/historic-moment-in-alzheimers-treatment-as-trial-drug-found-to-slow-cognitive-decline-12706978
- https://www.reuters.com/business/healthcare-pharmaceuticals/eisai-says-alzheimers-drug-succeeds-slowing-cognitive-decline-2022-09-27/
- https://pharmaphorum.com/news/getting-approval-will-only-be-the-first-challenge-facing-lecanemab/
- https://www.bbc.co.uk/news/science-environment-63012180
- https://www.who.int/health-topics/air-pollution#tab=tab_2
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Oliver May, Director
Oliver.May@vynamic.com
Peter Stevens, Manager
Peter.Stevens@vynamic.com
The World Health Organization (WHO) has designated climate change the top risk to global healthcare. The relationship between climate change and human health is becoming increasingly pronounced as health systems and organisations are responding to public/private sustainability initiatives to mitigate climate risks while advancing the pursuit of health equity. In this episode, Mindy and Ryan are joined by Vynamic’s Steph Ng and Ollie May to help us understand the NHS’s pledge to reach Net Zero emissions and how the healthcare industry can play a leading role in promoting greener business practices. The discussion begins with understanding the definition of Net Zero and how it is relevant to the healthcare industry (1:26). The conversation transitions to explaining the NHS’s carbon emission history and drivers impacting utilisation (3:27) before providing an overview of the system’s Net Zero commitment (6:50) and how waste factors into these plans (10:30). The team discusses the progress to-date since the NHS published their strategies (11:35) and the impact COVID-19 has had on their plans (15:49). The U.S. Net Zero practices are also discussed (19:05) before the team wraps up by weighing the benefits and challenges of these initiatives overall (21:45).
Podcast Tags: healthcare, healthcare news, Net Zero, Climate Change, NHS, COVID-19, health outcomes
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
List of Sources:
- https://www.england.nhs.uk/greenernhs/wp-content/uploads/sites/51/2022/07/B1728-delivering-a-net-zero-nhs-july-2022.pdf
- https://www.england.nhs.uk/greenernhs/a-net-zero-nhs/
- https://www.england.nhs.uk/2020/10/nhs-becomes-the-worlds-national-health-system-to-commit-to-become-carbon-net-zero-backed-by-clear-deliverables-and-milestones/
Mindy McGrath, Healthcare Industry Advisor
Mindy.Mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
Ryan.Hummel@vynamic.com
Steph Ng, Manager
Steph.Ng@vynamic.com
Oliver May, Director
Oliver.May@vynamic.com
Digital solutions have been a cornerstone of the healthcare industry for some time. In this episode, Mindy is joined by Vynamic’s Head of Healthcare Technology Sector, Mary Virzi, and special guest from Lifeguard Health Networks, Al Strohmetz, to discuss the interesting evolution, opportunities, and challenges in the digital health space. The discussion begins introducing Al Strohmetz and Lifeguard Health Network (0:40), then shifts to how digital health has changed over the last 10 years (2:47). Before diving deeply into these trends, Mindy, Mary, and Al discuss and define the meaning of digital health across different sectors (6:08). The conversation transitions to how COVID-19 has accelerated innovation and the adoption of telemedicine (8:00). Given this impact, it is discussed how the digital health space has become crowded and ways for companies to differentiate themselves for various audiences (10:50) while managing through some key market challenges (13:02). The team emphasizes the importance of patient engagement (17:40) and interoperability (20:43) in the success of these digital health products. The reality of how often providers are utilizing these tools in their practices (22:00) and what could help facilitate the adoption of digital offerings going forward (25:30) are discussed. At the end, the team identifies considerations for bringing a new digital health product into the market and what gaps these digital solutions can aim to address (30:15).
Podcast Tags: healthcare, healthcare news, digital health, COVID-19, health outcomes
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Mary Virzi, Head of Healthcare Technology
mary.virzi@vynamic.com
Al Strohmetz, Digital Health Executive at Lifeguard Health Network
astrohmetz@lifeguardmobile.com
As the cost to bring new therapeutics to the market continues to soar, it is more important than ever for Life Sciences companies to develop robust Market Access strategies. Mindy & Ryan are joined by Vynamic’s Raina Dhir and Maggie Gorman to discuss the criticality of Market Access in ensuring successful drug launches and how Life Sciences organizations can ensure they avoid pitfalls and are set up for success. There are many forces disrupting the Life Sciences marketplace that have led to increased complexities around bringing new drugs to market. Payors and Pharmaceutical Benefit Managers have undergone a period of marketplace consolidation, changing the structure of payments and formulary negotiations. We’ve also seen the emergence of larger ‘payviders’ – or integrated provider and payor groups - where the stakeholder is uniformly focused on cost-effectiveness. These payviders have rolled out prohibitive utilization management programs to curb spending on new therapeutics. Compounding this scrutiny on pricing is the increasing cost of specialty drugs as well as cell- and gene-therapies. All these factors clearly spell out the need for Life Sciences organizations to put a greater emphasis on the Market Access function (04:30). Planning needs to happen early and teams need to form robust yet agile strategic approaches to navigate the ever-shifting landscape (12:43). Most critically, the Market Access function needs to have cross-functional visibility and authority to help guide the strategic direction of new product launches (16:41).
Podcast Tags: healthcare, market access, product launch, life sciences, pharmaceuticals, biotech, payors, providers, utilization management, cost-effectiveness
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Raina Dhir, Vynamic Director
Raina.Dhir@vynamic.com
Maggie Gorman, Vynamic Manager
Maggie.Gorman@vynamic.com
Mindy McGrath, Healthcare Industry Advisor
Mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
In this minisode, Mindy and Ryan examine recent newsworthy items, including CVS Health’s announcement of winning the bid to acquire Signify Health (0:38), Walmart enlisting UnitedHealth Group in a value-based care partnership (4:44), the overall impact of these big retail healthcare clinics expanding their presence in primary care through strategic partnerships and planned acquisitions (6:25), and DHS reversing the ‘public charge’ immigration health care rule previously set under the Trump administration (10:48).
Podcast Tags: healthcare, healthcare news, public health, providers, Medicaid, primary care
Source Links:
· https://www.cvshealth.com/news-and-insights/press-releases/cvs-health-to-acquire-signify-health
· https://www.chiefhealthcareexecutive.com/view/cvs-health-s-plan-to-buy-signify-health-shows-care-is-moving-to-the-home-analysts-say
· https://www.fiercehealthcare.com/retail/cvs-wins-bidding-war-signify-health-will-acquire-company-8b-deal
· https://www.fiercehealthcare.com/payers/walmart-enlists-unitedhealth-group-10-year-value-based-care-partnership
· https://www.healthcaredive.com/news/walmart-health-unitedhealth-deal-medicare-advantage-virtual-care/631292/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue:%202022-09-07%20Healthcare%20Dive%20%5Bissue:44349%5D&utm_term=Healthcare%20Dive
· https://www.fiercehealthcare.com/payers/dhs-reverses-trump-era-public-charge-immigration-healthcare-rule
· https://www.fiercehealthcare.com/regulatory/healthcare-industry-groups-warn-final-public-charge-rule-could-impact-immigrant-health
· https://www.politico.com/news/2022/09/08/trump-public-charge-rule-immigrants-biden-00055505
· https://thehill.com/policy/national-security/3633774-dhs-unwinds-trump-era-public-charge-restrictions/
· https://www.beckershospitalreview.com/finance/cleveland-clinic-reports-1b-loss-in-first-half-of-this-year.html
· https://www.fiercehealthcare.com/providers/cleveland-clinic-reports-283m-loss-deferred-care-and-high-expenses-q1-2022
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Over the last two decades, the public health community has been highlighting how non-medical factors and the environments where people live, learn, and work can play a significant role in a person’s health and overall quality of life. In this episode, Mindy is joined by Vynamic’s Cassandra Zuluaga and special guest, Dr. Charlotte Cuddihy, a UK Public Health doctor, to discuss the critical importance of social determinants of health (SDOH) and how healthcare systems can aim to address these factors. The discussion begins introducing Dr. Charlotte Cuddihy and her interest with SDOH spurring upon seeing the inequalities in healthcare and wider determinants her patients faced in the UK and US (2:00). The conversation then shifts to defining and understanding the overall impacts of SDOH (6:22). The discussion continues on how the COVID-19 pandemic (9:50), the cost-of-living crisis (13:30), and the rise of social justice efforts (17:30) have further magnified the impact SDOH have on people’s well-being and overall health. At the end, Dr. Cuddihy provides examples and opportunities for how healthcare providers (20:35) and systems (24:33) can positively affect health outcomes while considering SDOH.
Podcast Tags: healthcare, healthcare news, social determinants of health, health inequality, COVID-19, social inequalities, health outcomes
Source Links:
· Cost of Living Crisis is Damaging Briton's Health
· A fairer future: how can the NHS tackle health and social inequalities?
· NHS - Our approach to reducing healthcare inequalities
· Coronavirus and the social impacts of ‘long COVID’ on people’s lives in Great Britain - Office for National Statistics (ons.gov.uk)
· Rising cost of living is damaging people’s health, says royal college | The BMJ
· Community champions programme: guidance and resources - GOV.UK (www.gov.uk)
· A Financial Lifeline (glasgowchildrenshospitalcharity.org)
· NHS Long Term Plan » The NHS as an ‘anchor institution’
· Time for local NHS leaders to take a first step in tackling poverty: pay staff the real Living Wage | The King's Fund (kingsfund.org.uk)
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Cassandra Zuluaga, Director
Cassandra.Zuluaga@vynamic.com
Dr. Charlotte Cuddihy, Public Health registrar, MFPH, MPH
C.cuddihy@nhs.net
To keep up with the ever-evolving healthcare landscape, it is critical for Life Science companies to identify ways to enhance and integrate business planning (IBP) across their operating functions. Mindy & Ryan are joined by Vynamic’s Dan Ahern and Owen Thomas to understand the why IBP is so important and explore how focusing on these processes can help organizations achieve their strategic and operational goals. The conversation begins with a detailed overview of IBP practices within Life Sciences organizations today (1:18), before transitioning into a broader conversation around the wide-reaching financial and efficiency gains if executed correctly (3:08). The group identifies key challenges that impact proper IBP planning processes, including supply chain disruptions and economic volatility (13:15). Finally, Dan and Owen discuss how organizations can anticipate and address these barriers by employing IBP best practices (16:08).
Podcast Tags: healthcare, healthcare news, Life Sciences, Business Planning, commercialization
Source Links:
· https://blogs.sap.com/2017/08/04/integrated-business-planning-for-the-life-science-industry/
· https://www.pwc.com/gx/en/pharma-life-sciences/pdf/pwc-integrated-rd-op-bus-plan.pdf
· https://www.fiercebiotech.com/biotech/vc-firms-biotechs-push-back-drug-pricing-reforms-would-render-small-molecule-drugs
· https://www.mckinsey.com/industries/life-sciences/our-insights/five-ways-that-life-science-companies-can-build-tech-talent
· https://www.mckinsey.com/industries/life-sciences/our-insights/pharma-operations-creating-the-workforce-of-the-future
· https://www2.deloitte.com/us/en/pages/regulatory/articles/life-sciences-regulatory-outlook.html
· https://www.mckinsey.com/industries/life-sciences/our-insights/reimagining-how-life-sciences-work-will-be-done-in-the-next-normal
· https://medium.com/the-slalom-daily-dose/case-study-how-did-a-global-life-sciences-company-transform-its-supply-chain-planning-processes-9bc322137a67
· https://www2.deloitte.com/content/dam/Deloitte/ch/Documents/life-sciences-health-care/deloitte-lshc-en-commercial-operations-in-life-sciences.pdf
· https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-life-sciences-regulation-predictions-2025.pdf
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Dan Ahern, Manager
dan.ahern@vynamic.com
Owen Thomas, Director
Owen.Thomas@vynamic.com
On Trending Health’s third Trending News EU episode, Mindy, Jack, and Ollie discuss a few recent EU-based newsworthy items including: Haleon’s demerger from GSK (0:58), a 'next generation' vaccine authorized by the UK in a world first (4:03), a sustainable medical device that will drastically reduce emissions (7.23), and the results from a survey ranking pharma companies in terms of their DE&I efforts (9.56).
Podcast Tags: healthcare, healthcare news, pharma, consumer health, vaccines, COVID-19, emissions, sustainability, DE&I, diversity, equity, inclusion
Source Links:
- https://www.ft.com/content/45dc4b67-f4a5-4fac-8c35-1d63b823c065
- https://www.gsk.com/en-gb/media/press-releases/gsk-introduces-haleon-to-investors/
- https://www.telegraph.co.uk/news/2022/08/15/uk-authorises-next-generation-covid-omicron-booster-vaccine/
- https://www.bbc.co.uk/news/health-62548336
- https://www.washingtonpost.com/world/2020/12/08/uk-pfizer-biontech-vaccine-faq/
- https://www.pharmatimes.com/news/chiesi_reinforces_commitment_to_reducing_emissions_1452746
- https://pharmaphorum.com/news/bayer-tops-pharma-rankings-for-diversity-inclusivity/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Executive and Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Jack Young, Director
jack.young@vynamic.com
Oliver May, Manager
oliver.may@vynamic.com
In this minisode, Mindy is joined by Vynamic’s Brian Schachter to discuss a few recent newsworthy items including: the Inflation Reduction Act signed by President Biden (00:50), the FDA granting Zynteglo a priority review (09:01), and the primary care market that is being reinvigorated by new entrants who are placing big bets on the healthcare system (14:40).
Podcast Tags: healthcare, healthcare news, life sciences, Inflation Reduction Act, Medicare, Zynteglo, primary care, value-based care, BlueBird Bio
Source Links:
· https://www.hhs.gov/about/news/2022/08/07/statement-by-hhs-secretary-xavier-becerra-on-senate-passage-of-the-inflation-reduction-act.html#:~:text=The%20Inflation%20Reduction%20Act%20locks,prescription%20drugs%20that%20they%20need.
· https://www.cnn.com/2022/08/07/politics/senate-democrats-climate-health-care-bill-vote/index.html
· https://www.cbsnews.com/news/insulin-price-cap-senate-republicans-block-inflation-reduction-act/
· https://www.google.com/search?q=FDA+to+approve+zynteglo&rlz=1C1GCEB_enUS943US943&oq=FDA+to+approve+zynteglo&aqs=chrome..69i57j33i160l2.3511j0j7&sourceid=chrome&ie=UTF-8
· https://endpts.com/bluebird-bio-may-finally-get-a-gene-therapy-approved-in-the-us/
· https://www.fiercepharma.com/pharma/cell-and-gene-therapy-makers-push-past-regulatory-payer-hurdles-to-set-up-high-hopes-for
· https://www.fiercehealthcare.com/providers/retailers-payers-and-startups-could-capture-30-primary-care-market-2030-report
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Brian Schachter, Manager
brian.schachter@vynamic.com
Experts have been ringing the alarm about the impending healthcare delivery professional workforce shortage for over a decade. Mindy & Ryan are joined by Vynamic’s Marisa Deline to explore the broad implications of this shortage and discuss ways healthcare leaders across sectors can think about addressing - or simply learning to live with - this foundational issue. The conversation begins with a detailed overview of the widespread nature of the shortage: from physicians to medical assistants there simply are not enough healthcare workers to meet demand and future projections only anticipate the trend worsening over time (01:54). The COVID-19 pandemic, which contributed to healthcare professional burnout, only served to hasten the trend (0:2:36); as has the ‘Great Resignation,’ where many in direct care delivery positions have left for more lucrative, flexible options in tech, healthcare startups, and other roles where their clinical skills are highly valued (05:11). This shortage has obvious implications for quality of delivery across delivery settings, but also snowballs into other healthcare sectors as well; insurers must focus more keenly on network adequacy and life science organizations must think about different models to provide therapeutic education to their provider partners (11:41). Despite these challenges, there are opportunities for the broader healthcare community to address these issues head-on, and we can take some solace in the knowledge that this is a global issue (16:13). We must collectively ‘ruthlessly prioritize’ to ensure that we are focused on opportunities that will have a real impact on the issue, such as subsidizing clinical training, increasing the number of clinical training opportunities, elevating non-physician/nurse professionals to provide more services, and ensuring that future healthcare delivery professionals feel like they are entering a field that will not just burn them out, but will provide them with a rich and fulfilling career (18:43).
Podcast Tags: healthcare, healthcare news, workforce crisis, public health, providers, physicians, nurses, Life Sciences
Source Links:
· https://www.beckershospitalreview.com/workforce/11-of-us-hospitals-critically-understaffed-21-anticipate-shortages-numbers-by-state.html
· https://www.advisory.com/Topics/Strategy-Planning-and-Growth/2021/12/Hard-truths-on-the-current-and-future-state-of-the-nursing-workforce
· https://www.fiercehealthcare.com/hospitals/lawmakers-aha-urge-white-house-to-investigate-nurse-staffing-agencies-price-hikes
· https://morningconsult.com/2021/10/04/health-care-workers-series-part-2-workforce/
· https://www.mercer.us/content/dam/mercer/assets/content-images/north-america/united-states/us-healthcare-news/us-2021-healthcare-labor-market-whitepaper.pdf
· https://www.theatlantic.com/health/archive/2021/11/the-mass-exodus-of-americas-health-care-workers/620713/?utm_source=STAT+Newsletters&utm_campaign=49ab812eb4-MR_COPY_01&utm_medium=email&utm_term=0_8cab1d7961-49ab812eb4-151759045
· https://www2.deloitte.com/us/en/insights/industry/health-care/health-care-workforce-trends.html
· https://www.healthcaredive.com/news/healthcare-trends-of-2022/618018/
· https://hbr.org/2022/01/11-trends-that-will-shape-work-in-2022-and-beyond
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Marisa Deline, Manager
marisa.deline@vynamic.com
In this minisode, Mindy and Ryan examine a few recent newsworthy items including trends impacting digital health funding (0:48), the newly operational 988 mental health and suicide crisis line (4:00), the latest impacts on the healthcare industry post Roe v. Wade (6:45), and discussions regarding the future of the 340B prescription drug program (13:49).
Podcast Tags: healthcare, healthcare news, women’s health, reproductive health, public health, providers, Roe v. Wade, mental health, maternal health, digital health, Medicaid, prescription drugs, Life Sciences
Source Links:
· H1 2022 digital health funding: Two sides to every correction | Rock Health
· https://www.fiercehealthcare.com/digital-health/market-downturn-dampens-digital-health-funding-ma-2022-here-are-sectors-raked-most
· https://www.npr.org/sections/health-shots/2022/07/15/1111316589/988-suicide-hotline-number
· https://apnews.com/article/abortion-bills-house-vote-fc24d99f184d7aeec4926a6520311da5
· Characteristics of U.S. Abortion Patients in 2014 and Changes Since 2008 | Guttmacher Institute
· https://www.advisory.com/blog/2022/07/abortion-restrictions?utm_source=public_db&utm_medium=email&utm_campaign=2022jul13&utm_content=public_headline_public_blog_x_x_x&elq_cid=4793240&x_id=
· https://thehill.com/homenews/senate/3559360-gop-senator-blocks-bill-to-protect-interstate-travel-for-abortion/
· https://www.hrsa.gov/about/organization/bureaus/opae/hrsa-information-quality-guidelines/agency-mission
· Merck joins other drugmakers in cutting off sales to 340B contract pharmacies | Fierce Healthcare
· https://www.fiercehealthcare.com/providers/merck-sues-hhs-avoid-fine-over-340b-contract-pharmacy-restrictions
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
On Trending Health’s second Trending News EU episode, Mindy, Jack, and Oliver discuss a few recent EU-based newsworthy items including: the outcome of the NHS Pay Review Body process, which advises on the pay for NHS staff (0.37), worrying General Practitioner (GP) workforce challenges amid unprecedented staff shortages (4.44), and the rise of Public Health infectious disease incidents and possible solutions to address (9.18).
Podcast Tags: healthcare, healthcare news, NHS, NHSPRB, clinician burnout, public health, monkeypox, COVID-19, polio, infectious diseases.
Source Links:
· https://www.theguardian.com/society/2022/jun/25/nhs-staff-should-get-4-percent-pay-rise-independent-experts-say
· https://www.rcn.org.uk/magazines/Action/2022/Mar/NHS-Pay-Review-Body-explainer
· https://www.theguardian.com/society/2022/jun/27/uk-doctors-demand-pay-rise-of-up-to-30-over-five-years
· https://news.sky.com/story/gp-workforce-experiencing-worrying-workload-amid-staff-shortages-12642851
· https://inews.co.uk/news/health/one-three-gp-practices-stop-routine-appointments-due-staff-shortages-patient-demand-1606747
· National incident declared over polio virus findings in London sewage | Polio | The Guardian
· https://www.telegraph.co.uk/global-health/science-and-disease/monkeypox-polio-why-many-viruses-attacking-uk/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Executive and Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Jack Young, Director
jack.young@vynamic.com
Oliver White, Director
Oliver.White@vynamic.com
Now more than ever, launching new biopharmaceutical products or indications is of paramount importance to ensuring its long-term success in the market. Mindy & Jen are joined by Vynamic’s Product Launch Service Leads, Ashley Stanley and Brian Stamm, to discuss the evolution of the importance of product launch and the implications for Life Sciences organizations and the healthcare industry at large. The catalyzing force shaping the launch space over the past several years is the sheer volume of trials and approvals occurring in both U.S. and global markets, leading to more market competition, especially in specialty and targeted therapy areas (01:15). This increase in volume has shaped the launch market by spurring activity in the ‘co-promote’ space (02:55), igniting talent acquisition battles (03:30) and creating a market for specialty vendors to assist with optimizing key components of launch activities (04:30). Other headwinds spurring change in the launch space include the high cost of bringing new products or indications to market (06:20) and increased pressure and requirements from regulatory (07:10). Given the variety of factors impacting launch activities today, Life Sciences organizations need to start early and operate within a structured yet flexible operating model that takes full pipelines into account (12:09). Leaders will need to be thoughtful about establishing clear team structures and goals to ensure that their necessarily cross-functional teams are moving in lock step as products approach FDA approval (16:46).
Podcast Tags: healthcare, product launch, life sciences, pharmaceuticals, biotech
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Brian Stamm, Executive and Product Launch Service Lead
Brian.stamm@vynamic.com
Ashely Stanley, Executive and Product Launch Service Lead
Ashely.stanley@vynamic.com
Mindy McGrath, Healthcare Industry Advisor
Mindy.mcgrath@vynamic.com
Jen Burke, Director and Healthcare Industry Strategist
jen.burke@vynamic.com
In our typical Trending News US episodes, we examine a few recent newsworthy items we think healthcare leaders should be considering. For today’s episode, we focus on the Supreme Court’s ruling on Dobbs v. Jackson, a case centered on a Mississippi law that bars most abortions after 15 weeks of pregnancy, a standard that directly challenged Roe v. Wade. On Friday June 24th, in one of the most consequential decisions in decades, the Court ruled in favor of overturning Roe – holding there is no longer a federal constitutional right to an abortion. Jen, Mindy, and Ryan discuss the implications of this decision on women’s reproductive health and the American healthcare industry.
Podcast Tags: healthcare, healthcare news, women’s health, reproductive health, public health, providers, Roe v. Wade, Dobbs v. Jackson
Source Links:
· https://s3.documentcloud.org/documents/22067237/19-1392_6j37.pdf
· https://www.justice.gov/opa/pr/attorney-general-merrick-b-garland-statement-supreme-court-ruling-dobbs-v-jackson-women-s
· https://www.whitehouse.gov/briefing-room/statements-releases/2022/06/24/fact-sheet-president-biden-announces-actions-in-light-of-todays-supreme-court-decision-on-dobbs-v-jackson-womens-health-organization/
· https://khn.org/news/article/abortion-ruling-roe-overturned-conservatives-supreme-court/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In Trending Health’s first Trending News EU episode, Mindy, Jack and Oliver discuss a few recent EU-based newsworthy items including: an unprecedented clinical trial where a dozen rectal cancer patients saw their tumors completely disappear (1:12), the Health & Care Act 2022 which is seen as the most significant health legislation in the UK in a decade (3:56) and a report that showed up to 1.2 million additional NHS patients are eligible for vital medicines that could extend their lives but are missing out (10:15).
Podcast Tags: healthcare, healthcare news, cancer, clinical trials, Health and Care Act, NHS, social care, life sciences, patient access, patient outcomes, innovative medicines fund
Source Links:
· https://www.livescience.com/remission-in-small-rectal-cancer-trial
· https://www.gov.uk/government/news/health-and-care-bill-granted-royal-assent-in-milestone-for-healthcare-recovery-and-reform
· https://www.kingsfund.org.uk/publications/health-and-care-act-key-questions
· https://www.pharmatimes.com/news/nhs_patients_missing_out_on_new_medicines_that_could_extend_lives_1448343
· https://www.england.nhs.uk/2021/07/nhs-england-announces-new-innovative-medicines-fund-to-fast-track-promising-new-drugs/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Jack Young, Director
jack.young@vynamic.com
Oliver White, Director and NHS Lead
Oliver.White@vynamic.com
As health systems around the globe grapple with addressing inequity in healthcare, one of the most tangible opportunities for change is the chronic underrepresentation of individuals by race, ethnicity, or sex in clinical trials. Jen & Ryan are joined by Vynamic’s Matt Howard to discuss how life science companies can integrate diversity, equity & inclusion throughout the clinical trials process to facilitate better outcomes. Better representation across patient types is critical to demonstrate safety and efficacy – it’s both good science and good business (01:18). However, truly integrating DEI is going to require more than ‘bolting on’ diverse patient recruitment practices – it will require an operational and mindset shift that necessitates an appreciation of the historic inequities within the clinical trial space (03:22). Opportunities to improve DEI abound throughout the clinical trial lifecycle – from reevaluating exclusion criteria (06:27) and protocol design (08:46), to reallocating resources across sites and focusing on tailored interactions with participant communities (15:00). Incorporating these tactics into a long-term strategy will require leaders to move away from a ‘speed first’ approach (21:30) and embrace opportunities for partnership across all stages of the clinical trial continuum (24:15)
For additional information on DEI in Clinical Trials, check out Vynamic’s insight “Integrating Diversity, Equity, & Inclusion Throughout Clinical Trials” and case study “Prioritizing Diversity, Equity, & Inclusion Across Research & Development.”
Podcast Tags: healthcare, health equity, diversity, DEI, clinical trials, life sciences, providers, FDA
Source Links:
· https://vynamic.com/insights/integrating-diversity-equity-inclusion-throughout-clinical-trials/
· https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enhancing-diversity-clinical-trial-populations-eligibility-criteria-enrollment-practices-and-trial
· https://www.abbott.com/diversity-in-clinical-trials.html
· https://www.fpm.org.uk/blog/fpm-conversation-blog-enabling-a-greater-diversity-of-people-in-clinical-trials/
· https://www.theatlantic.com/health/archive/2016/06/why-are-health-studies-so-white/487046/
· https://www.nejm.org/doi/10.1056/NEJMms2004740
· https://www.mckinsey.com/NotFound.aspx?item=%2findustries%2flife-sciences%2four-insights%2fno-place-like-home-stepping-up-the-decentralization-of-clinical-trials16&user=extranet%5cAnonymous&site=website
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Matt Howard, Director
Matthew.howard@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Director and Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the nationwide baby formula shortage and drug supply chain complexities (00:33), the underrepresentation of diverse groups in clinical trials (06:08), and the federal government probes initiated by the AHA into commercial payers who represent Medicare and routinely deny access to care and services (10:52).
Podcast Tags: healthcare, healthcare news, life sciences, baby formula shortage, drug supply chain, clinical trials, diversity and inclusiveness, Medicare, CMS
Source Links:
· https://www.fiercepharma.com/manufacturing/fda-lays-out-framework-manufacturers-and-developers-tackle-drug-shortages
· https://time.com/6177128/baby-formula-congress-monopoly-abbott/
· https://www.fiercebiotech.com/biotech/we-just-dont-have-studies-new-report-details-critical-diversity-shortcomings-us-clinical
· https://www.fiercehealthcare.com/payers/aha-presses-false-claims-act-probes-target-payers-over-medicare-advantage-denials
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Supreme Court draft majority opinion striking down Roe v. Wade (00:35), a report that up to 14 million enrollees could lose Medicaid coverage as states restart eligibility checks (07:00), and the newly proposed User Fee Agreements for medical devices and prescription drugs (11:30).
Podcast Tags: healthcare, healthcare news, public health, abortion, reproductive health, women’s health, Medicaid, FDA, life sciences, medical devices, prescription drugs
Source Links:
· https://www.fiercehealthcare.com/providers/advocates-weigh-roe-v-wade-draft-opinion
· https://www.nbcnews.com/news/senate-vote-nationwide-abortion-bill-ahead-roe-decision-rcna28183?utm_campaign=KHN%3A%20Daily%20Health%20Policy%20Report&utm_medium=email&_hsmi=212763088&_hsenc=p2ANqtz--POzUX5k8AQObTzBoaMqucOZZgfBce4DDz23nwT3wOmZ9AyoOmkweRxl3FA7oFBpEHAm_zghNL38iRp68QwPP6Xz-dzw&utm_content=212763088&utm_source=hs_email
· https://www.reuters.com/world/us/biden-considers-executive-orders-new-funds-abortion-2022-05-11/?mkt_tok=ODUwLVRBQS01MTEAAAGEUidnceow1_0iW6hSnevPEHB2hezo1nwsmwKWLVLUnkw3BTmgpHyktM8FmjV--4M8kkNI56bZvZCKVOVVKCmRWuCTriDKCeLhzBTvAbxoPUCs
· https://www.fiercehealthcare.com/payers/kff-14m-enrollees-could-lose-medicaid-coverage-states-restart-eligibility-checks
· https://www.medtechdive.com/news/House-MDUFA-bill-trial-diversity-cybersecurity-requir/623479/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue:%202022-05-10%20MedTech%20Dive%20%5Bissue:41633%5D&utm_term=MedTech%20Dive
· https://www.statnews.com/2022/05/04/congress-reform-fda-accelerated-approvals/?mkt_tok=ODUwLVRBQS01MTEAAAGEMzSQCdmfLkvDKQIGMA7zMUmNKcwGWsMs0B-4-r-a89sRqsMuN1urs_eEYpJ337lKE0taul_fyFIOlQ_SKYCffpBDDRNkF05bXG9tMNxz1Csf
· https://www.medtechdive.com/news/MDUFA-V-congress-FDA-roundup/621423/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue:%202022-05-04%20MedTech%20Dive%20%5Bissue:41497%5D&utm_term=MedTech%20Dive
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
One of the advantages of serving clients across multiple geographies is that Vynamic can see firsthand how the differences in health systems play out in terms of spend, outcomes, and innovation. Jen & Ryan are joined by Vynamic London’s Oliver White and Vynamic Boston’s Shari Robbins to discuss key differences between the health systems in each country and what they can learn from one another as they move healthcare delivery out of the hospital and into the community setting. In one sense, the US and UK represent two extremes on the delivery system spectrum: the US has the largest private sector system globally while the UK has the largest publicly funded system. They also differ in key metrics around healthcare spend and outcomes (01:19), science and technology (04:21), and wait times for elective procedures and emergency care (06:21). Despite these differences, both systems are focused on improving cost and customer satisfaction – especially when it comes to telehealth and home care (09:05). One model the NHS has put forward in this effort is Community Crisis Response Teams (12:38) – a model that could be attractive as US health systems look to transition care to the home and alleviate emergency department (ED) volumes (15:13). While implementing such a model could present scaling challenges in the US market (16:45), it could also offer opportunities for health plans and providers to improve quality, outcomes, and patient satisfaction (18:29).
Podcast Tags: healthcare, providers, health plans, public health, NHS, CMS, telehealth, crisis care
Source Links:
· https://www.usnews.com/news/healthiest-communities/articles/2019-12-11/survey-finds-fragmented-us-health-care-impedes-coordination-among-providers
· https://www.commonwealthfund.org/international-health-policy-center/countries/england
· https://www.commonwealthfund.org/international-health-policy-center/countries/united-states
· https://www.commonwealthfund.org/blog/2018/what-can-us-and-england-learn-each-others-health-care-reforms
· https://www.healthcareadministration.com/brief-comparison-uk-healthcare-system-vs-u-s-healthcare-system/#:~:text=While%20both%20systems%20have%20world,tax%20based%20system%20versus%20the
· https://www.england.nhs.uk/community-health-services/urgent-community-response-services/
· https://www.england.nhs.uk/wp-content/uploads/2020/11/B0252-Urgent-community-response-2-hour-and-2-days-standards-guidance-30-November-2020.pdf
· https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465904/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Oliver White, Director
Oliver.white@vynamic.com
Shari Robbins, Director
Shari.robbins@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Director and Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the extension of the COVID-19 public health emergency (00:35), the GoodRx acquisition of vitaCare Prescription Services (03:37), Clarify Health receiving $150 million to focus on value-based care (07:33), and some notable numbers published this month (10:59).
Podcast Tags: healthcare, healthcare news, public health, COVID-19, prescription drugs, drug prices, value-based care, life sciences, pharma, health plans, life expectancy
Source Links:
· https://aspr.hhs.gov/legal/PHE/Pages/COVID19-12Apr2022.aspx
· https://www.nytimes.com/2022/04/13/us/politics/biden-covid-public-health-emergency-extended.html
· https://investors.goodrx.com/news-releases/news-release-details/goodrx-closes-acquisition-vitacare-tech-enabled-pharmacy
· https://www.fiercehealthcare.com/health-tech/goodrx-picks-vitacare-prescription-services-150m-deal-expand-pharmacy-services-platform
· https://clarifyhealth.com/blog/150m-series-d-funding/
· https://www.fiercehealthcare.com/health-tech/clarify-health-clinches-150m-series-d-boosting-valuation-14b#:~:text=Clarify%20Health%20clinches%20%24150M%20series%20D%2C%20boosting%20valuation%20to%20%241.4B,-By%20Heather%20Landi&text=Enterprise%20analytics%20company%20Clarify%20Health,its%20value%2Dbased%20payments%20technology.
· https://www.fiercepharma.com/special-reports/top-20-pharma-companies-2021-revenue
· https://www.fiercehealthcare.com/finance/nationwide-drug-spending-grew-77-2021-will-increase-another-4-6-2022
· https://www.unitedhealthgroup.com/newsroom/2022/2022-04-14-first-quarter-results.html
· https://www.reuters.com/world/us/us-life-expectancy-fell-by-2-yrs-2020-sharpest-drop-among-high-income-peers-2022-04-13/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
The wave of price transparency is here, with regulations like the No Surprises Act and the Hospital Price Transparency Rules building momentum. Jen & Mindy are joined by Vynamic’s Keith Sutter and Head of Health Plans, Saurabh Raman, to discuss what these laws mean for payers, providers, and ultimately, consumers. The push towards transparency can be traced back over the last decade, but the recently implemented No Surprises Act (01:44) and Hospital Price Transparency Rules (02:13) are directly aimed at helping consumers understand true healthcare costs and make informed care decisions (03:30). Implementation is not without its challenges – with providers citing reporting burdens, administrative costs, and difficulties in accurately reflecting the costs of individual “care episodes” (07:28). With a summer deadline approaching, soon payers (10:00) will be dealing with pace pressures, the disconnect between posted prices vs. true cost, and how to capture quality vs. price (11:13). Despite these challenges, there are opportunities for provider and payer organizations associated with these changes (13:47) – especially for organizations experienced in value-based care and those prepared to leverage price transparency to improve customer satisfaction (18:08).
For additional information, check out Vynamic’s recent insight “Transparency in Coverage Is Here”.
Podcast Tags: healthcare, providers, health plans, price, surprise bills, transparency, value based care
Source Links:
· https://vynamic.com/insights/transparency-in-coverage-is-here/
· https://www.cms.gov/newsroom/fact-sheets/no-surprises-understand-your-rights-against-surprise-medical-bills#:~:text=The%20No%20Surprises%20Act%20protects,network%20air%20ambulance%20service%20providers.
· https://www.healthsystemtracker.org/brief/price-transparency-and-variation-in-u-s-health-services/
· https://www.commonwealthfund.org/publications/newsletter-article/health-care-price-transparency-can-it-promote-high-value-care
· https://jamanetwork.com/journals/jama/fullarticle/2778818
· https://healthpayerintelligence.com/news/what-the-healthcare-price-transparency-order-means-for-payers
· https://www.federalregister.gov/documents/2020/11/12/2020-24591/transparency-in-coverage#h-11
· https://revcycleintelligence.com/news/only-14-of-hospitals-met-price-transparency-rule-compliance
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Saurabh Raman, Director and Head of Health Plans Sector
Saurabh.raman@vynamic.com
Keith Sutter, Director
keith.sutter@vynamic.com
Mindy McGrath, Executive and Healthcare Industry Advisor
Mindy.mcgrath@vynamic.com
Jen Burke, Director and Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the advancement of the Dr. Lorna Breen (00:35) and PREVENT Pandemics acts (03:59), the response of life science organizations to sanctions against Russia (07:46), the continued shift away from inpatient care (12:03), and the recent recommendation for Medicare payments in 2023 (21:02).
Podcast Tags: healthcare, healthcare news, public health, mental health, COVID-19, life sciences, hospitals, value-based care, Medicare
Source Links:
· https://www.healthleadersmedia.com/nursing/president-biden-signs-dr-lorna-breen-act-law
· https://www.aamc.org/advocacy-policy/washington-highlights/senate-help-committee-marks-advances-prevent-pandemics-act
· https://www.idse.net/Policy--Public-Health/Article/03-22/Senate-Takes-Up-PREVENT-Pandemics-Act/66448
· https://khn.org/news/article/big-pharma-reaction-russia-ukraine-war/
· https://www.fiercehealthcare.com/providers/moodys-report-shifting-care-trends-will-continue-shrink-hospital-margins
· https://www.fiercehealthcare.com/providers/doctor-groups-press-lawmakers-ignore-medpac-recommendation-stand-pat-pay-2023
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
Now more than ever before, healthcare organizations are reflecting on how to improve health equity and address bias within their organizations. Jen & Ryan are joined by Vynamic’s Diversity Equity & Inclusion Service Leads, Stefanie Christmas & Shannon Connolly, to discuss what leaders should be thinking about as they address this industry imperative. 2020 ushered in a “cultural reset” for the business world, especially the healthcare industry, to think about DEI in a new way (01:05) – beyond being the right thing to do, we know embedding a culture that is committed to DEI has demonstrated benefits to healthcare organizations in terms of employee engagement, innovation, financial performance, and patient outcomes (02:00). However, impacting meaningful change requires a thoughtful approach – it is important for organizations to assess where they are on their DEI journey (11:00), develop a roadmap of outcome-driven short- and long-term goals (12:23), and communicate their strategy and successes along the way (16:04). This type of effort requires a true shift in mindset and embracing new conversations (19:10) – it may not always be comfortable, but that is where the true change begins (21:13).
For additional information on where to start your organization’s DEI Journey, check out Vynamic’s recent insight, service information, and case study.
Podcast Tags: healthcare, diversity, equity, inclusion, DEI, health equity, psychological safety
Source Links:
· https://vynamic.com/insights/diversity-equity-inclusion-journey-where-to-start/
· https://catalyst.nejm.org/doi/full/10.1056/CAT.21.0166
· https://www.healthleadersmedia.com/strategy/create-strong-workforce-through-diversity-equity-and-inclusion
· https://pubmed.ncbi.nlm.nih.gov/30765101/
· https://kirbybates.com/blog/diversity-healthcare-leadership-breaking-the-glass-ceiling/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Stefanie Christmas, Director and Diversity, Equity & Inclusion Service Lead
Stefanie.christmas@vynamic.com
Shannon Connolly, Director and Diversity, Equity & Inclusion Service Lead
Shannon.connolly@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Director and Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Senate confirmation of FDA Commissioner Dr. Robert Califf (00:34), the first female to be cured of HIV (04:47), a recent report on hospital price transparency (07:28), and an acquisition announcement from ChristianaCare (13:18).
Podcast Tags: healthcare, healthcare news, FDA, public health, stem cells, price transparency, healthcare costs, hospitals, acquisitions
Source Links:
· https://www.reuters.com/world/us/us-senate-confirms-bidens-fda-nominee-califf-2022-02-15/
· https://www.nytimes.com/2022/02/15/health/hiv-cure-cord-blood.html?
· https://www.bloomberg.com/news/articles/2022-02-09/trump-era-rule-to-report-hospital-pricing-gets-off-to-slow-start?mkt_tok=ODUwLVRBQS01MTEAAAGCgsedUi88cCl4sxBtLK4zJvQHyVx22C4bikTEBm0463vfILf5EcMA-H7r45HnBEmv3ohUnoZU5AEBnCWqhaU_gIHL14Tv-e8f5By7eezCyHB5
· https://www.fiercehealthcare.com/hospitals/report-143-hospitals-compliant-price-transparency-rules-one-year?utm_source=email&utm_medium=email&utm_campaign=LS-NL-FierceBiotech+Tracker&oly_enc_id=3569J2000334E1H
· https://www.fiercehealthcare.com/hospitals/christianacare-looking-acquire-crozer-health-prospect-medical-holdings?utm_source=email&utm_medium=email&utm_campaign=HC-NL-FierceHealthcare&oly_enc_id=3569J2000334E1H
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
Between rising drug prices, increased cost-sharing, and difficulty determining true out-of-pocket costs – drug discounting has grown in popularity as savvy consumers look for simple solutions and affordable options. Jen, Mindy & Ryan discuss this recent discounting explosion and what it means for the healthcare industry – starting with a quick primer on how one of the most popular methods, drug discount cards, actually work (01:06). Fueled by public concern around prescription affordability (08:34), discounting companies continue to proliferate and see enormous growth – often filling a market gap in consumer choice, transparency, and convenience (11:44). Discounting companies are poised to upend PBMs’ pharmacy benefit economics, plan sponsors’ decisions, and the entire generic market (14:13). They also present an opportunity for organizations who can harness the potential of increased access and empowered consumerism in the prescription drug space (18:10).
Podcast Tags: healthcare, drug costs, drug prices, drug discount cards, discount pharmacy, retail pharmacy, PBMs
Source Links:
· https://www.drugchannels.net/2020/08/how-goodrx-profits-from-our-broken.html
· https://www.drugchannels.net/2021/03/how-goodrxs-rapid-growth-creates.html
· https://www.drugchannels.net/2021/08/why-goodrxnot-amazonmay-be-true-pbm.html
· https://www.protocol.com/manuals/health-care-revolution/prescriptions-goodrx-coronavirus-interview
· https://www.pharmacytimes.com/view/the-truth-about-pharmacy-discount-cards
· https://www.frierlevitt.com/articles/service/pharmacylaw/the-hidden-dark-side-of-prescription-discount-cards-what-your-pharmacy-needs-to-know/
· https://www.uspharmacist.com/article/a-pharmacists-primer-on-prescription-discount-cards
· https://www.kff.org/health-costs/poll-finding/public-opinion-on-prescription-drugs-and-their-prices/
· https://www.beckershospitalreview.com/pharmacy/drug-prices-soared-by-nearly-4-times-the-inflation-rate-in-5-years-house-investigation-finds.html
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: our top headlines from the JP Morgan Healthcare Conference (00:32) and the preliminary national coverage decision for Aduhelm from CMS (14:29).
Podcast Tags: healthcare, healthcare news, healthcare workforce, gene therapy, whole person health, Medicare Advantage, CMS, Alzheimer’s
Source Links:
· https://www.bloomberg.com/news/articles/2022-01-12/rna-is-hot-but-mergers-are-not-at-jpmorgan-healthcare-conference
· https://www.modernhealthcare.com/finance/reporters-notebook-jp-morgans-2022-health-conference
· https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=Y&NCAId=305
· https://www.kff.org/policy-watch/medicares-coverage-decision-for-the-new-alzheimers-drug-and-why-it-matters/
· https://www.managedhealthcareexecutive.com/view/5-things-you-should-know-about-the-aduhelm-price-cut
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
With the start of a new year dampened by Omicron and yet another surge in COVID-19 infections, it's hard not to wonder what this "next normal" will look like for healthcare. After chatting with each of Vynamic's heads of sector, Jen, Mindy & Ryan bring it all together to discuss the trends expected to shape the industry this year. With immense cost strain across the system, plan sponsors are tightening budgets and revising benefit constructs (00:53) and consumers are feeling the squeeze. These costs are often hardest felt amongst those facing socioeconomic inequities – and the pandemic has brought the equity imperative front & center (06:57). The pandemic has also precipitated an innovation explosion – particularly as it relates to everywhere care (12:26) – and it seems data is positioned to become the currency of 21st century healthcare (17:41). A booming senior population with eyes on a new aging (23:25) and the proliferation of transformative therapeutics (27:38) means that industrywide change will be needed, soon.
View our 2022 Healthcare Industry Trends infographic at https://vynamic.com/insights/2022-healthcare-industry-trends/.
Podcast Tags: healthcare, health plans, providers, life sciences, health tech, health equity, telehealth, digital health, big data, EHR, Medicare, gene therapy
Source Links:
· https://www.beckershospitalreview.com/pharmacy/drug-prices-soared-by-nearly-4-times-the-inflation-rate-in-5-years-house-investigation-finds.html
· https://www.fiercehealthcare.com/payer/nationwide-out-pocket-spending-grew-10-to-1-650-per-person-2021-expect-to-continue-through
· https://catalyst.nejm.org/doi/full/10.1056/CAT.20.0569
· https://med.stanford.edu/dean/healthtrends.html
· https://rockhealth.com/aging-in-place/
· https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-global-market-report-2020-30-covid-19-growth-and-change
· https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.01470
· https://www.fiercehealthcare.com/tech/majority-healthcare-executives-don-t-trust-their-organization-s-data-survey-finds?oly_enc_id=4902E0496778J3Y
· https://www.advisory.com/daily-briefing/2021/11/17/health-equity
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this special minisode, Jen sits down with special guest Mary Virzi to discuss the trends she sees being most impactful to healthcare technology in 2022, including: virtual care expansion (01:34), utilization of devices in decentralized clinical trials (01:51), data as a product and adoption of actionable AI (02:06), integration of data across platforms and companies (02:34), and investment from Big Tech (02:53).
Podcast Tags: healthcare, technology, telehealth, wearables, data, AI, interoperability, big tech
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mary Virzi, Director
mary.virzi@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this special minisode, Jen sits down with Head of Life Sciences Karen Baldry to discuss the trends she sees being most impactful in 2022, including: the evolution of clinical trials (01:01), health equity (01:55), and optimizing the supply chain (03:48).
Podcast Tags: healthcare, life sciences, healthcare trends, clinical trials, health equity, supply chain
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Karen Baldry, Head of Life Sciences
karen.baldry@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this special minisode, Jen sits down with Head of Providers Ryan Hummel to discuss the trends he sees being most impactful in 2022, including: healthcare at home (00:55), incentive alignment (02:48), digital strategy & technology integration (04:11), data transparency & actionability (05:12), removing bias & improving health equity (06:02), and workforce strategy & engagement (06:59).
Podcast Tags: healthcare, providers, healthcare trends, telehealth, incentive design, health equity,
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Ryan Hummel, Head of Providers
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this special minisode, Jen sits down with Head of Health Plans Saurabh Raman to discuss the trends he sees being most impactful in 2022, including: post-pandemic plan design (00:38), strategic health equity initiatives (01:55), utilization management (03:41), and alternative coverage models (04:38).
Podcast Tags: healthcare, health plans, healthcare trends, benefits, utilization management, employer-sponsored coverage
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Saurabh Raman, Head of Health Plans
saurabh.raman@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this special minisode, Jen sits down with Healthcare Industry Advisor Mindy McGrath to discuss the public health trends she sees being most impactful in 2022, including: expanding access (01:15), addressing affordability (02:30), amplifying value (03:34), increasing interoperability & data sharing (04:42), and bolstering government payer solvency (05:30).
Podcast Tags: healthcare, public health, healthcare trends, access, affordability, Medicare, Medicaid, data
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: 23andMe’s intended entry into telehealth with the acquisition of Lemonaid Health (00:35), the Center for Medicare & Medicaid Innovation strategic plan refresh (04:15), a new partnership between Walmart and Transcarent (08:13), and the launch of virtual-first health plans (10:55)
Podcast Tags: primary care, genetic testing, telehealth, CMMI, Medicare, self-insured employers, health plans, healthcare, healthcare news
Source Links:
· https://www.fiercehealthcare.com/tech/23andme-jumps-into-telehealth-prescription-drug-delivery-400m-buyout-lemonaid-health?utm_source=email&utm_medium=email&utm_campaign=HC-NL-FierceHealthIT&oly_enc_id=3569J2000334E1H
· https://fortune.com/2021/10/22/dna-testing-giant-23andme-expands-into-telemedicine-with-400-million-lemonaid-acquisition/
· https://innovation.cms.gov/strategic-direction-whitepaper
· https://www.fiercehealthcare.com/payer/cmmi-rolls-out-strategic-refresh-to-make-payment-models-more-equitable-and-streamlined?utm_source=email&utm_medium=email&utm_campaign=HC-NL-FierceHealthPayer&oly_enc_id=3569J2000334E1H
· https://www.fiercehealthcare.com/payer/hlth21-unitedhealthcare-optum-collaborate-new-virtual-first-plan-design?oly_enc_id=3569J2000334E1H
· https://healthpayerintelligence.com/features/how-payers-can-launch-a-virtual-first-health-plan
· https://www.healthcarefinancenews.com/news/unitedhealthcare-and-optum-launch-virtual-first-health-plan-design
· https://www.modernhealthcare.com/patient-care/walmart-makes-headway-self-insured-space-transcarent-partnership
· https://www.healthcarefinancenews.com/news/walmart-and-transcarent-partner-lower-costs-self-insured-market
· https://www.healthcaredive.com/news/walmart-transcarent-partner-to-pitch-self-insured-employers/608355/
· https://www.fiercehealthcare.com/payer/walmart-unveils-employer-market-team-up-transcarent?oly_enc_id=3569J2000334E1H
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
With the explosion of digital channels and accompanying shifts in customer preferences, life sciences are reshaping their customer engagement models across commercial, medical, and market access organizations. In this episode, Jen and Mindy are joined by special guest Hunter Goga to how the customer engagement model has evolved and what leaders should be considering from a compliance perspective as they look to innovate in this space. Traditionally siloed interactions are evolving (00:47) in both who and how life science companies are engaging with customers (02:09). This evolution to a true omnichannel approach is not without its pain points (05:36) both operationally and from a compliance perspective (06:58). The demand on these groups within life science organizations is high (08:10) and success will require working in a new way. Healthcare leaders should be considering not only the structural implications for their customer facing organizations (10:16) but also how they can partner with compliance early and often to innovate safely (11:05).
Podcast Tags: omnichannel, life sciences, compliance, data, personalization, marketing, customer engagement
Source Links:
· https://www.pharmexec.com/view/why-pharma-marketers-are-embracing-omnichannel-marketing
· https://www.biopharmadive.com/spons/moving-pharma-marketing-from-multichannel-to-omnichannel/601275/
· https://www.lek.com/insights/omnichannel-engagement-pharma-key-success-factors-and-case-examples
· https://appexchange.salesforce.com/partners/servlet/servlet.FileDownload?file=00P3A00000b7dcTUAQ
· https://www.reutersevents.com/pharma/patients-and-medical/medical-affairs-social-media-brave-new-world
· https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/industry-using-social-media
· https://gdpr.eu/what-is-gdpr/
· https://www.phrma.org/resource-center/Topics/STEM/Code-on-Interactions-with-Health-Care-Professionals
· https://www.fda.gov/drugs/prescription-drug-advertising/drug-advertising-glossary-terms
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Hunter Goga, Manager
hunter.goga@vynamic.com
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the latest in COVID-19 vaccines and treatments (00:34), updates on Pfizer’s copay assistance legal battle (03:55) and surprise billing arbitration (06:30), and the start of Medicare Advantage & Part D open enrollment (10:42).
Podcast Tags: COVID-19, vaccines, Medicare, Medicare Advantage, surprise billing, copay assistance, healthcare, healthcare news
Source Links:
· https://www.nytimes.com/2021/09/22/us/politics/pfizer-boosters-fda-authorize.html
· https://www.fiercebiotech.com/biotech/merck-s-oral-covid-19-antiviral-slashes-hospitalizations-prevents-deaths-phase-3-sparking?mkt_tok=Mjk0LU1RRi0wNTYAAAF_26eZ92mFcnqWj2kp5mJmBNQxAYY92bvbzylD4BZwugrf-Cgj2MFcLKaDtVAgudm2ZoB_CwSBt4ZrAyzpplj9smBgVLNevUxhsi8R6BGMi0nHVRyiqg&mrkid=65631392
· https://www.nytimes.com/2021/10/01/us/politics/fda-pfizer-children-boosters-moderna-johnson.html
· https://www.nytimes.com/2021/10/04/us/politics/johnson-vaccine-booster-coronavirus.html?utm_campaign=KHN%3A%20Daily%20Health%20Policy%20Report&utm_medium=email&_hsmi=166828072&_hsenc=p2ANqtz-8zjAA2sq6MFpwO_AjAqN3mJu0jM89LHFfRU55EtZuYIYnmV5vsziga14y_jLNq9u2ehvyvxiaxzg-gkUuJdwpU1kEnoQ&utm_content=166828072&utm_source=hs_email
· https://www.statnews.com/pharmalot/2021/10/03/pfizer-medicare-kickbacks-copay-assistance-hhs-lawsuit/?mkt_tok=ODUwLVRBQS01MTEAAAF_6kX1RFxQX7PI_L66DtpDUawamai0HLEEnHaSmt0ATcAT48baYoL2p7rxaPINzCrkEAk9mLuHauRXyDDMRtYoSX_PSBrTNdYUWaxBCbB_MBP7
· https://www.fiercehealthcare.com/hospitals/biden-admin-releases-surprise-billing-rule-detailing-arbitration-process?mkt_tok=Mjk0LU1RRi0wNTYAAAF_3LPxV-4OsO5wC33D-Ukc9RW9RI95pNRuBwRkNX_dt8A2VORhoIb_jcD-w3VtkDYOlDJyq5y4bkGhL5qxE7XWtot6Cxf1QTJD0q4GLQ0HctkjsXzwXg&mrkid=65631392
· https://www.fiercehealthcare.com/payer/medicare-advantage-premiums-to-decline-slightly-2022-part-d-to-rise-by-nearly-5?utm_medium=nl&utm_source=internal&mrkid=65631392&mkt_tok=Mjk0LU1RRi0wNTYAAAF_1ced-_CJWe5bAtj7FVS_ngBpZ3lN-zDY2ZQ9YV5wwFelcw6QW1Cq5Xscpxj5XgtFnoukouNyaVYOzlGel6ILx5qZ7s4jTqiahM3PoLKrYum0kC1H5A
· https://www.fiercehealthcare.com/payer/unitedhealthcare-aetna-cigna-anthem-medicare-advantage-2022?utm_medium=nl&utm_source=internal&mrkid=65631392&mkt_tok=Mjk0LU1RRi0wNTYAAAF_6kQ3h-pgu8OegBwTgK1RPMvnDGIyyDJF1BWGkxJPnLZ2WZrIySzaQyTSsiK71dcZBDs05tuD4n1hoHunsQ6EP7QqJvbEoDW3ZxuHnMFe0aUt6-wVKg
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Learning Lead
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
The recent proliferation and adoption of digital health technologies is often heralded as a key mechanism in closing the gap when it comes to health disparities. In this episode, Jen and Mindy are joined by special guest DJ O’Connor to discuss equality barriers in digital health and how healthcare leaders can develop more equitable solutions. The pandemic has accelerated the availability and adoption of digital healthcare, socioeconomic disparities prevent vulnerable populations from accessing from these innovations and create a “digital divide” (01:30). Even when access is not an issue, digital healthcare tools may not provide equivalent benefits across users (04:39) and advanced technologies need to be checked for bias (06:31). There are opportunities for improving equity through digital health, both within and beyond the healthcare industry (10:04) – healthcare leaders should be considering the diversity of their user personas and the social disparities that could prevent access when developing new digital solutions (13:25).
Podcast Tags: digital health, telehealth, access, equity, equality, AI, bias, social determinants of health
Source Links:
· https://www.forbes.com/sites/forbestechcouncil/2021/07/13/digital-health-equity-and-how-to-achieve-it-in-a-post-pandemic-world/?sh=1ffed0dd346d
· https://www.jmir.org/2020/6/e19361/
· https://academic.oup.com/cid/article/72/6/913/5919799
· https://www.healthcareitnews.com/news/telehealth-use-rises-new-trends-highlight-demographic-divides
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
DJ O’Connor, Manager
dj.oconnor@vynamic.com
Mindy McGrath, Healthcare Industry Advisor
mindy.mcgrath@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Supreme Court’s decision to deny an emergency appeal to block enforcement of a controversial Texas abortion law (00:35), a recent report on Medicare hospital fund insolvency (03:25), and an FDA committee meeting on complex gene therapy safety questions (11:11).
Podcast Tags: reproductive health, gene therapy, Medicare, FDA, healthcare, healthcare news
Source Links:
· https://www.documentcloud.org/documents/21053670-whole-womans-health-v-jackson
· https://apnews.com/article/texas-courts-us-supreme-court-32ee7ae7eeec9bdfd1471a848c163321?mkt_tok=ODUwLVRBQS01MTEAAAF_VSIHgCfdE15ODT_em382LPs8xDyw7Tdt5XiQod61z5Qds2MuFATJcJIqFe_VJFQxNSCP0DyV-2J2He6Etr31dqXoPxWpMEQ0NMSd6zLv3W6h
· https://khn.org/morning-breakout/justice-department-urgently-exploring-challenges-to-texas-abortion-ban/?utm_campaign=KHN%3A%20Daily%20Health%20Policy%20Report&utm_medium=email&_hsmi=156849726&_hsenc=p2ANqtz--wYCjNrXiSeZLsMD2D1FlxOK838QoZlq2zllmYMa3diPB0Gr_PUx0C2xUlTqaBxcNg0rh8vYnAN9KJu5k5J83GyeEdEQ&utm_content=156849726&utm_source=hs_email
· https://www.fiercehealthcare.com/hospitals/medicare-trustees-project-hospital-fund-to-run-out-2026-same-deadline-as-year-before?utm_medium=nl&utm_source=internal&mrkid=65631392&mkt_tok=Mjk0LU1RRi0wNTYAAAF_SsaDIoa_GdEE8dXas08HXrZcaVizqhjTgUD4Cc1xJOl08rgPOFQhafr3v-et6CpfpHRO1MkAlVlHn1eVMS3SSr4N3wZJekLesyJnCrprs6mv6EtTDg
· https://www.cms.gov/files/document/2021-medicare-trustees-report.pdf
· https://www.fiercehealthcare.com/hospitals/medicare-s-hospital-fund-running-out-money-experts-have-five-ideas-how-to-help?utm_medium=nl&utm_source=internal&mrkid=65631392&mkt_tok=Mjk0LU1RRi0wNTYAAAF_SsaDIguC05LhKkmI7AXmacZAYwlhUTyS21yLLSKe7y60RiW0e1wxxpPqKy391LBq_QitIwfGV69YxyT8GT0mLoit6JTLv_cdb77KZpSgORMnDHboXQ
· https://www.fiercebiotech.com/biotech/fda-committee-takes-complex-gene-therapy-safety-questions-novartis-zolgensma-providing?mkt_tok=Mjk0LU1RRi0wNTYAAAF_X6XMggYm6GwfiUwjeCxSBcS8YEf0fg7e8TZBfSI9PiIni3prmR28AdixqveoYcwWYEJU-9MSfyMedLAfah4R0sAXO4hpzX8QBACruYfHQODP1onf9A&mrkid=65631392
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Learning Lead
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
Patient centricity is no longer a buzzword, it's redefining how the pharmaceutical industry operates to deliver the best outcomes and experiences for patients. In this episode, Jen is joined by Vynamic London team members Gemma Pfister and Jack Young to discuss opportunities to become more patient centric throughout the medicine development lifecycle. Inclusiveness, empowerment, and partnership are defining featured of a truly patient centric approach (00:41). There are opportunities for improving patient centricity across the entire lifecycle of a product, from development (03:13) to reimbursement (08:35) to commercialization (12:50). Pharmaceutical companies are uniquely positioned to drive and derive value from patient centricity efforts (19:25), but success in the space requires a focus on strategy, digital, and measurement (21:52). Read how Vynamic partnered with a global pharmaceutical company to help change the way the life sciences industry develops patient-focused solutions in the future in our Case Study - Building an Industry-Changing Patient Innovation Hub.
Podcast Tags: patient centricity, patient advocacy, life sciences, pharmaceutical, pharma, HTA
Source Links:
- https://www.zs.com/insights/whats-the-secret-to-becoming-patient-centric
- https://pharmaceuticalcommerce.com/brand-marketing-communications/accelerating-the-drive-toward-patient-centricity/
- https://deep-dive.pharmaphorum.com/magazine/market-access-2021/representation-empowerment-patients-centre-medicine-reimbursement/
- https://www.paconsulting.com/industries/life-sciences/patient-centricity/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Gemma Pfister, Executive & London Hub Lead
gemma.pfister@vynamic.com
Jack Young, Director
jack.young@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the impact of the Delta variant on the healthcare system (00:31), a crackdown on “pay for delay” in the generic space (05:53), and the fight to legalize Medicare copay assistance (09:25).
Podcast Tags: COVID-19, vaccination, drug prices, generics, biosimilars, Medicare, copays, healthcare, healthcare news
Source Links:
· https://khn.org/news/article/unraveling-the-mysterious-mutations-that-make-delta-the-most-transmissible-covid-virus-yet/?utm_campaign=KHN%20-%20Weekly%20Edition&utm_medium=email&_hsmi=145086783&_hsenc=p2ANqtz-_wMcbW2smTDdSj-wS3p_zbkj9-94CHKV6V5ywjwzuhjyXGO0H8kVETf6VE1Yvrz12rRDC2o5XK47oSm4GPuGRDDGIexg&utm_content=145086783&utm_source=hs_email
· https://www.fiercehealthcare.com/hospitals/cdc-brings-back-mask-recommendation-for-vaccinated-people-areas-high-covid-19-spread?mkt_tok=Mjk0LU1RRi0wNTYAAAF-m4fxAqHQ4MivLtindW3Cc8PNGILqc4EfBXo2E676y8IkQESOCK0vHnb_ssj3k-qmWCczjZo0ZeMwrOxCwJI4EOKRz2QqFPX0pHx2cklaUe1VN4Uubw&mrkid=65631392
· https://www.fiercehealthcare.com/hospitals/40-health-systems-requiring-mandatory-covid-19-vaccines-for-their-workforces?mkt_tok=Mjk0LU1RRi0wNTYAAAF-m4fxAoymvTocAxoJ-vI_Th82_qz69B-Y7KeLLWsOSfDtaG6Ky6TXys9xengpmEM7a4sRY6RUxzqqasEK1vsLjWb4AlUo56Bc2WNiLqhxI1_c98qvMg&mrkid=65631392
· https://www.fiercepharma.com/pharma/as-a-way-to-reduce-drug-prices-and-enhance-competition-senate-takes-aim-at-patent?mkt_tok=Mjk0LU1RRi0wNTYAAAF-l2IhJ68_p0hubbl5WsPZvKzWH-gphrkMs_cWo0cUZY0QFbg8QCMK4JZEdEuLM3wQAE9MCShH_znUDZfdQgtNVqq-RG-DA__bHxBYTKvCNP2L4GJXPw&mrkid=65631392
· https://www.fiercehealthcare.com/payer/kaiser-health-plan-files-pay-for-delay-suit-against-merck-over-cholesterol-drugs?utm_medium=nl&utm_source=internal&mrkid=65631392&mkt_tok=Mjk0LU1RRi0wNTYAAAF-loI_MRbfp3bTdFJGct_3ceVIkr2foNg0S57FCXtjbsyW3rOsuQj2fFBF78b_qPm3QVxvgtYb8p7fSLAMC_w9ufVxY0yiKyZxArpNmBRerpKIDzvBKg
· https://khn.org/news/article/pfizer-court-fight-could-legalize-medicare-copays-and-unleash-gold-rush-in-sales/?utm_campaign=KFF-2021-The-Latest&utm_medium=email&_hsmi=145155484&_hsenc=p2ANqtz-9QqVv7WvcPmmVpbKs6jTJ6DwsHglsdexNJOKhu6vKraHpk3zJT-8adi6MlU7WO5iAMBHzKaQyT4u-PHdYbE20b6Q5TRQ&utm_content=145155484&utm_source=hs_email
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Learning Lead
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
Climbing COVID-19 vaccination rates have enabled many countries to relax social distancing requirements and business leaders to implement their return to workplace plans. In this episode, Ryan and Jen are joined by Vynamic’s Lauren Scandone and Stefanie Christmas to discuss the importance of culture in developing and executing those plans. The past eighteen months have irrevocably changed how many employers and employees think about work – bringing technology, employee choice, and empathy to the forefront of the discussion (00:54). This discussion about the future of work should also include a discussion of culture, as it is a key driver of both team and business performance (03:13). Although each company’s culture is unique, there are several key areas of focus on the minds of organizations as they think through their culture roadmaps and return to workplace plans – communication and team dynamics (05:37), psychological safety, resilience and trust (06:03), equity and inclusion (07:45), and employee support and wellbeing (08:40). Healthcare industry leaders can jumpstart the incorporation of cultural considerations into their return to workplace planning by thinking through a few key questions (11:30).
For more information on this topic, check out Vynamic’s Insight “COVID-19 Business Response – Phase 4: The Great Culture Reset”.
Podcast Tags: COVID-19, return to work, culture, employee wellbeing, equity and inclusion
Source Links:
· https://vynamic.com/insights/covid-19-business-response-phase-4-the-great-culture-reset/
· https://www.bls.gov/news.release/flex2.htm
· https://www.pwc.com/us/en/library/covid-19/us-remote-work-survey.html
· https://www.gallup.com/workplace/283985/working-remotely-effective-gallup-research-says-yes.aspx
· https://www.nytimes.com/2016/02/28/magazine/what-google-learned-from-its-quest-to-build-the-perfect-team.html
· https://www.fastcompany.com/90636376/4-ways-to-prevent-employee-culture-shock-as-they-return-to-work
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Lauren Scandone, Executive
lauren.scandone@vynamic.com
Stefanie Christmas, Director
stefanie.christmas@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Biden administration’s interim final rule banning surprise billing (00:35), Walmart’s launch of a private band insulin analog (04:21), and interim trial results for in vivo CRISPR-based genome editing candidate NTLA-2001 (07:00).
Podcast Tags: surprise billing, health insurance, diabetes, drug prices, gene therapy, CRISPR, healthcare, healthcare news
Source Links:
· https://www.fiercehealthcare.com/payer/biden-admin-releases-first-interim-final-rule-to-ban-surprise-medical-bills-sets?mkt_tok=ODUwLVRBQS01MTEAAAF-ELDJl4M5DBFZ7_MJTdaVw2W_WtZeiSWcn
· https://www.beckershospitalreview.com/finance/cms-unveils-surprise-billing-rule-10-things-to-know.html
· https://www.fiercehealthcare.com/finance/walmart-teams-novo-nordisk-to-launch-private-band-analog-insulin?utm_medium=nl&utm_source=internal&mrkid=65631392&mkt_tok=Mjk0LU1RRi0wNTYAAAF9_AB9bhrYERn_F0_Z_CFgnxi3JFoDbFYYjLV3ub090Lsk6j0dRKGECO_qGldwPtxlXqbfHOT4W09v3LzWGRKpmSFxz_j8dNYwt3sqlB5Nr4esKYBRlg
· https://www.statnews.com/pharmalot/2021/06/29/walmart-insulin-novo-nordisk-diabetes/?mkt_tok=ODUwLVRBQS01MTEAAAF9-91CzqJAe-LL33Gy4FjrwKJDFCfhES48aNg7kB7S_naKvfyJrEjqeHn8s6J5z34wAaGJdW4uvctwaadx9b64EBOjreZh8VfoIbEaDj06GnUa
· https://www.fiercebiotech.com/biotech/first-human-trial-results-intellia-shows-world-gene-editing-has-arrived?mkt_tok=Mjk0LU1RRi0wNTYAAAF-BlNHkt2Maf8F2j4tTY34Nbfr768q_-NEJlovuUC8YR5R6kmRnizLOIUHMuBx4yD_H3cwxx1YhNslaO10Zfx505MYvFxg2Zd5w8yFVCJGLpWlyzkEjg&mrkid=65631392
· https://www.statnews.com/2021/06/26/intellia-therapeutics-ntla-2001-data/?utm_source=STATNewsletters&utm_campaign=63bbc01b83-MR_COPY_14&utm_medium=email&utm_term=0_8cab1d7961-63bbc01b83-149847573
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Learning Lead
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
Advancement in technologies and scientific platforms have enabled personalized approaches that acknowledge the future of healthcare shouldn’t be “one-size-fits-all”. Jen, Mindy, and Ryan discuss the drivers behind this innovation, and the impact on both the practice and development of therapeutics. The episode opens with a discussion of what’s sparking this demand for personalization (00:45) and key enablers of this future-state in healthcare, including the availability of data (01:57), connections across data sources (02:35), widespread automation (05:38), and proactive treatment (06:58). The potential of personalization isn’t limited to treatment paradigms alone – it can also be seen in how those treatments are developed and delivered (08:32). Precision medicine initiatives have seen early returns (10:12), particularly in oncology (10:27). Development of CAR-T and gene therapies are pushing individualization of therapeutics even further (11:47) – but there are key clinical (12:19) and developmental (13:56) challenges to be overcome in scaling the delivery of these treatments. As the shift toward personalization continues, healthcare leaders should be considering the strategic value potential, organizational resourcing, and required change management (17:25).
Podcast Tags: healthcare, personalization, precision medicine, AI, machine learning, data, gene therapy
Source Links - Below, we've listed links to some of the stories and resources discussed on this show.
· https://medlineplus.gov/genetics/understanding/precisionmedicine/
· https://www.fda.gov/medical-devices/in-vitro-diagnostics/precision-medicine
· https://www.fda.gov/drugs/news-events-human-drugs/personalized-medicine-biological-approach-patient-treatment
· https://www.pharmaceutical-technology.com/features/precision-medicine-2020/
· https://www.fiercehealthcare.com/tech/industry-voices-digital-twins-humans-are-closer-than-you-think?mkt_tok=Mjk0LU1RRi0wNTYAAAF9PVg2bgjzIuitbODg7932jkjRPktLd39jOVeKvq-xOH74Rfxoo41R3Qc55yhEiwPnzZfa95PbMsJqVadoVllijzgMc5X7T81YSkhZS1fHPC22at6tsZ4&mrkid=158244174
· https://www.forbes.com/sites/blakemorgan/2021/05/03/the-future-of-healthcare-personalization/?sh=3a7eba147e38
· https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02316-w
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Learning Lead
mindy.mcgrath@vynamic.com
Ryan Hummel, Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Supreme Court’s ruling to uphold the Affordable Care Act (ACA) (00:35), the announcement of additional mandatory payment models from the Center for Medicare & Medicaid Innovation (CMMI) (04:20), America’s Health Insurance Plans rebranding as “AHIP” (08:13), the Institute of Clinical and Economic Review’s (ICER) decision to investigate the impact of health plan policies on prescription drug costs (11:18), and finally, the FDA approval of Biogen’s Alzheimer’s therapy (15:15).
Podcast Tags: ACA, CMMI, value based care, AHIP, health insurance, ICER, drug prices, Alzheimer’s, healthcare, healthcare news
Source Links:
· https://www.healthcaredive.com/news/supreme-court-upholds-aca-in-7-2-decision-leaving-intact-landmark-us-healt/599060/
· https://www.healthcaredive.com/news/cmmis-fowler-more-mandatory-payment-models-likely/601258/
· https://www.fiercehealthcare.com/payer/ahip-launching-first-rebranding-effort-nearly-2-decades
· https://www.biopharmadive.com/news/icer-insurers-scrutiny-drug-plan-design/600767/
· https://www.fda.gov/drugs/news-events-human-drugs/fdas-decision-approve-new-treatment-alzheimers-disease
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Learning Lead
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive and Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
Six years after the Medicare Access and CHIP Reauthorization Act (MACRA 2015), Vynamic’s Mindy, Ryan, and Jen discuss where we are today in the transition from Fee-For-Service (FFS) reimbursement to Value-Based Care (VBC). The episode opens with an acknowledgment that VBC is at a crossroads – the transition has been bumpy, VBC models have been “consistently inconsistent” (2:10), and the misalignment of payer and provider compensation models continues to be an ongoing challenge (3:18). The conversation then moves to what is needed for this transition to VBC to be successful; it requires operational overhaul (5:10), robust analytics, appropriate engagement of providers, and health system transparency. Innovation takes time and transitioning to VBC requires a shift in cultural mindset and a detailed strategy for change and adoption (8:10). The episode then explores what VBC means for Life Sciences companies, as the industry starts to reckon with the development of more expensive products with higher intrinsic value (14:50), including curative one-time treatments and gene therapies. From a market access perspective, Life Sciences companies should be creative with contracting and how they approach payers and providers about the products they bring to the market (15:18). Ultimately, these stakeholders will need to reach a middle ground to make products accessible to the right patients (20:04). As an industry, we should strive for “the art of the possible” (21:33) and engage in cross-sector thinking to make VBC models successful.
Podcast Tags: healthcare, MACRA, fee-for-service, value-based care, reimbursement, innovation, Life Sciences, strategy, market access, value-based payment over time (VBPOT)
Source Links - Below, we've listed links to some of the facts and resources discussed on this show.
-
https://revcycleintelligence.com/features/entering-the-next-phase-of-value-based-care-payment-reform
-
https://www.fiercehealthcare.com/payer/new-cmmi-director-says-value-based-care-models-at-crossroads?mkt_tok=Mjk0LU1RRi0wNTYAAAF8k4XqnunZZyMo3p_xn3tEs3yH708uXgCNuApAFnJQHSR0EYcv1E2LCt6NlhnrwdH2JyVf-V_pxlSfU24GHKz3P3xDIZMa8jQIoLXYaPdibJyNaBh1Cc4&mrkid=152778267
-
https://www.fiercehealthcare.com/payer/verma-says-value-based-care-models-haven-t-made-good-return-investment
-
https://www.fiercehealthcare.com/payer/providers-call-for-another-chance-to-sign-up-for-direct-contracting-model?mkt_tok=Mjk0LU1RRi0wNTYAAAF8dKGQQGD5eCW9fP3QjJTt2D336_V8b5iB8tDE7JqOsFLKdsRpvjVAlrQMysKq4T7UamDcOD1mve6rocLCDDeRVC2cdYdiQ8iLjpaC6J0UFZyS_CaD5xk&mrkid=152778267
-
https://www.fiercehealthcare.com/practices/medical-groups-urge-cms-to-walk-back-aco-quality-overhaul-citing-potential-negative?mkt_tok=Mjk0LU1RRi0wNTYAAAF824GfFyUI8FL_gS064nifCYSR3Zuk0KLpuNBZaeS1tB3UYGjMu883L-Dr2vtKP2pn19XwOcAZW-KlyrW9Zq1P7IUionDrt-hi739yRxkSO6YfNeiaYl4&mrkid=152778267
-
https://revcycleintelligence.com/news/a-new-administration-value-based-payment-to-dictate-2021-success
-
https://www.fiercehealthcare.com/practices/industry-voices-3-questions-providers-need-to-prioritize-as-they-look-to-take-more-risk?mkt_tok=eyJpIjoiWW1JeFpESmlPRFEwWkRsaSIsInQiOiJ2dlcwTkRqUUVsUUpUVm94T2h3cTd5UzNYcWp0cUJwZHpKVWUxZUxZVXRFVTFWamx4Ykh1NDJXckptYVIxZitFQzBDM1VvcncrWGRsQ1JNUzdDK2lOTURPOVQ2RVAzQmNib0dsWDVIOUhhMmlqOEpGc01aUGd4dktrU1RXNmVnWHpqaGFSb3RBYWdBZ3hOWXMzZnpzWkE9PSJ9&mrkid=152778267
-
https://digitally.cognizant.com/value-based-care-in-life-sciences-whats-it-worth-to-you-third-of-a-multipart-series-codex5396/
-
https://www.zs.com/insights/new-era-value-based-contracts
-
https://www.bakertilly.com/insights/implications-of-value-based-care-for-the-life-sciences
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Learning Lead
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the potential waiving of international patent protections for COVID-19 vaccines (00:35), Walmart’s acquisition of telehealth company MeMD right as AmazonCare signs its first customer (05:20), and movement in the hospital-at-home space with Mayo Clinic and Kaiser Permanente’s investment into acute care company, Medically Home (08:53).
Podcast Tags: healthcare, healthcare news, telehealth, healthcare investment, COVID-19
Source Links - Below, we've listed links to some of the stories and resources discussed on this show.
· https://www.npr.org/sections/coronavirus-live-updates/2021/05/05/993998745/biden-backs-waiving-international-patent-protections-for-covid-19-vaccines
· https://www.bloomberg.com/news/articles/2021-05-08/eu-tells-biden-to-export-vaccines-now-and-worry-about-ip-later?mkt_tok=ODUwLVRBQS01MTEAAAF89Tk5m7ShsEm0KIkMwOZK39Dv8cr78LRG7Zgbx9L0rVPl7tdE1HirKtLrMu-etXgRb0GIFGXyrR8-bQ-4tRneOXc_zVB3C8kiIao0YiDN6Hyt
· https://www.fiercepharma.com/pharma/don-t-expect-lifting-covid-19-vaccine-patents-to-happen-quickly-if-at-all-analysts?mkt_tok=Mjk0LU1RRi0wNTYAAAF89hxn0kk_FRFBZ_3Iwevy1qT4RcJk2wCs46oWxbD8fmpyepvvK6RmMfySqLByOxW0hynnfzL9howEQAeszvDQSJTP4wfhqej51xQfU3KY7f16B8NdKg&mrkid=65631392
· https://www.reuters.com/business/healthcare-pharmaceuticals/wto-chief-says-hopes-covid-patent-issue-settled-by-december-2021-05-10/
· ttps://www.fiercehealthcare.com/tech/walmart-to-acquire-telehealth-company-memd-as-amazon-care-signs-first-customer?mkt_tok=Mjk0LU1RRi0wNTYAAAF89okEjqsNtLXuuD1iCcPyOubkq1L__X2wSAnpPvwgaltLmvcQFjYiGEvYgGEP2GK6f_SBsnPvy20xpbb90EGf1QZbzVHBsxDW-o1hw26fmGu8Fc8sOA&mrkid=65631392
· https://www.statnews.com/2021/05/12/telehealth-companies-are-fueling-a-lobbying-frenzy-to-protect-their-covid-boom/
· https://www.businessinsider.com/amazon-diagnostics-new-brand-home-medical-tests-covid-sti-genomics-2021-5#
· https://www.fiercehealthcare.com/tech/mayo-clinic-kaiser-permanente-to-scale-up-hospital-at-home-efforts-100m-investment-into-tech?mkt_tok=Mjk0LU1RRi0wNTYAAAF9DwRCUxxqoJ70XBEBsX0AFOPs6sbfyoNGgqhYxxoyKvSsMG7hMDITEzeITH-NTeupzCjSG7ChTbOZ7D41LhujDt_KqUUp8S4vIoYJi91Yhe1kPordfA&mrkid=65631392
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Learning Lead
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
Mental Health Awareness is a national focus in both the US and the UK during the month of May. Now, more than ever before, mental and behavioral health are at the forefront of healthcare discussions, as individuals across the globe grapple with the COVID-19 pandemic and the accompanying recession. In this special bonus episode, Vynamic’s Kevin Fletcher discusses the importance of mental and behavioral healthcare, and what challenges and opportunities industry leaders should be considering.
Podcast Tags: healthcare, mental health, behavioral health, telehealth, digital health
Source Links - Below, we've listed links to the resources referenced in the episode
· https://www.nami.org/Get-Involved/Awareness-Events/Mental-Health-Awareness-Month
· https://www.kff.org/coronavirus-covid-19/issue-brief/the-implications-of-covid-19-for-mental-health-and-substance-use/
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Kevin Fletcher, Director
kevin.fletcher@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
Social, non-medical factors (including economic factors, neighborhoods, employment, and physical safety) play a major role in individual and population health – Jen, Mindy, and Ryan discuss how partnerships and technology solutions are addressing key social determinants of health, and what leaders should be thinking about as the system evolves its focus and investment in “whole person care.” The episode opens with a discussion of healthcare partnerships and innovations addressing food insecurity (01:44), housing instability (04:52), financial strain (07:40), and transportation (09:45). Complexity and fragmentation in both the healthcare and social services systems are driving a wave of innovations linking patients to social services at the point of care (12:40). As the industry continues to move toward whole person care, healthcare leaders should be considering how they harness data to determine ROI (16:50) and if their goals are best achieved through partnerships with local organizations (20:49).
Podcast Tags: healthcare, whole person care, social determinants, population health, public health
Source Links - Below, we've listed links to some of the stories and resources discussed on this show.
· https://www.fiercehealthcare.com/payer/blue-cross-nc-takes-aim-at-food-insecurity-slew-new-pilot-programs
· https://www.prnewswire.com/news-releases/cvs-health-invests-114-million-in-affordable-housing-across-the-country-in-2020-301232866.html
· https://www.fastcompany.com/90291860/this-healthcare-giant-invests-millions-in-affordable-housing-to-keep-people-healthy
· https://news.ibx.com/independence-gradfin-reduce-student-loans/
· https://www.fiercehealthcare.com/digital-health/lyft-pass-for-healthcare-lets-patients-book-their-own-rides-to-doctor?mkt_tok=Mjk0LU1RRi0wNTYAAAF8ebWO55uo0uCPrvrnKsgvNRT-zpwscBBoxU3JD2Mb5IzuV-O9OXgNrfI4vWQElqoSaSVZCY_z2WKFYLmYaf-v_Ku2EvuycMO0j6iu_XxX7HfwPv8a6Fk&mrkid=152778267
· https://www.roundtriphealth.com/
· https://www.nowpow.com/
· https://www.fiercehealthcare.com/tech/health-tech-startup-building-social-care-networks-and-it-just-reached-unicorn-status
· https://www.bluezones.com/blue-zones-results-albert-lea-mn/#section-2
· https://www.healthleadersmedia.com/welcome-ad?toURL=/clinical-care/social-determinants-health-lead-or-partner-0
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Learning Lead
mindy.mcgrath@vynamic.com
Ryan Hummel, Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: President Biden’s plans for healthcare in the budget, infrastructure, and American Families Plans (00:43), the recent CMMI announcements regarding payment models (09:05), and a flurry of activity in the EHR space (15:32).
Podcast Tags: healthcare, healthcare news, CMS, direct contracting, EHR
Source Links - Below, we've listed links to some of the stories and resources discussed on this show.
· https://www.fiercehealthcare.com/payer/3-major-health-items-included-president-biden-s-budget-request?utm_medium=nl&utm_source=internal&mrkid=65631392&mkt_tok=Mjk0LU1RRi0wNTYAAAF8ZSpp0j-jtHWMAfGixLTfQeFoKl4m3TuzlhioeaeHGZQWuZ__w72lH5jg5GabFoTKeNp1T8VcFLSAoJL4o5YlZIBEC0QfhToXANutUyti93CVcTdCxQ
· https://www.npr.org/sections/health-shots/2021/04/09/985567929/whats-in-bidens-400-billion-plan-to-support-families-long-term-health-needs
· https://www.vox.com/2021/4/15/22383587/biden-american-jobs-plan-long-term-care
· https://www.washingtonpost.com/us-policy/2021/04/12/sanders-pelosi-biden-obamacare-medicare/?mkt_tok=ODUwLVRBQS01MTEAAAF8ZRDWoJHYKl66dg0Si4uXfkKCBWh9R5lK3RU7l7egshsgkHIvcqYxh3qQ2ehZMHuvB9xjrvRJuQn-O3FXCIFxHUKDXRJje0yTim4IXzLoqNmA
· https://www.fiercehealthcare.com/payer/providers-call-for-another-chance-to-sign-up-for-direct-contracting-model?mkt_tok=Mjk0LU1RRi0wNTYAAAF8dKBFwN78GcSsM-2atfK7uToG4V8zncrqNmbDJHag3XUOgeB5M9wNobnIVJsIt7EzDGd9j8x2EHs0B5dk64ftHmDC6FD6-swFo7SIliLNdLZ5kkaczw&mrkid=65631392
· https://www.fiercehealthcare.com/payer/here-are-payment-models-cms-has-either-pulled-for-review-or-delayed
· https://www.healthcareitnews.com/news/confusion-remains-about-onc-information-blocking-rules-even-after-start-date
· https://www.healthcareitnews.com/news/google-has-another-go-patient-health-record-software
· https://www.bloomberg.com/news/articles/2021-04-12/microsoft-makes-big-bet-on-health-care-ai-technology-with-nuance?mkt_tok=ODUwLVRBQS01MTEAAAF8ZRDWn1VlEJ1RYylQefJ0RpmQECdFaqNI4TZ9qJvQ2j8pF_MHB3fS1bLfCVFrQ3At2soUsZP16JiOg2p0py8bLh52Sae8paqPvi5oirHqtn1P
· https://www.fiercehealthcare.com/tech/ehr-startup-canvas-medical-lands-17m-series-a-and-new-partnership-anthem?utm_medium=nl&utm_source=internal&mrkid=65631392&mkt_tok=Mjk0LU1RRi0wNTYAAAF8ZSpp0q5yv3DZt_vJ5JkvKRItiHnaMsfE5k96OfGrrWKi8qpl-OO-28BW1yRkbHdRaNTetZ7mNasg7kBIvJDxv_Z-oTyXBDOd1RYyC4GREaax76Om5Q
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Learning Lead
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
The episode opens with a discussion of what’s spurring these changes (00:50), including the importance of the establishment of the Center for Medicare and Medicaid Innovation (05:11) and the Quadruple Aim (06:45). Over the last decade, ACO models have been a huge source of savings and learnings for CMS (07:13), and even commercial markets (10:05). Reimbursement truly sets the tone and shape for care model innovation (13:17), whether we’re talking about Next Generation ACOs, Direct Contracting (14:28), or even Direct-to-Employer Contracting (18:00). As care model innovation continues, healthcare leaders should be thinking beyond the technical aspects (20:48), not overlooking the importance of change management, capability building, and culture development.
Podcast Tags: healthcare, care models, innovation, ACO, direct contracting, quadruple aim
Source Links - Below, we've listed links to some of the stories and resources discussed on this show.
· https://innovation.cms.gov/innovation-models#views=models
· https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/Value-Based-Programs/MACRA-MIPS-and-APMs/MACRA-MIPS-and-APMs#:~:text=The%20Medicare%20Access%20and%20CHIP,the%20Quality%20Payment%20Program%20that%3A&text=Streamlines%20multiple%20quality%20programs%20under,Based%20Incentive%20Payments%20System%20(MIPS)
· https://robertpearlmd.com/lessons-macra/
· https://www.fiercehealthcare.com/payer/naacos-calls-for-becerra-to-stem-losses-aco-participation-calls-for-increase-to-aco-savings?mkt_tok=Mjk0LU1RRi0wNTYAAAF7_ioIe6hTHSK2F64EV9LUrhxTPE2HHobV27D-br6GMS2McZnhTwnbCbARn-XYqXeQZKR0hxDk7zwo3jCO_HGwDI9r6-bt8PjKqfYW_ahOZHX3S5Iu_eA&mrkid=152778267
· https://innovation.cms.gov/innovation-models/gpdc-model
· https://www.fiercehealthcare.com/payer/industry-voices-direct-contracting-providers-opportunity-for-forward-thinking-employers?mkt_tok=Mjk0LU1RRi0wNTYAAAF8HRFPlmGwEzapC2b0t14Ks8pYOt74YCWHjBNyzp6ltMGGTkhsg1WzuO7GYD5Jfufw6ninujRfZX6Px4mZyy4tXYxDnoIQ54Zl-ViUHmz8XNLJPnb9xYY&mrkid=152778267
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Learning Lead
mindy.mcgrath@vynamic.com
Ryan Hummel, Head of Provider Sector
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the 11th anniversary of the Affordable Care Act (00:46), the confirmation of Xavier Becerra (06:29), and recent announcements from Transcarent and Amazon Care (11:05).
Source Links - Below, we've listed links to some of the stories and resources discussed on this show.
• https://www.washingtonpost.com/health/becerra-squeaks-through-confirmation-vote-to-become-hhs-secretary/2021/03/18/cd11bac4-8750-11eb-8a8b-5cf82c3dffe4_story.html?mkt_tok=ODUwLVRBQS01MTEAAAF79SJML2Iwo2rw8_Ud2DXU7lNrBRfFv8DvZiNcbRBjYUwb2VoIJbmfCxidf0cLphTwFpoSRcKk4D-Dfe7lqBYeawTzN6irdWbugSzXFoZlbzO-
• https://www.fiercehealthcare.com/tech/game-competition-healthcare-space-heats-up-as-amazon-care-expands-analysts-say
• https://www.forbes.com/sites/katiejennings/2021/03/18/concierge-medicine-on-steroids-startup-raised-40-million-to-disrupt-primary-care/?sh=22466aa55650
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Learning Lead
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
The journey into motherhood comes with its own unique risks and outcomes that are determined by one’s country of birth, socioeconomic status, education, and even race.In this bonus episode of Trending Health, Vynamic’s Diversity & Inclusion Council presents excerpts from a recent panel on the Disparities in Maternal Health in honor of International Women’s Day. The panel discussion was led by Vynamic Director Tilewa Otunba Nwaeze and featured Kassandra Margetis, LCSW-R, former Manager of Mental Health & Strategic Partnerships at the NYC Bureau of Maternal, Infant & Reproductive Health and Kendra Mitchell, an MFA candidate in the Peter Stark Producing Program at USC and currently working as Associate Producer on Maternity, an upcoming short film highlighting the black maternal mortality crisis.
The episode opens with a discussion of what is driving this change (00:47), specifically the acceleration due to COVID-19 – from rapid stand up due to necessity, to increased comfort as more patients experienced virtual care, to the removal of regulatory and reimbursement barriers. While “telehealth” may be the first thing that comes to mind when talking about virtualization in healthcare, there is so much more (06:05) – including remote patient monitoring to manage chronic disease (06:20), the incorporation of patient-generated health data into care management (08:22), decentralized clinical trials (09:40), and digital HCP engagement in life sciences (10:40). As virtualization continues to mature, healthcare leaders should be thinking about (12:35) operationalization, information security and data privacy (13:03), data mapping and management (13:45), and capabilities development (14:05). Virtualization in healthcare provides an opportunity for increased access and reach across geographies (15:25), demographics (16:21), and mental health services (17:00). Payment parity and favorable policy decisions will be critical in maintaining momentum in virtualization (18:02).
Podcast Tags: healthcare, virtualization, telehealth, remote patient monitoring, e-detailing,
Source Links - Below, we've listed links to some of the stories and resources discussed on this show.
· https://www.jmir.org/2020/9/e20786/
· https://www.kff.org/womens-health-policy/issue-brief/opportunities-and-barriers-for-telemedicine-in-the-u-s-during-the-covid-19-emergency-and-beyond/
· https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448894/
· https://news.careinnovations.com/blog/rpm-growing-in-popularity-for-chronic-disease-management
· https://mdgroup.com/blog/why-decentralisation-is-the-future-of-clinical-trials/
· https://www.accenture.com/us-en/insights/life-sciences/coronavirus-changing-pharma-hcp-engagement
· https://www.fiercehealthcare.com/hospitals/money-behind-mental-health?utm_medium=nl&utm_source=internal&mrkid=152778267&mkt_tok=eyJpIjoiT0RVek1EVTRZelZoTlRrMiIsInQiOiJsWWNQNVJVTnNDMXl0V3NMWEJkZU1YV3dRVCtJK1lyQm9Zd1E5bEViUnhNdXJVR3Z0eHlsMU9vOGlkWDFQQ3JrMXRPRFlQWFdQZU0waWlNck1LMFF2T1JcL1F4QUxOUENndGlCZTJwR1k5N3lLOGRLRWFrOWZuUHhwNUhnTE1MWVhPeWNrVk1PNkpGcFZrWlBOVzNzVm13PT0ifQ%3D%3D
· https://www.fiercehealthcare.com/tech/house-health-leader-calls-for-permanent-medicare-telehealth-expansions-but-concerns-about?mkt_tok=Mjk0LU1RRi0wNTYAAAF7nIf
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Learning Lead
mindy.mcgrath@vynamic.com
Ryan Hummel, Executive
ryan.hummel@vynamic.com
Jen Burke, Healthcare Industry Strategist
jen.burke@vynamic.com
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the latest in vaccine development from Pfizer, Moderna, J&J, and AZ (00:29), the review of 340B in the courts (06:48), Aetna’s re-entry into the ACA exchanges (13:38), and the announcement of the new health data start-up, Truveta (16:33)
With healthcare organizations expanding across the value chain and blurring boundaries across sectors, Jen, Mindy, and Ryan discuss the trend towards business model and partnership innovation. The episode opens with a discussion of what is driving this change (00:45), specifically consumers, complexity, connected care, cost, the need to create and capturing value, and of course, COVID-19 (04:08). At (06:28) the conversation shifts to discussing a few specific business model and partnership innovation examples, including the Oak Street-One Medical partnership (06:50), the Humana-Dispatch health partnership (08:44), and the Hims/Hers-Privia Health partnership (10:32). Traditional life science companies continue to pursue unique launch partnerships, licensing opportunities, and distribution agreements (11:06), while healthcare organizations are spinning out their in-house technology solutions as independent offerings (12:37). The episode concludes with a discussion of what healthcare leaders should be considering to make these new partnerships and models successful (13:48), including clearly defined goals and success metrics, transparency, and agility.
In this new minisode series, Mindy, Ryan, and Jen discuss a few recent newsworthy items healthcare leaders should be considering. The episode opens with a discussion of the Biden administration’s initial response to the COVID-10 pandemic (00:35), including the pledge to administer 100 million doses in his first 100 days, the invocation of the Defense Production Act, and the establishment of his COVID Response Taskforce. The conversation then moves to analyzing key healthcare hires in the Biden administration (06:47), including the nomination of Xavier Becerra for HHS Secretary, Vivek Murty for Surgeon General, Rochelle Walensky of the CDC, and Janet Woodcock of the FDA. Outside of the political landscape, vaccine development and distribution continues to make headlines (10:52), with more Americans expressing willingness to receive the vaccine, J&J releasing positive trial results, trials starting in juvenile populations, and Merck pulling their vaccine candidates from development. The episode concludes with a discussion of how Biden’s regulatory freeze memo (15:12), could directly counteract some lame-duck Trump decisions, particularly changes to HIPAA privacy rules, the FDA’s authority over medical devices, and prior authorization requirements.
The episode opens with a discussion of widespread virtualization (00:58), as the industry shifts focus from the rapid adoption precipitated by the COVID-19 crisis to operationalization and refinement of the customer experience, particularly as a generation of digital natives move into leadership positions and increasingly utilize healthcare services (03:06). At (06:30) the conversation shifts to business model and partnership innovation trends, as new and existing players look to unlock new opportunities across the value chain and become more agile in how they bring solutions to the marketplace (09:30). Organizations are diversifying their portfolios – pursuing multiple partnerships, working across sectors, and entering new spaces. Accompanying this is an innovation in care models (12:50), as the industry starts to reimagine healthcare as an interconnected ecosystem in response to increasing cost pressures and consumer demands. The healthcare hub model, whether pharmacy, health system, or IDN-driven, could be a key factor in success and sustainability in this new environment (16:05). Driving both the business and care model innovation trends is the industry shift to value as the differentiator (18:03) – the pandemic’s exposure of the risks of the fee-for-service model, the success of early CMS programs, and industry recognition that the system needs to change is likely to accelerate the operationalization and expansion (23:41) of value-based models. Beyond reimbursement, across the industry there is an acknowledgement of whole person care (24:40) – a recognition of the importance of social determinants of health and changing consumer preferences around health and wellness. Technology and data sharing are enabling the personalization of health (28:16) that today’s consumers are starting to demand when it comes to their care experience.
As 2020 winds down, we want to look to the year ahead. In this minisode, we sit down with Vynamic’s Healthcare Technology Sector Advisor, Chrisna Govin, to discuss the trends she sees being the most impactful in 2021. The episode opens with a discussion of the accelerants that are causing rapid adoption of technologies across the healthcare ecosystem, including COVID-19, continued growth of the aging population, increasing diversity and inclusion expectations, and overall comfort with technology (00:35). The scope of virtual care is rapidly expanding across care settings, use cases, and specialty care (01:15) and health plans and providers are considering new digital front doors in seamlessly connecting patients with care (01:59). Consumer whole person focus is broadening the definition of health, what it means for their portfolios, and what technology and data partnerships they will need to support this shift (02:42). The race for actionable intelligence is making new and innovative partnerships with technology companies critical to success across the healthcare industry (03:56). The interview closes with consideration of the impact of these trends (05:10), including the faster evolution, increased flexibility, and improved resilience of the healthcare industry.
As 2020 winds down, we want to look to the year ahead. In this minisode, we sit down with Vynamic’s Health Plans Sector Advisor, Saurabh Raman, to discuss the trends he sees being the most impactful in 2021. The episode opens with a discussion of medical utilization and the impact on consumer costs (01:20). The conversation then moves to the impact on reimbursement of the shift to virtual care (02:49) and the continued expansion of voluntary and specialty benefits (03:50). The interview closes with consideration of the impact of these trends (05:20), including potential spending spikes and cost pressures from decreased utilization (05:40), and improved cost of care and outcomes through telehealth and expanded coverage (06:45).
As 2020 winds down, we want to look to the year ahead. In this minisode, we sit down with Vynamic’s Provider Sector Advisor, Ryan Hummel, to discuss the trends he sees being the most impactful in 2021. The episode opens with a discussion of the rapid expansion of telehealth, the recent decline in preventative care services, and system recovery in the wake of the COVID-19 pandemic (0:50). The conversation then moves to the impact of these trends (04:24), including the need to change strategies to capitalize on telehealth opportunities and proactively work to mitigate long-tail effects of missing key preventative care measures like mammograms, colonoscopies, prostate exams, and childhood vaccinations. The interview closes with a call for provider organizations to be proactive, mobile, and agile in patient engagement and future care delivery (6:20)
As 2020 winds down, we want to look to the year ahead. In this minisode, we sit down with Vynamic’s Life Sciences Sector Advisor, Karen Baldry, to discuss the trends she sees being the most impactful in 2021. The episode opens with a discussion of the COVID-19 vaccine and the shift in focus from clinical trials to supply, distribution, pricing, and access (01:15). Even after a vaccine is available, life sciences organizations will likely still see long term impacts of the pandemic across the business (01:52), with digital becoming an increasing area of concentration and innovation (02:15). The conversation then moves to the impact of these trends (03:00), including changes to future vaccine and drug development, interactions with HCPs (04:05), and investment in omnichannel (5:04). The interview closes with the hope that learnings from 2020 unlock new opportunities for life sciences companies and organizations across the entire healthcare industry (6:09).
The 2020 election saw historic turn out with over 62% of the eligible voting population and more than 148 million votes cast. Healthcare was a key issue this election, particularly given candidates’ divergent policies and the increased attention on public health during the current COVID-19 pandemic. The episode opens with a discussion of what a Biden presidency could mean most immediately for the healthcare industry (01:11), from a more federally-driven approach to managing the pandemic, to reversing President Trump’s decision to leave the World Health Organization, to expanding funding for mental health services and the 21st Century Caregiving Workforce. At (04:09), the conversation shifts to a wider perspective of Biden’s healthcare agenda, from building off the Affordable Care Act to expand access and affordability in the modern healthcare ecosystem, to reversing some of President Trump’s healthcare executive orders and increasing awareness of the ACA marketplaces. With run-off elections in Georgia likely to determine the Senate majority, the President-Elect will need to be thoughtful in his cabinet selections (08:30) and which levers he can pull to impact healthcare change outside of congressional channels (10:00). However, there is no escaping that core components of his agenda require Senate cooperation, such as adding a public option, allowing CMS to negotiate directly with drug manufacturers, and increasing the premium tax credits (10:52). Adding to the uncertainty over what a Biden administration will be able to accomplish from their healthcare agenda is the looming Supreme Court ruling on the Affordable Care Act (12:46). Unwinding the ACA would have far-reaching implications across the healthcare industry, from individual coverage to value-based care to biosimilars approval (13:55). Scenario planning will be key for healthcare organizations as they navigate the uncertainty around the severability of the individual mandate (16:37); however, recent events have shown the strength of the ACA marketplaces even in the absence of a functioning federal mandate (17:56). Anticipation is high to see just what next year’s run-offs and Supreme Court rulings mean for Biden’s policy and healthcare industry.
As 2020 winds down, we want to take a look at the year ahead. In this minisode, we sit down with Vynamic’s Public Health Sector Advisor, Mindy McGrath, to discuss the trends she sees being the most impactful in 2021. The episode opens with a discussion around the uncertainty of the Affordable Care Act (01:06) and the CMS commitment to total value reimbursement (02:40). An increasing push toward interoperability and data sharing (03:48), accelerated FDA approvals (04:54), and the incorporation of social determinants into public health policy and practices (05:30) are also notable trends. The conversation closes (07:05) with a discussion of the potential impact of these trends.
The COVID-19 pandemic has spread to more than 33 million people worldwide, sending the healthcare industry racing to find a safe and effective vaccine. With over 42 candidates now in human trials, the conversation is evolving from not only when a vaccine(s) will be available, but also how those vaccines will be distributed to effectively halt the spread of the virus. The episode opens with a discussion of the changes to the traditional vaccine development process being undertaken to meet the objectives of Operation Warp Speed and (05:11) the potential long-term impacts it could have on future vaccines. At (07:18), the conversation shifts to a discussion of potential challenges for local health organizations developing and executing COVID-19 vaccine distribution plans – from storage requirements (08:39), to the need for consecutive doses (10:15), to difficulties of reaching underserved patients (10:54). Innovative partnerships (12:00) will be critical in ensuring widespread distribution, the spread of public health information, and ensuring patient compliance (13:00). Capacity planning (13:17) and provider recruitment (13:38) will be critical as demand and scope change from phase to phase of distribution. The conversation closes (14:13) with a discussion of how public health providers, health plans, and other industry players might encourage adoption of future COVID-19 vaccines, the importance of building public trust in the safety of the vaccines being brought to market, spreading information on when and how to receive the vaccine (16:28), and communicating the long-term efforts that will be required to bring the virus under control (18:17). Based on public opinion polls (19:50), there will certainly be a need for public education on (21:03) potential side effects, (21:55) the risk/benefit ratio, and (23:05) the long-term safety protocols in place in order to ensure widespread adoption of a COVID-19 vaccine.
Introducing Season 2 of Trending Health. Over the last year we’ve featured entrepreneurs and experts from across the healthcare industry, covering topics from AI, telehealth, and cloud pharmacy, to organizational culture, design thinking, and innovation. Check out the episode to hear what will be new in Season 2!
On this bonus episode we dive deeper into the topic of digital pharmacies. The often confusing world of prescription drug pricing is experiencing revolutionary change. As digital and cloud solutions enable new online pharmacy service offerings to emerge, new ways for consumers, patients, and providers to open the curtain to lower prices for medications are being created. Friend of Vynamic Albie Salvatore, VP of Clinical Technology Sales at Blink Health joins us to chat about this topic and how his organization is providing services to help lower cost and improve access.
Digital solutions have been a cornerstone of Life Sciences marketing efforts for some time. Will that continue and how do Life Sciences organizations utilize digital to enhance customer experience? On this bonus episode of Trending Health we take a deeper look at this topic with friend of Vynamic Ryan Billings, Head of US Oncology Digital Marketing & Customer Experience at GSK. With many years of social media and digital experience spanning across various healthcare organizations, Ryan shares the interesting evolution, opportunities, and challenges in digital.
On this bonus episode we dive deeper into the topic of entrepreneurial methodologies and idea harvesting within healthcare organizations. While medication is meant to help in the treatment of people, the combination of highly sensitive medicines, complex workflows, and disparate technology platforms can risk patient safety and present avoidable costs for healthcare organizations. We are joined by friend of Vynamic Sean O'Neill to chat about this topic and how his organization, Bainbridge Health, is providing services to hospitals to enhance medication data.
On this episode we are looking at the topic of entrepreneurial methodologies and idea harvesting within healthcare organizations. As competitive pressures escalate in the search for value and new entrants come to the market offering disruptive solutions to try and address access, quality, cost, and improved consumer experience, opportunities exist within all healthcare organizations to adopt entrepreneurial methodologies that could pave the way to future growth. To help us dive into this topic is friend of Vynamic and thought expert Patrick FitzGerald, President & CEO of TFC Ventures Group.
Right now, countless initiatives between innovators, health systems, and public health organizations are being adopted in an effort to expand access to affordable, quality healthcare and improve health outcomes for patients around the world. In this episode of Trending Health, we talk to Vynamic partner Innovations in Healthcare and Duke Global Health Innovation Center about their aim to improve healthcare worldwide by supporting the scale and impact of promising innovations. Friend of Vynamic Lisa Bourget, Senior Director, Strategy, Management and Partnerships at Duke Global Health Innovation Center shares more on the promising new strategies underway to address global health challenges.
When we think about HIV, what do we associate with it? Many of us will think about the AIDS epidemic in the US that took off in the 1980s, or perhaps the tangential relationship with the LBGQT community. While tremendous progress has been made in the science of HIV treatment through the development of better anti-retroviral therapies which have significantly reduced AIDS-related deaths and improved long-term health outcomes for people living with HIV, stigma continues to exist. Today, we’re going to take a closer look at HIV and how advocacy efforts continue to address associated stigma.
We are taking a deeper look at this topic with friend of Vynamic Greg Langan, Program Manager for the South Jersey Regional Partner of the Northeast/Caribbean AIDS Education & Training Center. Greg holds a Master’s Degree in Social Work and Master’s Degree in Public Health from Temple University. In addition, he is an Adjunct Professor of Health Communication with The College of New Jersey. As a self-identified cisgender gay man, his passions reside in stigma reduction and the elimination of health disparities for folks within the LGBTQ community.
Design thinking may be one of the hottest buzzwords echoing throughout the halls of the business and technology worlds today, but the concept is not new. Since the late 1950s, designers of products of all types have employed and adhered to principles of design thinking like empathy, prototyping, co-creation, and user-centricity to create technical and physical products we all use today. Recently, as the gap between patient and healthcare companies has narrowed, the life sciences sector has shown a heightened interest in applying design thinking to the products and services they create and offer. To dive deeper into this topic I am joined by our resident expert Mike Cottone, a Director at Vynamic.
Nimble innovation has accelerated in the face of the coronavirus pandemic. The collective response to the crisis has inspired an outpouring of creativity and ingenuity as individuals and organizations are innovating overnight to respond to the challenges this crisis presents. In this episode, we’re discussing some of these innovations and the people and organizations behind these incredible efforts.
The onset of COVID-19 and its rapid spread across the globe presents uncertainty today. As measures like social distancing settle into everyday life, businesses are contending with a myriad of decisions about when and how to move forward thoughtfully to ensure their employee’s health, safety and wellbeing along with business livelihood. In this episode we are discussing the considerations of a phased approach to re-entry in the workplace.
The rapidly evolving coronavirus pandemic is a public health crisis. It has highlighted both the powerful spirit of partnership to respond and the fragmented nature of healthcare today. In this special episode we're sharing our initial observations and reflections including how the pandemic may impact the future of the healthcare industry.
With approximately 62 million Americans (1 in 5) living in rural areas, time can be a critical factor in treating individuals suffering from acute conditions like strokes. Telehealth has become a cornerstone of delivery options in the healthcare industry, and while many associate this technology with more basic primary care services, the market has evolved with a focus on life-saving delivery services such as telestroke support between specialists and hospitals. On this month’s episode we speak with Dr. Rajiv Narula, Co-Founder StatSeva, and Former Director of Teleneuroscience at Cooper University Hospital about the advancements in telehealth and how health systems can adopt it in specialty areas. Listen now and subscribe to Trending Health at trendinghealth.com.
Poor financial health can lead to poor mental and physical health. Poor health can drastically increase medical expenses, which deplete savings and increase debt. While social determinants of health has emerged as a topic of significant discussion in the healthcare industry, its intersection with financial health has not frequented as many discussions. To help us better understand the importance and challenges of this connection, we’re joined by Peter Rubenstein, Founder of About Financial Health and a financial health innovator. Listen to the latest episode and subscribe to Trending Health at trendinghealth.com.
Lean leadership and transformation in the healthcare industry is no longer isolated to manufacturers as organizations seek to transform their business into nimble operating models that focus on high quality and high value outcomes. In this episode of Trending Health, we are joined by Friend of Vynamic, Hugh McGill, Founder and Principal of Powerful Results, to discuss the creation of healthy cultures through lean transformation and the climate of change within the healthcare industry that aligns with lean transformation efforts.
Technology advancements such as Artificial Intelligence are enabling the rapid growth of remote health and greater opportunity to provide global access to care. In this episode of Trending Health, we are joined by Christina Hu, Product Manager of AI for Babylon Health, to discuss how AI is powering delivery of care and self-care models globally.
Studies by the U.S. Centers for Disease Control and Prevention and others demonstrate that well-being — a combination of physical, mental, and spiritual health — is of primary importance in the workplace. Establishing a culture of health and well-being continues to garner the commitment and attention of organizations and we are exploring it further in this Trending Health episode. To help us dive into this topic Dr. Heather Farley, Chief Wellness Officer at Christiana Care Health System, is joining us to discuss why healthy culture and well-being matters.
The Electronic Health Record (EHR) is receiving considerable attention as efforts by Providers and other sectors are underway to extend capabilities and value far beyond their original intent. In this episode we are diving into the topic of looking "Beyond the EHR" and clinical data to explore how healthcare organizations are wrapping solutions around the EHR and discussing trends that not many are thinking about. To help us dive into this topic, we’ve invited Friend of Vynamic, Shahrukh Tarapore, Arc Web Technologies Head of Engineering.
Clinical research development has long been targeted as an area of opportunity for pharmaceutical companies and investigator sites to find more efficient methods of adoption to drive success in commercializing a product. Friend of Vynamic, Amy Nordo joins us on this episode as we dive into the topic of Clinical Trials and how innovation is making its way into this critical function between a pharmaceutical company and the provider settings.
Resources
Mindy discussed an article published by Kaiser Health News entitled “Death By 1,000 Clicks: Where Electronic Records Went Wrong.” The article provides an evaluation on the growth of the EHR industry as part of the Digital Revolution.
https://khn.org/news/death-by-a-thousand-clicks/
Ryan discussed the news coming from the Cleveland Clinic of the first baby in North America delivered by a mother who received a uterus transplant from a deceased donor.
https://health.clevelandclinic.org/for-the-first-time-in-north-america-woman-gives-birth-after-uterus-transplant-from-deceased-don
In 2017 the US spent an estimated 450 billion dollars on prescription drugs, about 12% of the total healthcare spending. With public and political uproar surrounding the life sciences industry pricing practices, we ask “why is drug pricing so complicated?”. In this episode, we’ll discuss drug pricing and, more specifically, explore the question of why prices are so high. The panel will discuss why drug pricing is so complicated and why proposed efforts to drive down costs may have unintended and undesired effects.
Resources
Mike discussed a recent episode of the Verdict podcast in which they discussed a recent study regarding a machine learning algorithm that is able to predict heart attacks and death from heart disease with 90% accuracy, overtaking human practitioners.
https://www.verdict.co.uk/machine-learning-predicts-heart-attacks/
Mindy discussed an article in Health Affairs entitled “The Administration’s Drug Rebate Reforms: Four Implementation Questions That Will Influence Whether Drug Costs Fall”. The article focused on the impact that the Blueprint has on Medicare Part D plans, disruption of Part D enrollment, how CMS ensures point of care discounts and whether Medicaid recipients will receive any benefit.
https://www.healthaffairs.org/do/10.1377/hblog20190418.520197/full/
Ryan highlighted a Rueters article about the higher likelihood of physicians recommending cancer screenings during morning appointment times.
https://www.reuters.com/article/us-health-primary-care-screening/during-a-m-appointments-doctors-more-likely-to-advise-cancer-screening-idUSKCN1SG2AE?feedType=RSS&feedName=healthNews
Recent policy discussions have centered on the headline of Medicare for All. What does Medicare for All really mean? In short, the proposed policies mean many things to many people. In today’s episode, we are chatting about Medicare for All. Just in time for the kick off to primary season we will provide you with insight into the various proposals and the potential impacts. And stay tuned for our parting thought – its that thing that we have either read, heard or seen that we recommend to you.
Resources
https://en.wikipedia.org/wiki/Medicare_(United_States) https://en.wikipedia.org/wiki/Medicare_(United_States)#cite_note-1
https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/ReportsTrustFunds/downloads/tr2018.pdf
https://www.kff.org/health-reform/poll-finding/kff-health-tracking-poll-january-2019/
Mike discussed a podcast series called “50 Things That Made The Modern Economy”. A recent episode discusses the invention of penicillin. Listen to Antibiotics from 50 Things That Made the Modern Economy in Podcasts.
https://podcasts.apple.com/us/podcast/50-things-that-made-the-modern-economy/id1172889381?i=1000380211032
Mindy discussed a recent article in Modern Health entitled “CMS to launch new direct-contracting pay models in 2020” and the continued efforts of the Center for Medicare and Medicaid Services to pivot reimbursement from fee-for-service into more value-driven models. CMS' Innovation Center is introducing new voluntary innovation models called under CMS Primary Cares, an initiative that provides primary care practices with five new payment options, including three direct contracting models. All of the new model options link performance to payments, to varying degrees. The article provided insight into the various models and associated timelines.
https://www.modernhealthcare.com/payment/cms-launch-new-direct-contracting-pay-models-2020?utm_source=modern-healthcare-am-tuesday&utm_medium=email&utm_campaign=20190423&utm_content=article1-readmore
Ryan discussed the recent Measles outbreak and why adults who are vaccinated may need it again.
https://www.reuters.com/article/us-usa-measles/u-s-measles-outbreak-raises-questions-about-immunity-in-adults-idUSKCN1S40GI?feedType=RSS&feedName=healthNews
Clinical Research is traditionally thought of as an opportunity belonging to Academic Medical Centers. In this release of our Hi 5 podcast episode you will understand what clinical research is, the benefit and the challenge, but more importantly, why both sponsored and non-sponsored research should be considered a focus for all hospitals, not just AMCs. Our guest, Shirley Trainor-Thomas, President and Principal Strategist at Phase Up Research also shares her thoughts on how hospitals can evaluate clinical research as a strategic opportunity.
Resources
https://www.kubotaholdings.co.jp/en/ir/docs/20180517E.pdf
http://www.ndcenterfornursing.org/wp-content/uploads/2013/02/Comparison-of-QI-EBP-and-Nursing-Research-Final-Document.pdf
https://www.americannursetoday.com/quality-improvement-research/
Mindy recommended reading a recently published article from Modern Healthcare entitled “Why Prescription Drug List Price Matters.” The national conversation on drug list price has focused on the rebate structures that exist throughout the pharmacy supply chain. The article dives into an often-missed element of why prescription drug price matters – the changing benefit construct.
https://www.modernhealthcare.com/technology/why-prescription-drug-list-prices-matter
Ryan discussed a recent New York Times article pertaining to the revolutionary progress on HIV treatment and what this means in possibly advancing medicines and treatment beyond disease progression.
https://www.nytimes.com/2019/03/08/health/hiv-aids-research.html
Effective doctor-patient communication is a central clinical function in building a therapeutic doctor-patient relationship, which is the heart, and some would say the art of medicine. The panel is joined by Vynamic colleague & guest, Deepa Mischler, to discuss the "how" around improving provider/patient interactions, and friend of Vynamic, Mike Puchtler, VP Patient Experience at Christiana Care Health System. Mike’s focus is in driving excellence in patient experience at Christiana and we can’t think of a better guest to join us in this conversation.
Resources
http://www.medxm1.com/3-studies-show-patient-physician-interaction-affects-health-outcomes/
Mike discussed the development of an augmented reality headset by Apple and the variety of applications in the healthcare industry.
https://apple.news/AE95GZR0uSrCgO2xPuKkyFw
Mindy mentioned a recent report released by Medscape regarding physician burnout and some key attributes that were cited in the study as major causes to a problem that is plaguing the healthcare industry.
https://www.medscape.com/slideshow/2019-lifestyle-burnout-depression-6011056
Ryan discussed a recent University of Penn study around the significant increase in broken bones in the elderly, due in large part to dog walking!
https://www.sciencedaily.com/releases/2019/03/190306110620.htm
The strategic process of establishing a plan that maximizes the value of a brand has been practiced in similar fashion for, well, a long time. As the healthcare landscape changes, the question the team discussed is whether the brand planning process needs to change and what are the opportunities for improvement? We will discuss the practice that Life Science brand teams employ and generally, what is and isn’t working in the process.
Resources
Mindy discussed a recent article published in Fierce Healthcare that announced the addition of Aetna and Ascension Health to the blockchain-focused alliance, Synaptic, that was initiated in 2018.
https://www.fiercehealthcare.com/tech/aetna-ascension-join-blockchain-alliance-targeting-provider-directories
Ryan discussed an interesting statistic published in Reuters regarding the high number of foreign-born individuals employed in a variety of healthcare industry roles in the United States.
https://www.reuters.com/article/us-health-professions-us-noncitizens/u-s-relies-heavily-on-foreign-born-healthcare-workers-idUSKBN1O32FR
The adoption of Electronic Health Records (EHR’s or EMR’s) has been, like many healthcare solutions, a revolution, with implementations happening in an extremely rapid fashion. And there are no plans on it slowing down. We discuss whether the Electronic Health Record is structured to be the ultimate gatekeeper in the industry. And joining us is guest, Chris Notti, Chief Information Strategist for Jefferson Health System to dig into the good, bad, and potential of EHRs.
Resources
According to the Grand View Research group, the EHR market will total $33.41 billion —by 2025. The growth in market size indicates a dramatic increase.
https://www.grandviewresearch.com/press-release/global-electronic-health-records-market
There are visceral reactions to the use of EHRs. While many physicians understand the need for electronic health records, there are equally as many reasons why physicians detest the solutions they are required to use. In his article, "Why Doctors Hate Their Computers," Atul Gawande, MD and current CEO of the Amazon/Berkshire Hathaway/JP Morgan Chase initiative, shares his argument that screens are taking a toll on the physician/patient relationship.
https://www.newyorker.com/magazine/2018/11/12/why-doctors-hate-their-computers
In one of the largest IT contracts in the government, The Department of Veterans Affairs has taken the initiative of replacing its’ legacy Vista EHR platform with the implementation of Cerner’s solution.
https://www.beckershospitalreview.com/ehrs/10-ehr-implementations-with-the-biggest-price-tags-in-2017.html
Mindy discussed an article from the Wall Street Journal on a hospital bed manufacturer’s adoption of sensors to enhance patient monitoring and notifications during a hospital stay.
https://www.wsj.com/articles/hospital-beds-get-digital-upgrade-1544371200?utm_campaign=KHN%3A%20Daily%20Health%20Policy%20Report&utm_source=hs_email&utm_medium=email&utm_content=68184501&_hsenc=p2ANqtz-_MDNrZDw1PKUjTRyJQ6jcYTclYLZZAwI1ZbrgRb9HsIAGgqxRIqdqLVQx9beyIPnJlyre9jwnYsRatpbaKQHpRLi_4Kg&_hsmi=68184501
Ryan discussed a recent CMS report detailing a lower than expected growth trajectory in key US health expenditure categories such as clinical services and prescription drug services.
https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/highlights.pdf
Digital technologies are all around us, permeating the way we work, play, and live. The team discusses the various ways in which healthcare enterprises are adopting digital solutions and the resulting impact in the healthcare industry.
Resources
https://www.forbes.com/sites/bernardmarr/2018/05/21/how-much-data-do-we-create-every-day-the-mind-blowing-stats-everyone-should-read/
https://medium.com/@astorya_vc/digital-health-how-technology-could-reshape-health-insurance-9e066041826d
https://www.healthedge.com/three-cs-digital-health-plan
https://sph.unc.edu/cphm/how-has-digital-technology-changed-public-health/
https://davidleescher.wordpress.com/2016/11/28/five-public-health-needs-for-digital-health-technology/
https://getreferralmd.com/2018/01/future-healthcare-technology-advancements-2018/
https://medium.com/datavant/the-health-analytics-ecosystem-af13c2f0052
Blockchain is entering common discussions in the healthcare industry. This emerging technology offers tremendous hope to addressing some of the largest issues in the healthcare industry including efficiency & privacy. How soon can we expect to see this hit mainstream? The panel discusses timing and use cases for Blockchain technology across the healthcare system.
Resources
Mindy discussed the FDA’s interest in Artificial Intelligence and the agency’s initiation of their tech incubator for AI innovation.
https://www.fda.gov/NewsEvents/Speeches/ucm605697.htm
Ryan discussed a recent study that was published in Science Daily about the utilization of Artificial Intelligence in advancing the diagnosis of Alzheimer’s Disease.
https://www.sciencedaily.com/releases/2018/11/181106104249.htm
Mike referenced a recent NPR podcast episode about the balance of simplicity and complexity when it comes to organizational adoption of technologies.
https://www.npr.org/2018/08/27/642310810/you-2-0-check-yourself
In our fast-paced world, the healthcare industry is no different in its quest to quickly and successfully transition patients through their ‘continuum of care’. Unfortunately, many times there is a knowledge gap between patient/caretaker and their respective provider, nurse, or physician. In this episode, Vynamic tries to tackle these issues and discuss the differences between ‘lowercase a’ advocates, and “capital A” Advocacy to find some solutions to mitigate these risks. Special guest and friend of Vynamic, Dr. David Fajgenbaum, stops by to tell us his amazing story of advocacy around a disease that he was diagnosed with; one that almost killed him.
Resources
https://www.ncbi.nlm.nih.gov/pubmed/24841071
http://www.commonwealthfund.org/~/media/files/publications/case-study/2009/jun/1278_mccarthy_kaiser_case_study_624_update.pdf.
https://www.scitechnol.com/peer-review/patient-navigators-as-essential-members-of-the-healthcare-team-a-review-of-the-literature-V2aY.pdf
https://www.academyhealth.org/files/RapidEvidenceReviewConsumerEngagementFinal2.pdf
The rise of the empowered consumer is a trend healthcare organizations are trying to better understand in the context of putting the consumer in the center of healthcare. But how real is consumerism in the industry and has it had an impact? Ryan, Mindy, Mike, and guest Kristen Sherman debate what is working and what is not when it comes to empowering individuals. And stay tuned to the episodes parting thought.
Resources
https://www.kff.org/health-costs/report/2017-employer-health-benefits-survey/view/print/
http://www.healthleadersmedia.com/finance/consumerism-growing-rapidly-putting-more-demands-providers
https://www.strategyand.pwc.com/media/file/The-birth-of-the-healthcare-consumer.pdf
https://medcitynews.com/2015/11/patient-healthcare-consumer/
https://www.wsj.com/articles/can-consumers-be-smart-health-care-shoppers-1491962640
https://www.realclearhealth.com/articles/2018/05/03/empowered_patients_are_the_future_of_health_care_110784.html
https://www.ctpost.com/news/article/Murphy-Merkley-bill-would-expand-Medicare-12845530.php
https://catalyst.nejm.org/consumerism-in-health-care/
Mindy, Ryan, and Mike discuss the powerful trends at work globally, forcing changes in how healthcare will be conceived and delivered in the future. In an interview, Sylvia Twersky, PhD, Temple University, discusses the relevant and intriguing trends across the healthcare industry.
Resources
https://www.chcs.org/highlight/accountable-care-organizations-in-2016-private-and-public-sector-growth-and-dispersion/
https://www.pcpcc.org/resource/national-scorecard-and-compendium-payment-reform
https://bipartisanpolicy.org/topics/health/
https://www.kff.org/health-costs/report/2017-employer-health-benefits-survey/
https://rockhealth.com/research/#data
https://www.kff.org/private-insurance/report/medical-debt-among-people-with-health-insurance/
http://theonebrief.com/cracking-the-code-of-rising-health-costs/
http://www.healthleadersmedia.com/health-plans/amazon-pouring-gasoline-fire-health-plans-must-respond?utm_source=edit&utm_medium=ENL&utm_campaign=HLM-HP-SilverPop_02142018&spMailingID=12932271&spUserID=MTY3ODg4NjU5MDM1S0&spJobID=1341293074&spReportId=MTM0MTI5MzA3NAS2&page=0%2C1
Disruptive innovation are common terms being used to describe the state of the healthcare market. Looking beyond the hype, Vynamic discusses the management framework of Disruptive Innovation and why it is difficult to achieve in the colossal healthcare industry.
With Amazon diving head first into the healthcare market, it is no longer a question of will they but what this titanic organization will do to disrupt the healthcare industry. Mindy, Ryan and Mike debate how disruptive Amazon’s entry into the market may be and which sectors could be most impacted.
The CMS and FDA have been actively promoting proposed rule changes, rolling out new programs and adopting new technologies in an effort to advance the US healthcare system and modernize their agencies. From efforts to increase transparency, waivers to experiment, and adoption of Artificial Intelligence, these agencies are taking action. The team discusses some of these activities and what the impact could be to the healthcare industry.
The healthcare services industry is going through rapid change as a slew of giant companies propose deals that may result in new value propositions to healthcare stakeholders. The panel discusses the moves being made and whether vertical integrations will result in similar outcomes.
MACRA represents a transformative shift in the direction of physician payment, and will impact strategy across the provider community. CMS contends that parts of MACRA are working and parts need a redo. Do Mindy and Ryan agree? Is MACRA achieving its intended goals of improving quality and lowering costs? They will discuss the recently concluded “transition” year and what to expect in 2018.
Mindy and Ryan are joined by friends and colleagues, Karen Baldry & Chris Savage to debate why new medicines matter. With novel therapies addressing complex disease states that come with significant price points, the panel discusses why the launch of a new product is critical for life science organizations. The panel discusses what it means that an increasing number of launches fall into specialty markets and how launch practices are shifting to reflect new dynamics and complexity.
While much of the attention this year has focused on activity in the beltway, healthcare technology continues to introduce innovative and disruptive solutions and services that could offer transformational movement in the way that healthcare is conceived, delivered, accessed, and reimbursed. Mindy and Ryan discuss whether tech can heal the healthcare system with colleagues, Chrisna Govin and Sam Farmer.
In the inaugural episode, Mindy and Ryan discuss how home infusion therapy is part of the broader trend in delivering healthcare in the home to better meet the needs of patients. While many providers and pharmacies are interested in adopting this line of business, there are obstacles to consider. In an interview, guest Connie Sullivan, Vice President of Research and Innovation for the National Home Infusion Association joins us to share what she is observing in the home infusion industry.
Vynamic approaches the healthcare industry as five interwoven sectors, providing access to our unique perspective during a time of continuous change. There are many interesting activities in the healthcare industry that go beyond the headlines. The Hi 5 podcast shares our perspective on healthcare topics that are real, relevant and worth exploring.